CD20
Synonyms
B-lymphocyte surface antigen B1, MS4A1, B-lymphocyte antigen CD20, Membrane Spanning 4-Domains A1, Leukocyte Surface Antigen Leu-16, CD20 Antigen, CD20, Bp35, Membrane-Spanning 4-Domains Subfamily A Member 1, CD20 Receptor, LEU-16, CVID5, MS4A2, B1, S7, Antigens, CD20, Membrane-Spanning 4-Domains, Subfamily A, Member 1, B-Lymphocyte Cell-Surface Antigen B1,Description
B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes . Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR .
KO Status
F1 (+/-)
Drug Information
Launched drugs: 72
Drugs in clinical trials: 22
Latest Research Phase:Approved
Drug Name
Code
Phase
Company
Indications
Clinical Trials
Rituximab biosimilar (Mabion)
MabionCD-20
NDA/BLA
Mabion
Arthritis, Rheumatoid, Lymphoma, Large B-Cell, Diffuse
Rituximab biosimilar (Probiomed)
PBO-326
Approved
Probiomed
Arthritis, Rheumatoid, Lymphoma, Non-Hodgkin
NCT Number
NCT01277172
Intervention Type
Biological
Indications
Diffuse Large B Cell Lymphoma
Study Phase
Phase 2/Phase 3
Recruitment Status
Unknown status
Recombinant chimeric anti-CD20 monoclonal antibody (Sinocelltech)
SCT-400
NDA/BLA
Shenzhou Cell Engineering Co Ltd
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
NCT Number
NCT02772822
NCT02456207
NCT02206308
Intervention Type
Drug
Drug
Biological
Indications
Diffuse Large B Cell Lymphoma
B-cell Non Hodgkin's Lymphoma
B-cell Non Hodgkin's Lymphoma
Study Phase
Phase 3
Phase 2
Phase 1
Recruitment Status
Unknown status
Unknown status
Completed
Rituximab biosimilar (AryoGen Biopharma)
Approved
Aryogen Biopharma
Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Arthritis, Rheumatoid, Lymphoma, Non-Hodgkin
Rituximab-arrx (Amgen)
ABP-798, APB-798
Approved
Amgen Inc
Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT02003222
NCT01886872
NCT02792699
NCT02747043
NCT02048813
NCT03984448
NCT04404088
NCT01434472
NCT04155840
NCT02727803
NCT03856216
NCT00602459
NCT04216524
NCT04220008
NCT04285268
NCT03505762
NCT01424982
NCT04115631
NCT04047797
NCT01145495
NCT03749018
NCT04022239
NCT03704714
NCT03579927
NCT04323956
NCT03742258
NCT03991884
NCT04447716
NCT00880815
NCT04231877
Intervention Type
Procedure;Other;Biological;Drug
Other;Biological;Drug
Drug
Biological
Other;Biological;Drug
Biological;Drug
Biological;Drug
Procedure;Other;Radiation;Biological;Drug
Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Procedure;Biological;Drug
Other;Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Indications
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Arthritis, Rheumatoid
Lymphoma, Non-Hodgkin
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia; Lymphocytic Neoplasm; Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Blastic Plasmacytoid Dendritic Cell Neoplasm
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
B-Cell Non-Hodgkin Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Liver Lymphoma; Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
Aggressive Non-Hodgkin Lymphoma; ALK-Positive Large B-Cell Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Withdrawn
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Recruiting
Recruiting
Completed
Recruiting
Rituximab biosimilar (Siam Bioscience)
NDA/BLA
Siam Bioscience
Lymphoma, B-Cell
Rituximab biosimilar (Biosidus)
Approved
Biosidus
Hematologic Neoplasms
Rituximab biosimilar (Hetero Drugs)
Approved
Hetero Drugs
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Recombinant anti-CD20 monoclonal antibody (Geneky Biotech)
IND
Xinlitai (Chengdu) Biological Technology Co Ltd
Arthritis, Rheumatoid, Lymphoma
Rituximab biosimilar (Nichi-Iko Pharmaceutical/Aprogen)
AP-056
NDA/BLA
Nichi-Iko Pharmaceutical, Aprogen
Leukemia, Autoimmune Diseases, Rejection of organ transplantation, Lymphoma, Non-Hodgkin
Recombinant anti-CD20 humanized monoclonal antibody (Shanghai Crosslink Pharmaceutical)
IND
Shanghai Crosslink Pharmaceutical R & D Co Ltd
Rituximab biosimilar (Reliance Life Sciences)
R-TPR-017
Approved
Reliance Life Sciences
Arthritis, Rheumatoid, Lymphoma, Non-Hodgkin
Rituximab biosimilar (Center of Molecular Immunology)
Approved
Center Of Molecular Immunology
Lymphoma, Non-Hodgkin
Ocrelizumab
R-1594, RG-1594, PRO-70769, RO-4964913, rhuMab 2H7
Approved
Genentech Inc
Multiple Sclerosis, Relapsing-Remitting, Arthritis, Rheumatoid, Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive, Lupus Erythematosus, Systemic, Lymphoma, Non-Hodgkin
NCT Number
NCT04466150
NCT03589105
NCT03599245
NCT02688985
NCT04387734
NCT04261790
NCT03853746
NCT04650321
NCT04377555
NCT03535298
NCT04688788
NCT02545868
NCT03606460
NCT00476996
NCT04548999
NCT01247324
NCT00485589
NCT00406419
NCT02637856
NCT00673920
NCT03085810
NCT02980042
NCT00539838
NCT04035005
NCT01194570
NCT04544436
NCT00626197
NCT03691077
NCT04175834
NCT03523858
NCT02861014
NCT00779220
NCT03835728
NCT04075266
NCT00808210
NCT00676715
NCT00077870
NCT02723071
NCT03971487
NCT02720120
NCT03972306
NCT03593590
NCT04676555
NCT04640818
NCT03562975
NCT03344094
NCT04459988
NCT02807285
NCT03873389
NCT04519710
NCT03784547
NCT04448977
NCT04387110
NCT03025269
Intervention Type
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Diagnostic Test;Biological;Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Indications
Relapsing Multiple Sclerosis; Clinically Isolated Syndrome
Multiple Sclerosis
Multiple Sclerosis
Relapsing Multiple Sclerorsis; Multiple Sclerosis, Primary Progressive
Relapsing Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis
Multiple Sclerosis
Multiple Sclerosis, Relapsing
Multiple Sclerosis, Relapsing-Remitting
Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis; Primary Progressive Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis
Rheumatoid Arthritis
Multiple Sclerosis
Relapsing Multiple Sclerosis
Rheumatoid Arthritis
Rheumatoid Arthritis
Multiple Sclerosis, Relapsing-Remitting
Rheumatoid Arthritis
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis
Systemic Lupus Erythematosus
Multiple Sclerosis, Primary Progressive
Multiple Sclerosis, Primary Progressive
Multiple Sclerosis
Lupus Nephritis; Systemic Lupus Erythematosus
Multiple Sclerosis; Relapse; Primary Progressive Multiple Sclerosis
Multiple Sclerosis; Infusion Reaction
Progressive Multiple Sclerosis (PMS)
Multiple Sclerosis, Relapsing-Remitting
Rheumatoid Arthritis
Autoimmune Encephalitis
Multiple Sclerosis
Rheumatoid Arthritis
Multiple Sclerosis, Relapsing-Remitting
Rheumatoid Arthritis
Non-Hodgkin's Lymphoma
Schizo-Affective Type of Psychosis; Schizophrenia
Rheumatoid Arthritis
Multiple Sclerosis (MS)
Multiple Sclerosis
Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Multiple Sclerosis; Pathologic Processes; Demyelinating Diseases; Nervous System Diseases; Autoimmune Diseases; Immune System Diseases; Primary Progressive Multiple Sclerosis; Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis; Immune System Diseases
Multiple Sclerosis
Multiple Sclerosis
Multiple Sclerosis
HBV
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis; Clinically Isolated Syndrome
Multiple Sclerosis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Terminated
Recruiting
Active, not recruiting
Terminated
Terminated
Completed
Terminated
Active, not recruiting
Completed
Terminated
Recruiting
Active, not recruiting
Recruiting
Terminated
Recruiting
Recruiting
Recruiting
Active, not recruiting
Terminated
Completed
Recruiting
Terminated
Active, not recruiting
Completed
Completed
Recruiting
Terminated
Recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Unknown status
Recruiting
No longer available
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Enrolling by invitation
Rituximab biosimilar (Celltrion)
CT-P10
Approved
Celltrion
Microscopic Polyangiitis, Arthritis, Rheumatoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT02149121
NCT01886872
NCT02048813
NCT02260804
NCT02003222
NCT02162771
NCT03984448
NCT02727803
NCT01434472
NCT04216524
NCT04220008
NCT03749018
NCT04047797
NCT01145495
NCT04285268
NCT02339922
NCT04627753
NCT04115631
NCT03505762
NCT04404088
NCT01424982
NCT04155840
NCT00602459
NCT04421560
NCT03704714
NCT03579927
NCT04022239
NCT02628405
NCT02160015
NCT04231877
NCT03321643
NCT04447716
NCT01534884
NCT01829568
NCT03991884
NCT00880815
NCT03220022
NCT03440567
NCT04323956
NCT04156828
NCT01873443
NCT03742258
NCT01534949
NCT01695941
NCT04268277
Intervention Type
Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological
Procedure;Other;Biological;Drug
Biological;Drug
Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Procedure;Other;Radiation;Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Drug
Other;Biological;Drug
Procedure;Biological;Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Biological
Other;Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Other;Biological;Drug
Procedure;Other;Biological;Drug
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Biological
Other;Biological;Drug
Drug
Indications
Rheumatoid Arthritis
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Follicular Lymphoma
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Lymphoma, Follicular
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Blastic Plasmacytoid Dendritic Cell Neoplasm
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Chronic Lymphocytic Leukemia; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
Primary CNS Lymphoma
Liver Lymphoma; Mantle Cell Lymphoma
B-Cell Non-Hodgkin Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Primary Central Nervous System Lymphoma; Recurrent Cancer
Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma
Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Aggressive Non-Hodgkin Lymphoma; ALK-Positive Large B-Cell Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma; Richter Syndrome; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Rheumatoid Arthritis
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Mantle Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Grade 3b Follicular Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Non-Hodgkin's Lymphoma
Rheumatoid Arthritis
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma
Marginal Zone Lymphoma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
Recruitment Status
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Withdrawn
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Not yet recruiting
Recruiting
Recruiting
Recruiting
Completed
Recruiting
Terminated
Active, not recruiting
Not yet recruiting
CD20-directed CAR-T cell therapy (Tongji Hospital)
C-CAR066
Tongji Hospital
NCT Number
NCT04316624
NCT04036019
Intervention Type
Drug
Biological
Indications
Diffuse Large B Cell Lymphoma
B Cell Lymphoma
Study Phase
Phase 1
Phase 1
Recruitment Status
Recruiting
Recruiting
Rituximab biosimilar (Pfizer)
PF-5280586, PF-05280586
Approved
Pfizer Pharmaceuticals Ltd (China)
Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Arthritis, Rheumatoid, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Pemphigus
NCT Number
NCT02003222
NCT02048813
NCT01886872
NCT02213263
NCT03984448
NCT02727803
NCT03505762
NCT01424982
NCT04115631
NCT02339922
NCT04216524
NCT01434472
NCT04404088
NCT00602459
NCT01145495
NCT04220008
NCT04047797
NCT01526057
NCT03749018
NCT04285268
NCT02628405
NCT04022239
NCT03704714
NCT03579927
NCT03742258
NCT03440567
NCT03321643
NCT02160015
NCT01695941
NCT01829568
NCT04323956
NCT04447716
NCT03991884
NCT03220022
NCT00880815
NCT01643928
Intervention Type
Procedure;Other;Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological
Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Procedure;Other;Radiation;Biological;Drug
Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological
Biological;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Procedure;Other;Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Biological
Indications
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
B-Cell Non-Hodgkin Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Liver Lymphoma; Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
Blastic Plasmacytoid Dendritic Cell Neoplasm
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Rheumatoid Arthritis
Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Mantle Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma; Richter Syndrome; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
Recruitment Status
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Completed
Recruiting
Withdrawn
Recruiting
Recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Completed
Completed
rituximab biosimilar (Zenotech)
Approved
Zenotech Laboratories
Lymphoma, Non-Hodgkin
Rituximab biosimilar (Biocad)
BCD-020
Approved
Biocad
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT01759030
NCT01701232
NCT02744196
Intervention Type
Drug
Biological
Biological;Drug
Indications
Rheumatoid Arthritis
Follicular Non-Hodgkin's Lymphoma; Nodal Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Completed
Completed
Completed
Rituximab biosimilar (mAbxience)
RTXM-83, mAbx-02
Approved
Mabxience
Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT01886872
NCT02268045
NCT02003222
NCT02048813
NCT03984448
NCT03749018
NCT04155840
NCT04285268
NCT04115631
NCT04047797
NCT03505762
NCT01434472
NCT01145495
NCT04216524
NCT01424982
NCT02727803
NCT04220008
NCT04404088
NCT00602459
NCT04022239
NCT03704714
NCT03579927
NCT03742258
NCT04156828
NCT00880815
NCT03991884
NCT04323956
NCT04146103
Intervention Type
Other;Biological;Drug
Biological
Procedure;Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Other;Radiation;Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Procedure;Biological;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Drug
Indications
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Liver Lymphoma; Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
B-Cell Non-Hodgkin Lymphoma
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Blastic Plasmacytoid Dendritic Cell Neoplasm
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Grade 3b Follicular Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Non-Hodgkin's Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Benign Prostatic Hyperplasia
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
Recruitment Status
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Completed
Recruiting
Recruiting
Completed
Rituximab biosimilar (Intas Biopharmaceuticals)
Approved
Intas Biopharmaceuticals
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
TAT-014
BCIA-07, TAT-014
Preclinical
Tot Biopharm International Company Ltd
Lymphoma, Mantle-Cell
HSK-III-001
HSK-III-001
IND
Haisco Pharmaceutical Group Co Ltd
Hematologic Neoplasms
Hyaluronidase/Rituximab
Approved
Genentech Inc
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT03719131
Intervention Type
Biological;Drug
Indications
Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV; Stage III Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Unresectable Melanoma
Study Phase
Phase 2
Recruitment Status
Recruiting
Obinutuzumab
GA-101, R-7159, RG-7159, RO-5072759, B-HH6-B-KV1-GE, RG-7195
Approved
Genentech Inc
Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral, Solid tumours, Leukemia, Lymphoid, Lymphoma, Large B-Cell, Diffuse, Lupus Nephritis, Lymphoma, Follicular, Colorectal Neoplasms, Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Kidney Failure, Chronic
NCT Number
NCT03817853
NCT04221477
NCT04269902
NCT04629248
NCT03737981
NCT01010061
NCT03836261
NCT03492775
NCT03701282
NCT02264574
NCT01998880
NCT01287741
NCT02053610
NCT01905943
NCT03406156
NCT01659099
NCT04608318
NCT04702256
NCT01059630
NCT01332968
NCT02242942
NCT02475681
NCT01980875
NCT04408638
NCT03462719
NCT04285567
NCT02950051
NCT02846623
NCT03086395
NCT02987400
NCT02393157
NCT02962401
NCT04505254
NCT02666898
NCT02401503
NCT02320383
NCT03755947
NCT03276468
NCT02758665
NCT03410875
NCT04515238
NCT03145480
NCT04450173
NCT03824483
NCT03872180
NCT02983617
NCT02689869
NCT02445131
NCT02670317
NCT02320487
NCT03890289
NCT02896582
NCT02629809
NCT03311126
NCT03341520
NCT04639362
NCT02871219
NCT02550652
NCT01868893
NCT00576758
NCT03198026
NCT03332017
NCT03153514
NCT01414205
NCT04059081
NCT02867384
NCT02071225
NCT02498951
NCT03787264
NCT03679455
NCT03229382
NCT03580928
NCT04082897
NCT02750670
NCT03269669
NCT01889797
NCT02736617
NCT04703686
NCT04169737
NCT04447768
NCT03322865
NCT02225275
NCT02345863
NCT02495454
NCT02968563
NCT02371590
NCT03516617
NCT02420210
NCT01414855
NCT00517530
NCT03980171
NCT01582776
NCT01691898
NCT02427451
NCT02229422
NCT03010358
NCT02631577
NCT02529852
NCT01992653
NCT02558816
NCT01995669
NCT02596971
NCT03135262
NCT02055820
NCT02406742
NCT02391545
NCT02729896
NCT03671018
NCT02315768
NCT02257567
NCT02624986
NCT02336048
NCT04077723
NCT03223610
NCT04434196
NCT03533283
NCT03075696
NCT03432741
NCT02877550
NCT02569476
NCT03113695
NCT01644253
NCT02992522
NCT02611323
NCT04073147
NCT02611908
NCT02174172
NCT00825149
NCT04578600
NCT02457598
NCT04657302
NCT02296918
NCT03866239
NCT03759184
NCT02453087
NCT02586051
NCT02220842
NCT02324257
NCT01300247
NCT04313608
NCT04245722
NCT02292225
NCT02537613
NCT01671904
NCT04464798
NCT04246086
NCT02600897
NCT03039114
NCT04599634
NCT02417285
NCT02100852
NCT01685892
NCT01680991
NCT04023071
NCT02915224
NCT04034056
NCT03374137
NCT03059251
Intervention Type
Drug
Drug
Other;Biological;Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Radiation;Drug
Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Procedure;Biological
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Drug
Drug
Biological
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Indications
Advanced Follicular Lymphoma
Lupus Nephritis
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Primary Membranous Nephropathy
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia, Chronic
Chronic Lymphocytic Leukemia
Indolent Non-hodgkin Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Small-Cell Lymphoma
Lymphocytic Leukemia, Chronic
Diffuse Large B-Cell Lymphoma
Lymphocytic Leukemia, Chronic
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Diffuse Large B Cell Lymphoma CD20 Positive
Chronic Lymphoid Leukemia
Lupus Nephritis; Systemic Lupus Erythematosus (SLE)
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Lymphocytic Leukemia, Chronic
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; Recurrent Transformed Chronic Lymphocytic Leukemia; Refractory Transformed Chronic Lymphocytic Leukemia; Richter Syndrome; Small Lymphocytic Lymphoma
Post-transplant Lymphoproliferative Disorder; PTLD
Lymphoma, Large B-Cell, Diffuse
Non-Hodgkin Lymphoma; Burkitt Lymphoma; Diffuse Large B-Cell Lymphoma; Primary Mediastinal B-cell Lymphoma; CD20+ Lymphoblastic Lymphoma; Follicular Lymphoma, Grade III
Waldenstrom Macroglobulinemia
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Chronic Lymphocytic Leucemia
Chronic Lymphocytic Leucemia
B-Cell Chronic Lymphocytic Leukemia; B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
Follicular Lymphoma; Diffuse Large B Cell Lymphoma; Marginal Zone Lymphoma; Mucosa Associated Lymphoid Tissue
Leukemia, Lymphocytic, Chronic
Hairy Cell Leukemia; Leukemia; Leukemia, Hairy Cell
Chronic Lymphoid Leukemia
Richter Syndrome
Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Leukemia (SLL)
CCND1 Positive; Mantle Cell Lymphoma; t(11;14) Positive
Chronic Lymphocytic Leukemia
Indolent Non-Hodgkin Lymphoma
Chronic Lymphocytic Leucemia
Lymphoma, B-Cell
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Mantle Cell Lymphoma; Non-hodgkin Lymphoma; Non Hodgkin Lymphoma
Stage II Grade 1 Follicular Lymphoma; Stage II Grade 2 Follicular Lymphoma; Stage I Follicular Lymphoma Grade 1; Stage II Follicular Lymphoma Grade 2
CLL
Ann Arbor Stage II Grade 1 Follicular Lymphoma; Ann Arbor Stage II Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Bulky Disease; Fatigue; Fever; Grade 3a Follicular Lymphoma; Night Sweats; Splenomegaly; Weight Loss
Lupus Nephritis
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia; Richter's Transformation
Lymphocytic Leukemia, Chronic
Chronic Lymphocytic Leukemia
Graft vs. Host Disease
Chronic Lymphocytic Leukemia
Central Nervous System B-Cell Non-Hodgkin Lymphoma
Chronic Lymphoid Leukemia
Waldenstrom Macroglobulinemia
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia (CLL)
CLL Transformation
Lymphoma, Non-Hodgkin's
Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular Lymphoma
Indolent Non-Hodgkin's Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma Refractory; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Transformed B-cell Non-Hodgkin Lymphoma; Refractory Primary Mediastinal Large B-Cell Cell Lymphoma; Refractory Mantle Cell Lymphoma
Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia (CLL)
Marginal Zone Lymphoma
Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Chronic Lymphocytic Leucemia
CD20 Positive Diffuse Large B-cell Lymphoma; Elderly Unfit Patients
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
Lymphoma
Follicular Lymphoma
Follicular Lymphoma Patients (Phase IB); Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
Follicular Lymphoma; Diffuse Large B-Cell Lymphoma
Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
CLL
Anemia; B-Cell Prolymphocytic Leukemia; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Hairy Cell Leukemia; Lymphoplasmacytic Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Richter Syndrome
Lymphoma, Follicular
Lymphoma
Lymphoma, Non Hodgkin
Mantle Cell Lymphoma
Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Follicular Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma, Lymphoma Follicular
Follicular Lymphoma; Lymphoma, Large B-Cell, Diffuse
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell
CD20+ Follicular Lymphoma
Lymphoma
B-cell Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Lymphoma, Non-Hodgkin
Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Burkitt Lymphoma
Lymphoma, Non-Hodgkin
Non-Hodgkins Lymphoma
Non-Hodgkin's Lymphoma
Breast Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Nodal Marginal Zone Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Breast Cancer AJCC v6 and v7
Follicular Lymphoma
B-cell Lymphoid Malignancies
Richter's Syndrome; CLL
Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Transformed Recurrent Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Primary CNS Lymphoma
Chronic Lymphocytic Leukemia
Solid Cancers
Non-Hodgkin's Lymphoma
Indolent B-Cell Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Mucosa-Associated Lymphoid Tissue Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hairy Cell Leukemia; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Mucosa-Associated Lymphoid Tissue Lymphoma; Refractory Follicular Lymphoma; Refractory Hairy Cell Leukemia; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Small Lymphocytic Lymphoma
B-cell Malignancies
Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Prolymphocytic Leukemia
Colorectal Cancer
Leukemia; Lymphocytic; Chronic; B-Cell
Non-Hodgkin's Lymphoma
Kidney Failure, Chronic
Lymphoma
Solid Tumors
Lymphocytic Leukemia, Chronic
B-cell Lymphoma
Lymphoma, B-Cell; Chronic Lymphocytic Leukemia
Lymphocytic Leukemia, Chronic; Lymphoma, Small Lymphocytic
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Follicular Lymphoma
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Lymphoma
Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Chronic Lymphocytic Lymphoma; B-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia, Chronic
Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
Acute Myelogenous Leukemia; B-cell Lymphoma
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Chronic Lymphocytic Leukemia; Follicular Lymphoma
Chronic Lymphocytic Leukemia
Study Phase
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
N/A
N/A
N/A
Recruitment Status
Active, not recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Completed
Recruiting
Recruiting
Recruiting
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Not yet recruiting
Not yet recruiting
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Withdrawn
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Terminated
Not yet recruiting
Recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Recruiting
Recruiting
Terminated
Completed
Recruiting
Recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Terminated
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Completed
Terminated
Active, not recruiting
Withdrawn
Recruiting
Terminated
Completed
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Terminated
Completed
Completed
Terminated
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Terminated
Completed
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Suspended
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Suspended
Active, not recruiting
Recruiting
Withdrawn
Completed
Completed
Recruiting
Active, not recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Terminated
Active, not recruiting
Completed
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Active, not recruiting
Completed
Completed
Completed
Recruiting
Active, not recruiting
Recruiting
Recruiting
Completed
Rituximab biosimilar (Shanghai Henlius Biotech)
HLX-01
Approved
Shanghai Henlius Biotech Co Ltd
Lymphoma, B-Cell, Arthritis, Rheumatoid, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT04525729
NCT02787239
NCT03522415
NCT04671420
NCT04246359
NCT03355872
NCT02584920
NCT03218072
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
IgA Nephropathy
B-cell Non Hodgkin's Lymphoma
Moderately to Severely Active Rheumatoid Arthritis
CD20-positive Follicular Lymphoma, With Low Tumour Burden
Lymphoma, B-Cell
Rheumatoid Arthritis
B-cell Non Hodgkin's Lymphoma
B-cell Lymphomas
Study Phase
Phase 4
Phase 3
Phase 3
Phase 3
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Recruiting
Completed
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Ofatumumab
2F2, OMB-157, HuMax-CD2, GSK-1841157
Approved
Genmab
Leukemia, Arthritis, Rheumatoid, Lymphoma, Large B-Cell, Diffuse, Multiple Sclerosis, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Pemphigus
NCT Number
NCT04667117
NCT00802737
NCT01659021
NCT00748189
NCT01313689
NCT01200589
NCT02792231
NCT01077518
NCT01920477
NCT04486716
NCT04510220
NCT00603525
NCT02792218
NCT00824265
NCT04353492
NCT03650114
NCT01678430
NCT01039376
NCT02613910
NCT01612988
NCT01113632
NCT03560739
NCT01258933
NCT03136146
NCT01131247
NCT02394106
NCT03249714
NCT00494780
NCT00811733
NCT01078922
NCT02388048
NCT01563055
NCT01555541
NCT03488225
NCT01481272
NCT01361711
NCT01520922
NCT01243190
NCT00394836
NCT01626352
NCT01195766
NCT02710643
NCT01145209
NCT01363128
NCT01294579
NCT01286272
NCT01527149
NCT01497496
NCT01010568
NCT00410163
NCT01263418
NCT01239394
NCT02412267
NCT01455051
NCT02394119
NCT00622388
NCT00823719
NCT01171378
NCT01123356
NCT01465334
NCT02135133
NCT01191190
NCT01496976
NCT01024010
NCT01536067
NCT01195714
NCT01329900
NCT02877303
NCT01848145
NCT00349349
NCT01108341
NCT01187303
NCT01244451
NCT02199184
NCT01437709
NCT01002755
NCT01190449
NCT02689141
NCT01444716
NCT02419469
NCT01457924
NCT01613300
NCT00640328
NCT01397591
NCT01681563
NCT01762202
NCT01125787
NCT00291928
NCT01809847
NCT01376713
NCT00655824
NCT01060384
NCT01680965
NCT01221103
NCT01458366
NCT00093314
NCT00092274
NCT01515176
NCT01691807
NCT00686868
NCT00742144
NCT01110031
NCT01352312
NCT01768338
NCT02614508
NCT01088048
NCT01453062
NCT04676555
Intervention Type
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Drug
Other;Biological
Drug
Drug
Drug
Combination Product
Drug
Biological;Drug
Drug
Other;Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Procedure;Biological
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Procedure;Radiation;Biological;Drug
Procedure;Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Procedure;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological
Biological;Drug
Biological
Drug
Biological
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Procedure;Drug;Genetic
Drug
Drug
Other;Biological;Drug
Drug
Other;Drug
Drug
Biological
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Indications
Relapsing Multiple Sclerosis
Leukaemia, Lymphocytic, Chronic
Chronic Lymphocytic Leukemia
Leukaemia, Lymphocytic, Chronic
Leukaemia
Non-Hodgkin's Lymphoma
Relapsing Multiple Scelrosis
Lymphoma, Follicular
Pemphigus Vulgaris
Relapsing Multiple Sclerosis
Relapsing Multiple Sclerosis
Arthritis, Rheumatoid
Relapsing Multiple Sclerosis
Leukaemia, Lymphocytic, Chronic
Relapsing Multiple Sclerosis
Relapsing Multiple Sclerosis
Chronic Lymphocytic Leukaemia
Leukaemia, Lymphocytic, Chronic
Pemphigus
B-cell Chronic Lymphocytic Leukemia (B-CLL)
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Multiple Sclerosis
Leukemia; Lymphoma
Burkitt Leukemia; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Recurrent Acute Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Burkitt Leukemia; Recurrent Burkitt Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Acute Lymphoblastic Leukemia; Refractory Burkitt Leukemia; Refractory Burkitt Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Lymphoblastic Lymphoma
Chronic Lymphocytic Leukemia (CLL)
Nephrotic Syndrome
Relapsing Multiple Sclerosis
Lymphoma, Follicular
Waldenstrom Macroglobulinaemia
Non-Hodgkin Lymphomas
Leukemia, Lymphoblastic, Chronic
Leukaemia, Lymphocytic, Chronic
Diffuse Large Cell Lymphoma Relapsed/Refractory
Acute Lymphoblastic Leukemia in Remission; B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Diffuse Large B Cell Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL); Leukaemia, Lymphocytic, Chronic
Chronic Lymphocytic Leukemia
Lymphoma, Follicular
Diffuse Large B-Cell Lymphoma
Hodgkin Disease
Follicular Lymphoma, Grade 1; Follicular Lymphoma, Grade 2; Follicular Lymphoma Grade 3A
Small Lymphocytic Lymphoma; CLL (Chronic Lymphocytic Leukemia)
Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; Burkitt Leukemia; Burkitt Lymphoma; CD20 Positive; Childhood Acute Lymphoblastic Leukemia in Complete Remission; Lymphoblastic Lymphoma
Lymphoma, Non-Hodgkin
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Stage I Mantle Cell Lymphoma; Stage II Contiguous Mantle Cell Lymphoma; Stage II Non-Contiguous Mantle Cell Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Leukaemia, Lymphocytic, Chronic
Lymphoma, Non-Hodgkin; Lymphoma, Follicular; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Low-Grade; Lymphoma, Intermediate-Grade
Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma
Diffuse Large B-cell Lymphoma
Chronic Lymphocytic Leukemia
Nephrotic Syndrome
Lymphoma, Large-Cell, Diffuse
Lymphoma, Large-Cell, Diffuse
Richter's Syndrome
Chronic Lymphocytic Leukemia
CLL; SLL
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
CLL
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Waldenström Macroglobulinemia
Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma
Lymphoma
B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma
Chronic Lymphocytic Leukemia
Leukaemia, Lymphocytic, Chronic
Non-Hodgkin's Lymphoma (NHL)
Relapsed NLPHL
Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or; Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines
AIDS-Related Burkitt Lymphoma; Atypical Burkitt/Burkitt-Like Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Recurrent Acute Lymphoblastic Leukemia; Recurrent Burkitt Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Burkitt Lymphoma
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia; Fatigue; Fever; Hypogammaglobulinemia; Lymphadenopathy; Lymphocytosis; Night Sweats; Paraproteinemia; Small Lymphocytic Lymphoma; Thrombocytopenia
Lymphoma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma
Multiple Sclerosis
B-Cell Lymphomas
Multiple Sclerosis
Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
B-cell Lymphoid Leukemia; Young Patients
Chronic Lymphocytic Leukemia (CLL)
Arthritis, Rheumatoid
Chronic Lymphatic Leukemia
Stage III Melanoma; Stage IV Melanoma
Arthritis, Rheumatoid
Non-Hodgkin's Lymphoma
Chronic Graft Versus Host Disease
Lymphoma, Mantle-Cell
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Lymphoma, Follicular
Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia
Cancer
Arthritis, Rheumatoid
Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular
Leukaemia, Lymphocytic, Chronic
Chronic Lymphocytic Leukemia; B-Cell Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma
Leukaemia, Lymphocytic, Chronic
Relapsing Forms of Multiple Sclerosis
Study Phase
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
N/A
Recruitment Status
Not yet recruiting
Completed
Terminated
Terminated
Completed
Terminated
Completed
Terminated
Terminated
Recruiting
Not yet recruiting
Terminated
Completed
Completed
Recruiting
Recruiting
Unknown status
Terminated
Terminated
Terminated
Completed
Completed
Active, not recruiting
Recruiting
Withdrawn
Terminated
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Completed
Withdrawn
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
Active, not recruiting
Unknown status
Active, not recruiting
Withdrawn
Withdrawn
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Terminated
Completed
Completed
Not yet recruiting
Rituximab
R-105, RG-105, IDEC-102, IDEC-C2B8, RO-452294
Approved
Biogen Inc
Granulomatosis with Polyangiitis, Purpura, Thrombocytopenic, Idiopathic, Rejection of renal transplantation, Microscopic Polyangiitis, Rejection of liver transplantation, Lymphoma, Large B-Cell, Diffuse, Arthritis, Rheumatoid, Multiple Sclerosis, Lupus Nephritis, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Lymphoproliferative Disorders, Lymphoma, Non-Hodgkin, Burkitt Lymphoma, Nephrotic Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Pemphigus
NCT Number
NCT01358253
NCT00430352
NCT02714634
NCT01638715
NCT01280682
NCT00462345
NCT04033276
NCT02198248
NCT03598725
NCT00797810
NCT00199004
NCT02382575
NCT00504777
NCT02169219
NCT00131313
NCT02525172
NCT01271010
NCT02844322
NCT01124526
NCT00934648
NCT02328222
NCT00701129
NCT01056510
NCT00198978
NCT03164473
NCT00753597
NCT01283386
NCT02749292
NCT01312064
NCT03258866
NCT00908583
NCT00498368
NCT01088724
NCT00502853
NCT02526823
NCT00090038
NCT02858804
NCT02040116
NCT01382940
NCT02445586
NCT02731560
NCT03194321
NCT00476164
NCT00576433
NCT02571842
NCT00199082
NCT00466258
NCT02626845
NCT01000610
NCT02378298
NCT04542629
NCT00820469
NCT02844361
NCT00782821
NCT01768195
NCT01021735
NCT03535298
NCT01117129
NCT00168727
NCT02115997
NCT02314273
NCT04256252
NCT01765374
NCT01095172
NCT01000441
NCT00424502
NCT01593332
NCT00722137
NCT01732926
NCT02003222
NCT00209209
NCT02204982
NCT01324596
NCT01299857
NCT04688788
NCT02005471
NCT03994783
NCT00363636
NCT00909077
NCT02390869
NCT00209222
NCT01244958
NCT01731561
NCT02406092
NCT01118234
NCT00499018
NCT00981838
NCT01650701
NCT00052936
NCT03336333
NCT00054587
NCT02303119
NCT00381810
NCT02746744
NCT00784589
NCT02703272
NCT02576275
NCT01852435
NCT00625898
NCT00841945
NCT02304354
NCT02367040
NCT04529772
NCT00137995
NCT01449344
NCT02950155
NCT02772822
NCT03790293
NCT00003595
NCT02649504
NCT01697267
NCT00987389
NCT03942887
NCT01332994
NCT01126541
NCT02468791
NCT00088530
NCT00078949
NCT01350882
NCT01103388
NCT00103233
NCT01670812
NCT02268045
NCT00089115
NCT00921414
NCT00057343
NCT01613482
NCT00719472
NCT04494438
NCT00006721
NCT03295383
NCT02569996
NCT01974440
NCT00012051
NCT01886872
NCT02951156
NCT00004031
NCT01996865
NCT02097745
NCT00502840
NCT01478542
NCT02383589
NCT00748644
NCT03206671
NCT03018535
NCT00317096
NCT00320385
NCT00639366
NCT01085617
NCT01732913
NCT01955187
NCT00577161
NCT01938001
NCT01980888
NCT00404157
NCT00168740
NCT02137681
NCT00448279
NCT04578639
NCT01148446
NCT00169169
NCT02834468
NCT03018626
NCT00275054
NCT01066689
NCT02767674
NCT00266227
NCT00324831
NCT00004112
NCT00254163
NCT01117662
NCT00090051
NCT00578565
NCT00135499
NCT00422383
NCT00003440
NCT03274492
NCT02807103
NCT03318835
NCT00877214
NCT00112931
NCT00486759
NCT01701232
NCT00801281
NCT03443570
NCT02867553
NCT01506414
NCT01933711
NCT00003204
NCT03213977
NCT00144755
NCT01776840
NCT00430001
NCT00052923
NCT02994927
NCT01734057
NCT00645606
NCT01285765
NCT00005589
NCT01303887
NCT00578305
NCT02366663
NCT02586025
NCT02149121
NCT01987505
NCT00210353
NCT01808911
NCT04680962
NCT00278421
NCT02792699
NCT00006708
NCT00564512
NCT03501459
NCT00667251
NCT02006706
NCT00384111
NCT00180882
NCT00299130
NCT01609010
NCT02617485
NCT04384484
NCT00003150
NCT02950051
NCT01868269
NCT02531841
NCT03123718
NCT00992030
NCT01073163
NCT00991211
NCT00846157
NCT00269113
NCT01611090
NCT04075292
NCT01508468
NCT00028717
NCT00140582
NCT00769522
NCT04680052
NCT00554164
NCT03979456
NCT01134432
NCT01889069
NCT02514772
NCT01754714
NCT00799773
NCT01724021
NCT01461928
NCT02735876
NCT02423837
NCT00718549
NCT00312845
NCT01456351
NCT02990286
NCT00004179
NCT00288002
NCT00003280
NCT00344149
NCT01164098
NCT03899103
NCT01973387
NCT01181154
NCT01510184
NCT02054559
NCT02128061
NCT02842931
NCT00525616
NCT01476787
NCT01321541
NCT00327678
NCT00259974
NCT00443651
NCT04182204
NCT02165397
NCT00227695
NCT00118209
NCT01974518
NCT00278408
NCT01144364
NCT01662102
NCT00468546
NCT02433522
NCT00299104
NCT01759030
NCT01810393
NCT03312907
NCT02972840
NCT03112603
NCT02048813
NCT03010202
NCT01569295
NCT01539512
NCT00490139
NCT01525836
NCT01232556
NCT02162771
NCT03267433
NCT00770562
NCT00140595
NCT00637325
NCT01765842
NCT00774826
NCT02213263
NCT03263026
NCT01865110
NCT00329030
NCT00503425
NCT00060671
NCT02390362
NCT00515554
NCT03298698
NCT03372837
NCT00136552
NCT00281918
NCT00075946
NCT03078855
NCT00282347
NCT01649856
NCT03384277
NCT00877006
NCT02626455
NCT01272908
NCT00140660
NCT00115700
NCT02947347
NCT02229942
NCT00562965
NCT02285062
NCT02144012
NCT00272987
NCT00435955
NCT00064116
NCT00517218
NCT00816959
NCT01773616
NCT02320292
NCT02063685
NCT00513747
NCT02438982
NCT01200758
NCT02428751
NCT00400478
NCT00577993
NCT00355199
NCT04531865
NCT00502996
NCT02079532
NCT03180723
NCT01673295
NCT04285567
NCT00551239
NCT00384150
NCT04442412
NCT01855750
NCT03150693
NCT00854568
NCT02777736
NCT02162667
NCT00213512
NCT03829566
NCT00432653
NCT00565331
NCT00774202
NCT03117751
NCT02251964
NCT01748084
NCT00261118
NCT03002038
NCT00595335
NCT03593902
NCT00848692
NCT00425217
NCT01268033
NCT00641095
NCT00096460
NCT01716442
NCT00045877
NCT01862926
NCT00137969
NCT01805557
NCT00740948
NCT03984448
NCT00749112
NCT02405676
NCT01046825
NCT00147121
NCT01277172
NCT00087529
NCT03366272
NCT01180036
NCT04274257
NCT00580229
NCT00306670
NCT00697996
NCT02871869
NCT00104299
NCT00293072
NCT04668365
NCT00127569
NCT00669877
NCT02636322
NCT02007044
NCT02433795
NCT00309881
NCT00448019
NCT01307592
NCT01521689
NCT00788606
NCT04113226
NCT02789397
NCT00772655
NCT00669318
NCT01393756
NCT00444912
NCT01279616
NCT00079443
NCT00740415
NCT00492050
NCT00558220
NCT03943901
NCT00906841
NCT00191373
NCT03274375
NCT03620903
NCT00833534
NCT03069703
NCT00422942
NCT01001780
NCT00006669
NCT00472056
NCT00053027
NCT01818908
NCT00343447
NCT00286780
NCT03232307
NCT04375228
NCT01926639
NCT03789240
NCT02758925
NCT00086775
NCT01448096
NCT02157181
NCT02229149
NCT01040871
NCT00225875
NCT01116232
NCT01750697
NCT00104858
NCT00453102
NCT00242203
NCT00472225
NCT00193479
NCT04115631
NCT04224571
NCT01686165
NCT00436904
NCT00946374
NCT00433537
NCT00290511
NCT03623373
NCT00071955
NCT00069966
NCT00001805
NCT00895661
NCT00072449
NCT01206777
NCT02371161
NCT04138875
NCT01470456
NCT00254410
NCT00076752
NCT00310128
NCT02689921
NCT01810926
NCT01446562
NCT02060656
NCT01313611
NCT00812669
NCT00080847
NCT00863460
NCT01388959
NCT00038623
NCT01186458
NCT00250718
NCT00238238
NCT01576588
NCT00067002
NCT00265915
NCT00337246
NCT02259348
NCT04624958
NCT00114738
NCT04155840
NCT00080886
NCT01854372
NCT04659044
NCT00310037
NCT01359592
NCT01497275
NCT00720876
NCT01929265
NCT00869323
NCT04189952
NCT00940342
NCT01700946
NCT00093808
NCT00074490
NCT02633137
NCT03630042
NCT00028665
NCT01127841
NCT04025593
NCT00689169
NCT00490646
NCT00385125
NCT00381004
NCT00628238
NCT00050245
NCT00427856
NCT01235793
NCT00831597
NCT01737177
NCT01030900
NCT01625741
NCT01446900
NCT04337827
NCT00285389
NCT00504491
NCT00504751
NCT00478140
NCT01424982
NCT00115193
NCT02592876
NCT00274989
NCT01524068
NCT01811368
NCT00496340
NCT00834951
NCT02238509
NCT00003658
NCT00936546
NCT00759603
NCT00927797
NCT01472562
NCT00336843
NCT01830465
NCT00493467
NCT02142335
NCT03949855
NCT01208896
NCT01828736
NCT01662050
NCT00646750
NCT01216683
NCT01399372
NCT00145613
NCT01059786
NCT01812005
NCT02044822
NCT00278161
NCT00183976
NCT03194815
NCT00161564
NCT01748773
NCT02855359
NCT00093769
NCT03368131
NCT01329354
NCT01925612
NCT00989352
NCT00664521
NCT00427557
NCT01097057
NCT02531308
NCT01066429
NCT02260934
NCT01980654
NCT02631538
NCT00896519
NCT02900976
NCT00581776
NCT00020800
NCT01145495
NCT01419561
NCT00567229
NCT00003820
NCT00436280
NCT02510781
NCT01848132
NCT00450801
NCT03651518
NCT00797472
NCT02284984
NCT00107614
NCT01679119
NCT01779167
NCT00771875
NCT02232386
NCT00053092
NCT00690560
NCT00106184
NCT00169208
NCT00308087
NCT02734771
NCT00005609
NCT00556127
NCT04679012
NCT00169156
NCT00059904
NCT00490529
NCT01278602
NCT00005592
NCT00248534
NCT02446457
NCT00216164
NCT00509379
NCT03700229
NCT04216524
NCT00057811
NCT00581854
NCT00298272
NCT00117975
NCT00301795
NCT03147612
NCT00577278
NCT00004889
NCT02110706
NCT02419469
NCT00656656
NCT00024154
NCT03399747
NCT01998893
NCT01423539
NCT00923013
NCT00799136
NCT02533401
NCT00617929
NCT00983944
NCT00006072
NCT00869999
NCT02093026
NCT03023878
NCT01161628
NCT01520519
NCT00376961
NCT00723658
NCT00715208
NCT01859819
NCT00072007
NCT01082939
NCT02376335
NCT00121199
NCT00076349
NCT03536039
NCT03688451
NCT00169195
NCT00980304
NCT00521014
NCT00412594
NCT01554514
NCT01392716
NCT00290407
NCT02400437
NCT00992134
NCT03269552
NCT02042391
NCT01019863
NCT00514475
NCT00045864
NCT01939327
NCT02961816
NCT02877303
NCT00931918
NCT00244127
NCT00005652
NCT02834286
NCT00899431
NCT00568477
NCT00119392
NCT04481815
NCT00577629
NCT02205047
NCT00005601
NCT00003757
NCT00764517
NCT00003539
NCT00193492
NCT00044902
NCT02753062
NCT00771602
NCT04566887
NCT01429610
NCT01569451
NCT02197767
NCT03837873
NCT00945724
NCT01181258
NCT03569995
NCT01830478
NCT00186628
NCT00517049
NCT00389818
NCT00003397
NCT00485979
NCT00039195
NCT00346684
NCT00333008
NCT04400994
NCT01523860
NCT02135874
NCT00695786
NCT00193466
NCT01015248
NCT01804127
NCT01412879
NCT00141700
NCT00393107
NCT00711828
NCT00379431
NCT02815397
NCT00184002
NCT00151281
NCT00274924
NCT01990144
NCT00265928
NCT01234467
NCT00986947
NCT01458730
NCT00143871
NCT00142116
NCT00859001
NCT00845104
NCT00074165
NCT02955823
NCT00545714
NCT00413959
NCT00242996
NCT00662948
NCT00691015
NCT00070447
NCT03949062
NCT00770224
NCT01539174
NCT03863184
NCT03827603
NCT01361191
NCT00994643
NCT04585893
NCT00238368
NCT01009970
NCT00796978
NCT02260531
NCT04479267
NCT00547534
NCT02371148
NCT00440388
NCT01973062
NCT00003659
NCT01419795
NCT00208975
NCT00369707
NCT03401853
NCT02836847
NCT00331006
NCT02660710
NCT01514344
NCT00555542
NCT01754857
NCT00411086
NCT00107393
NCT01087151
NCT02427620
NCT00637832
NCT04594798
NCT02682641
NCT01516593
NCT00029107
NCT02266888
NCT00143065
NCT00816595
NCT00041730
NCT00366275
NCT00074282
NCT00006228
NCT00588822
NCT02199184
NCT00968331
NCT03422523
NCT02853370
NCT00193440
NCT02693210
NCT00878254
NCT00280878
NCT00373594
NCT02043587
NCT01461057
NCT00003963
NCT02966717
NCT00085696
NCT00290498
NCT01010217
NCT01013961
NCT01401959
NCT02398240
NCT00005857
NCT00081861
NCT00301899
NCT01316523
NCT00588094
NCT00392834
NCT00855205
NCT03023046
NCT00225212
NCT01592981
NCT01156922
NCT00126243
NCT00974792
NCT01582048
NCT01029730
NCT00062114
NCT00891839
NCT00472420
NCT03003520
NCT00311129
NCT00801060
NCT00268853
NCT00006089
NCT04665765
NCT00001586
NCT02564744
NCT00907348
NCT00072514
NCT01238692
NCT01434472
NCT00004040
NCT00092222
NCT00858117
NCT00133991
NCT04404088
NCT01678404
NCT00810017
NCT00992446
NCT03970577
NCT01560117
NCT02013817
NCT01808599
NCT01263704
NCT00098774
NCT00088985
NCT00193505
NCT00510887
NCT00282308
NCT03392714
NCT00026351
NCT01279902
NCT01135641
NCT00505895
NCT03518112
NCT04546620
NCT03919175
NCT00284180
NCT00258960
NCT01493479
NCT01066598
NCT00758693
NCT00552461
NCT00422799
NCT01556347
NCT00944047
NCT00971763
NCT00980395
NCT00607854
NCT00006436
NCT02790515
NCT00202930
NCT02544724
NCT04220008
NCT02451111
NCT03749018
NCT02171104
NCT00005631
NCT04235036
NCT00496873
NCT00244855
NCT02532257
NCT00071396
NCT01670084
NCT02857426
NCT00073957
NCT00553943
NCT04047797
NCT00426543
NCT01889797
NCT01044745
NCT03899337
NCT01678417
NCT00324779
NCT01702038
NCT00451178
NCT00468442
NCT00525603
NCT00532129
NCT01754870
NCT00821886
NCT01939730
NCT00096044
NCT00566696
NCT00392392
NCT00097188
NCT00794820
NCT01130194
NCT02399189
NCT02757196
NCT00818961
NCT03488225
NCT00026182
NCT01538641
NCT00003716
NCT00003605
NCT00070018
NCT00032019
NCT00602836
NCT01719159
NCT00958256
NCT00267865
NCT00842595
NCT00062296
NCT00850512
NCT00079326
NCT00279305
NCT00847171
NCT01095757
NCT00371904
NCT00450385
NCT03804372
NCT03304288
NCT00229619
NCT02187861
NCT03834688
NCT01278745
NCT01325194
NCT01415752
NCT00126191
NCT00732498
NCT00055640
NCT02481297
NCT00774462
NCT04626791
NCT01661881
NCT00142168
NCT01181999
NCT00386685
NCT01092182
NCT03697512
NCT01688609
NCT01502267
NCT00860457
NCT00258206
NCT03201471
NCT00005780
NCT01144403
NCT01457144
NCT01718691
NCT01665768
NCT00654732
NCT01573533
NCT01134575
NCT00003849
NCT03458260
NCT00867529
NCT01490723
NCT03505762
NCT04002401
NCT00004039
NCT01107951
NCT00568815
NCT00250861
NCT00177554
NCT02747732
NCT01427114
NCT00201877
NCT03609593
NCT01290120
NCT02460276
NCT00531089
NCT00636792
NCT02086175
NCT00851552
NCT04004819
NCT00066469
NCT00388193
NCT00290667
NCT00391066
NCT01480583
NCT00504504
NCT03615105
NCT01011920
NCT00867087
NCT02251548
NCT00367497
NCT00726700
NCT00439556
NCT00001379
NCT00671658
NCT01309997
NCT04590820
NCT03697356
NCT01086540
NCT01345708
NCT00169143
NCT02329080
NCT00460109
NCT03136146
NCT03495960
NCT02677155
NCT00110149
NCT04062448
NCT00100737
NCT00005635
NCT00258336
NCT03096782
NCT03719989
NCT00455897
NCT00582166
NCT00387959
NCT03804359
NCT00977977
NCT01054781
NCT02456207
NCT03788291
NCT01502982
NCT01810588
NCT00562328
NCT00214266
NCT00117156
NCT00058461
NCT01914718
NCT03844061
NCT00005959
NCT00120198
NCT00578591
NCT03758989
NCT04120831
NCT02258529
NCT00361621
NCT02890602
NCT00575406
NCT01549886
NCT00243412
NCT00892827
NCT00054639
NCT00911183
NCT01133158
NCT00088881
NCT01611259
NCT02674750
NCT00784927
NCT02339922
NCT00609869
NCT03019640
NCT00656812
NCT00591630
NCT00446251
NCT01046006
NCT00307125
NCT00905034
NCT00912223
NCT01125176
NCT00656084
NCT01173679
NCT01902862
NCT02789657
NCT00119730
NCT00664599
NCT03467867
NCT01207765
NCT00182793
NCT00801632
NCT00901927
NCT00401427
NCT00558181
NCT03630211
NCT00003248
NCT00849355
NCT03188198
NCT00169468
NCT01969409
NCT00550342
NCT01421667
NCT00939328
NCT00166439
NCT02004769
NCT00098670
NCT01213095
NCT01199575
NCT01153971
NCT01370772
NCT00842114
NCT00848328
NCT00261612
NCT00845832
NCT00783367
NCT02420938
NCT01446133
NCT01203930
NCT01472029
NCT00937131
NCT02670616
NCT04624906
NCT03373019
NCT03286556
NCT03054896
NCT03069248
NCT02623920
NCT00602459
NCT00541034
NCT00401817
NCT02727803
NCT00250926
NCT02792491
NCT02436707
NCT01307605
NCT02006667
NCT00039130
NCT02752204
NCT00301821
NCT00553501
NCT01319981
NCT02753647
NCT02538926
NCT01253460
NCT00529503
NCT03332888
NCT02594163
NCT00324467
NCT01682044
NCT00424749
NCT02420717
NCT00074438
NCT00280241
NCT00946023
NCT01964755
NCT00007865
NCT00049413
NCT00147966
NCT04285268
NCT04588194
NCT00475423
NCT00965289
NCT00281931
NCT01007292
NCT00836173
NCT00712582
NCT00183989
NCT03746223
NCT00856245
NCT01267812
NCT00590447
NCT04622579
NCT02692248
NCT00785330
NCT01458548
NCT00904722
NCT00425932
NCT00204659
NCT01118845
NCT01087424
NCT02605694
NCT01670370
NCT00091897
NCT00372892
NCT00109967
NCT00493454
NCT01516567
NCT00104949
NCT00427791
NCT01562977
NCT00636155
NCT00537290
NCT01956695
NCT01470196
NCT02638428
NCT00210379
NCT00147953
NCT00974233
NCT00738374
NCT03736616
NCT00809341
NCT01157988
NCT01676558
NCT01813227
NCT00893477
NCT03367676
NCT00499343
NCT00144807
NCT00536978
NCT03161054
NCT00881387
NCT01282476
NCT01156909
NCT01653067
NCT00431873
NCT00907751
NCT00801216
NCT00020943
NCT00517699
NCT03455517
NCT00058422
NCT00060346
NCT00007852
NCT00003663
NCT00001563
NCT00086203
NCT00001337
NCT00087425
NCT03399513
NCT00759798
NCT00695409
NCT00369681
NCT01856192
NCT04181489
NCT02545959
NCT04660799
NCT00005089
NCT00107380
NCT01058239
NCT02689986
NCT02099292
NCT01453205
NCT00647049
NCT00041067
NCT00629499
NCT02012088
NCT00481832
NCT00180895
NCT00049036
NCT00335140
NCT00556192
NCT02113007
NCT03710772
NCT01686321
NCT01234766
NCT00428142
NCT00101010
NCT01880567
NCT00765245
NCT01027000
NCT00041132
NCT00201721
NCT00003554
NCT00509184
NCT00251394
NCT00582725
NCT02267915
NCT01703364
NCT00031642
NCT01381692
NCT01397825
NCT00954005
NCT00787722
NCT00634179
NCT02018861
NCT00918723
NCT04663347
NCT00633594
NCT00317720
NCT01386580
NCT00384553
NCT03763643
NCT00299182
NCT00949988
NCT00048737
NCT01713738
NCT02843126
NCT02408042
NCT01562990
NCT04507477
NCT03689894
NCT02073097
NCT02158091
NCT02729896
NCT02142049
NCT01306942
NCT00281983
NCT02733042
NCT00251277
NCT03704714
NCT01509300
NCT03135262
NCT03579927
NCT01460602
NCT03500731
NCT02481310
NCT01983761
NCT02596971
NCT00584935
NCT01125293
NCT00089284
NCT02624986
NCT03576547
NCT01415765
NCT01389427
NCT00258349
NCT01269385
NCT03169790
NCT00536341
NCT02356159
NCT00294632
NCT00295932
NCT01371630
NCT02059239
NCT03356054
NCT02678299
NCT02971982
NCT00261547
NCT00472849
NCT00372905
NCT01983969
NCT02953509
NCT04494503
NCT02589145
NCT01780454
NCT00424151
NCT04421560
NCT00415506
NCT00829205
NCT02315118
NCT00692939
NCT01527422
NCT02180711
NCT01958996
NCT01479179
NCT00201682
NCT00286325
NCT00036491
NCT03671018
NCT01078142
NCT02077166
NCT00134082
NCT02257567
NCT01664910
NCT00863369
NCT00086957
NCT02213913
NCT00458237
NCT01851551
NCT02066532
NCT03808610
NCT03892421
NCT01596127
NCT03072199
NCT00972478
NCT00667615
NCT00691652
NCT00546377
NCT00396812
NCT03571568
NCT01004991
NCT00520130
NCT02228512
NCT02889523
NCT00625729
NCT00064246
NCT01538472
NCT01473628
NCT03653338
NCT03259529
NCT03064867
NCT00364819
NCT02055820
NCT04074330
NCT01994850
NCT00048555
NCT01178216
NCT03307746
NCT00963534
NCT02336984
NCT01369849
NCT03456466
NCT00807196
NCT01959698
NCT04607772
NCT02391545
NCT01238146
NCT00397800
NCT00901615
NCT02628405
NCT00477412
NCT00619671
NCT01622439
NCT01318317
NCT00299494
NCT02911142
NCT01922921
NCT01165112
NCT01035463
NCT00400764
NCT00293475
NCT00150111
NCT00642655
NCT00983619
NCT00078234
NCT00987493
NCT00244361
NCT04517435
NCT00006108
NCT01584388
NCT02141451
NCT01266317
NCT01274182
NCT01096992
NCT00103558
NCT00003356
NCT00077961
NCT02265731
NCT02843061
NCT00582816
NCT03571308
NCT02281279
NCT00601718
NCT02957019
NCT02898259
NCT00363350
NCT03368729
NCT00151320
NCT01805037
NCT00738829
NCT00012298
NCT00244985
NCT01388647
NCT03778619
NCT02384954
NCT01992653
NCT00057447
NCT01193842
NCT00216762
NCT02701673
NCT00452374
NCT00288067
NCT00068250
NCT01558167
NCT00567879
NCT01326702
NCT01241734
NCT01788189
NCT01994382
NCT01691898
NCT02933320
NCT02500251
NCT02282514
NCT00438880
NCT00572013
NCT01212094
NCT02983097
NCT04022239
NCT00086944
NCT04673617
NCT00136396
NCT01701986
NCT00379587
NCT03900377
NCT03225924
NCT02257242
NCT01429025
NCT00556699
NCT02717624
NCT00612612
NCT01078974
NCT02240407
NCT01671904
NCT01729806
NCT00392691
NCT01742988
NCT03283202
NCT01400685
NCT03036904
NCT02200848
NCT02914938
NCT02532192
NCT04231877
NCT00275613
NCT02049541
NCT01491841
NCT00022971
NCT01390441
NCT03013218
NCT00498316
NCT02657447
NCT02168907
NCT00060294
NCT00060684
NCT00383994
NCT00598169
NCT00182650
NCT01373229
NCT02541565
NCT00068315
NCT02293109
NCT02337985
NCT01569750
NCT00366418
NCT04688151
NCT01421173
NCT01729104
NCT03361852
NCT00667329
NCT00794638
NCT03259503
NCT02453087
NCT01209130
NCT03703167
NCT01005979
NCT02600897
NCT04023071
NCT01829568
NCT04318678
NCT01445535
NCT00063817
NCT00880815
NCT01410513
NCT00058227
NCT00788684
NCT01479842
NCT01300793
NCT00014430
NCT02332941
NCT00724971
NCT02446236
NCT04661007
NCT00416923
NCT00864942
NCT00720135
NCT02700022
NCT03061838
NCT00010192
NCT01534949
NCT02423915
NCT01542918
NCT03805932
NCT00509678
NCT00410982
NCT03352765
NCT02280525
NCT01086631
NCT01775631
NCT01831505
NCT04245722
NCT00772486
NCT01705847
NCT02776813
NCT00347971
NCT03742258
NCT00477815
NCT00473551
NCT01439750
NCT03523975
NCT00040950
NCT03236857
NCT03524235
NCT02253264
NCT00476515
NCT03189836
NCT01055496
NCT00101829
NCT01871675
NCT04323748
NCT03558750
NCT03136497
NCT01900496
NCT00501748
NCT03991884
NCT03245021
NCT01088048
NCT01695941
NCT03432741
NCT01815749
NCT03531736
NCT01290549
NCT01304797
NCT01292135
NCT04609046
NCT01045928
NCT00036855
NCT03636503
NCT01076556
NCT00644124
NCT01307267
NCT03963024
NCT00080925
NCT03321643
NCT00500058
NCT02203526
NCT01682616
NCT00907205
NCT00278564
NCT03255096
NCT03349346
NCT01226849
NCT00972101
NCT03424122
NCT00210340
NCT00901069
NCT03440567
NCT00787969
NCT04156828
NCT02055924
NCT00824135
NCT03220022
NCT01534884
NCT02219737
NCT03571321
NCT00868413
NCT00058292
NCT04323956
NCT01185262
NCT02471911
NCT00038922
NCT02741388
NCT02598427
NCT02663518
NCT00176475
NCT01384253
NCT02954406
NCT02296918
NCT00072592
NCT02728531
NCT03121677
NCT03934814
NCT03639324
NCT01567475
NCT00694590
NCT02705638
NCT03795571
NCT00070083
NCT02960646
NCT00330252
NCT01644253
NCT01292603
NCT03530683
NCT02194374
NCT01594229
NCT01650727
NCT01416974
NCT02442648
NCT00031902
NCT02031419
NCT01838434
NCT04045028
NCT00255593
NCT04502706
NCT01619761
NCT00655837
NCT02611323
NCT00004260
NCT01880385
NCT00543114
NCT00042809
NCT02160015
NCT01832922
NCT00259805
NCT01744626
NCT00110071
NCT01032122
NCT00087009
NCT04555811
NCT02594384
NCT01471067
NCT04540380
NCT02187133
NCT04279938
NCT01842386
NCT02343536
NCT04447716
NCT04361409
NCT00930514
NCT01317901
NCT02367196
NCT00221325
NCT00098488
NCT02605915
NCT00334438
NCT01334502
NCT00033423
NCT01022021
NCT01804712
NCT01875666
NCT01760226
NCT00405340
NCT00734773
NCT03684980
NCT00486421
NCT01318915
NCT00790413
NCT03131934
NCT03295240
NCT00017381
NCT02484053
NCT00515138
NCT03155984
NCT01482754
NCT00963703
NCT01072240
NCT01140152
NCT00443443
NCT03154385
NCT01685918
NCT01150643
NCT02732236
NCT01480674
NCT00429065
NCT03187444
NCT02922192
NCT01843868
NCT00594815
NCT00274794
NCT00387023
NCT02341781
NCT03288584
NCT01557348
NCT03715296
NCT02656589
NCT03582098
NCT02156726
NCT01266668
NCT02486952
NCT01763398
NCT01995747
NCT03269292
NCT00984711
NCT03022123
NCT01408342
NCT04496037
NCT00476229
NCT02474888
NCT00772668
NCT00301301
NCT01083563
NCT01317966
NCT00038883
NCT00267826
NCT00416312
NCT01096069
NCT00307593
NCT02316691
NCT02844491
NCT02110394
NCT00695097
NCT01340443
NCT00898963
NCT01230788
NCT04572620
NCT01839500
NCT02240316
NCT00038844
NCT00863187
NCT01196780
NCT03087929
NCT01613027
NCT00525876
NCT03193866
NCT00579592
NCT00244010
NCT01381705
NCT01724294
NCT00350545
NCT01283399
NCT02050581
NCT03289182
NCT01643928
NCT03496831
NCT02199301
NCT00574730
NCT00908986
NCT01609023
NCT01406782
NCT02658461
NCT03054883
NCT02381899
NCT01144754
NCT02322801
NCT01809600
NCT01502397
NCT00142155
NCT00689845
NCT03530462
NCT00822731
NCT02649725
NCT00736450
NCT01131208
NCT02354846
NCT00651755
NCT02472756
NCT00931229
NCT01599559
NCT02883946
NCT00110006
NCT01586858
NCT01402661
NCT04640818
NCT02136511
NCT01862445
NCT00933127
NCT00844714
NCT03791827
NCT02316613
NCT01309282
NCT01488162
NCT01311232
NCT02821572
NCT02461290
NCT00561379
NCT01829958
NCT01075477
NCT02927717
NCT00833963
NCT02075697
NCT02555852
NCT00145587
NCT02694913
NCT01071798
NCT02072967
NCT01101295
NCT02361229
NCT02461316
NCT00167791
NCT01609036
NCT02474550
NCT01613963
NCT02622503
NCT01224769
NCT02564770
NCT01178086
NCT00544219
NCT01338103
NCT02993536
NCT02491398
NCT02654379
NCT02699892
NCT01350232
NCT00960713
NCT01971684
NCT00400907
NCT01727232
NCT00416819
NCT02507752
NCT01625650
NCT00398372
NCT03045471
NCT01641952
NCT03211702
NCT02555267
NCT00898157
NCT00648037
NCT00854321
NCT00433407
NCT03847727
NCT03343834
NCT02199288
NCT01684865
NCT02520895
NCT02652468
NCT01832597
NCT01719692
NCT01279772
NCT01592292
NCT01224093
NCT02536664
NCT00466037
NCT00023530
NCT00082836
NCT02287649
NCT01451879
NCT01613599
NCT01403740
NCT01702961
NCT00590941
NCT01042509
NCT04519710
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Procedure;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Device
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Biological;Radiation;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Other;Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Biological
Biological
Other;Drug
Drug
Radiation;Drug
Drug
Drug
Biological;Radiation;Drug
Drug
Drug
Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Other;Biological;Drug
Procedure;Radiation;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Biological;Drug
Biological;Radiation;Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Biological
Drug
Biological
Drug
Drug
Radiation;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Biological;Drug
Biological;Drug
Drug
Biological
Drug
Procedure;Biological;Drug
Drug
Biological;Drug
Procedure;Radiation;Biological;Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Biological
Biological;Drug
Drug
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Radiation;Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Biological;Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological;Drug
Drug
Biological;Radiation;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Procedure;Other;Biological
Drug
Drug
Drug
Biological
Drug
Biological
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Other;Biological;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Other;Radiation;Biological
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug;Device
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Procedure;Radiation
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Biological
Biological;Drug
Drug
Biological;Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Other;Procedure;Biological;Radiation;Drug
Drug
Procedure;Radiation;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Radiation;Drug
Drug
Other;Drug
Procedure;Biological;Drug
Drug
Procedure;Drug
Biological
Procedure;Biological;Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Other;Procedure;Biological;Drug
Procedure;Drug
Drug
Biological;Drug
Biological
Drug
Drug
Other;Biological;Drug;Genetic
Other;Biological;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Radiation;Drug
Biological
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Drug
Biological;Drug
Drug
Other;Biological;Radiation;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Other;Biological;Drug;Device
Biological;Drug
Procedure;Drug;Genetic
Drug
Drug
Procedure;Radiation;Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Diagnostic Test;Drug
Procedure;Drug
Drug
Drug
Other;Biological
Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Radiation;Drug
Procedure;Drug
Radiation
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Radiation;Biological;Drug
Procedure;Drug;Device
Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Radiation;Drug
Drug
Drug
Radiation;Drug
Biological
Drug
Drug
Biological;Drug
Procedure;Other;Drug
Procedure;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Biological
Drug
Biological;Drug
Other;Biological;Drug
Other;Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Radiation;Drug
Drug
Drug
Drug
Drug
Biological
Procedure;Radiation;Drug
Drug
Drug
Biological
Procedure;Biological;Drug
Drug
Radiation;Biological
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug;Dietary Supplement
Biological
Other;Biological
Biological;Drug
Procedure;Other;Biological;Radiation;Drug
Biological
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Other;Biological
Other;Biological;Drug
Drug
Other;Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Other;Biological;Drug
Biological
Drug
Drug;Dietary Supplement
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Biological
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Other;Biological;Drug
Procedure;Biological;Drug
Drug
Procedure;Radiation;Biological;Drug
Drug
Drug
Other;Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Biological;Radiation;Drug
Biological;Radiation;Drug
Drug
Biological;Radiation;Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological
Drug
Procedure;Radiation;Biological;Drug
Drug
Procedure;Other;Biological
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Radiation
Biological;Drug
Other;Biological;Drug
Drug
Drug
Other;Biological
Procedure;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological
Biological;Drug
Drug
Other;Biological;Drug
Biological;Radiation;Drug
Drug
Drug
Radiation;Drug
Drug
Biological
Drug
Biological;Drug
Biological
Procedure
Biological;Drug
Other;Biological
Biological
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Biological
Drug
Drug
Biological;Drug
Drug
Biological
Drug
Drug
Biological;Drug
Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Radiation
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological
Biological;Drug
Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Other;Radiation;Biological;Drug
Biological
Other;Drug
Biological
Biological;Drug
Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Biological;Drug;Device
Drug
Biological
Procedure;Biological;Drug
Drug
Biological;Drug
Biological;Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Biological;Radiation;Drug
Drug
Biological;Drug
Drug
Biological
Other;Procedure;Biological;Radiation;Drug
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Drug;Device
Drug
Drug
Drug
Other
Drug
Drug
Procedure;Biological;Drug
Other;Biological;Drug
Other;Procedure;Biological
Drug
Biological
Biological;Drug
Biological;Radiation;Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Biological;Drug
Drug
Other;Procedure;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug;Genetic
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Biological
Drug
Biological
Other;Procedure;Drug
Procedure;Other;Biological
Procedure;Drug
Other;Biological;Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Biological;Drug
Drug
Other;Radiation;Biological;Drug
Drug
Drug
Drug
Procedure;Radiation;Drug;Device
Other;Radiation;Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Diagnostic Test;Other;Biological;Drug
Drug
Procedure;Drug
Radiation;Drug
Biological
Biological;Drug
Radiation;Drug
Radiation;Biological
Biological;Radiation
Drug
Drug
Biological;Drug
Biological
Procedure;Biological;Radiation;Drug
Drug
Drug
Drug
Procedure;Radiation;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Radiation;Drug;Device
Biological
Drug
Drug
Other;Biological;Drug
Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological
Biological;Drug
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Procedure;Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Biological
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Biological;Drug
Procedure;Radiation;Biological;Drug
Drug
Drug
Drug
Radiation;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Biological;Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Other;Procedure;Biological;Radiation;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Biological
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Other;Procedure;Biological;Genetic
Drug
Other;Biological;Drug
Drug
Drug
Biological;Radiation;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Procedure;Drug
Procedure;Drug
Drug
Drug
Other;Biological;Drug
Procedure;Biological;Drug
Drug
Drug
Drug
Other;Biological;Genetic
Drug
Procedure;Drug
Procedure;Drug
Other;Procedure;Radiation;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Biological;Radiation;Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Procedure;Radiation;Biological;Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Radiation;Drug
Biological;Radiation;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Radiation;Drug
Biological;Drug
Biological;Drug
Other;Biological;Drug
Drug
Procedure;Biological;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Radiation
Other;Biological;Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Biological
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Other;Biological;Drug
Biological;Radiation;Drug
Drug
Procedure;Biological;Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug;Genetic
Biological;Radiation;Drug
Drug
Procedure;Biological;Drug
Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Drug;Combination Product
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Procedure;Drug
Radiation;Drug
Drug
Drug
Drug
Other;Biological;Drug;Dietary Supplement
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Other;Biological;Drug;Genetic
Other;Procedure;Biological;Drug;Genetic
Drug
Biological
Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Biological;Radiation
Procedure;Drug
Other;Radiation;Biological
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Other;Drug
Other;Biological;Drug
Drug
Drug
Biological;Drug
Biological;Radiation;Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Procedure;Other;Biological;Drug;Genetic
Drug
Drug
Other;Biological
Other;Biological;Drug
Procedure;Biological;Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Other;Drug;Device
Drug
Other;Biological;Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Biological
Biological;Drug
Drug
Biological;Drug
Biological
Drug
Drug
Other;Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Radiation;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological;Drug
Other;Procedure;Radiation;Biological;Drug
Procedure;Drug
Other;Drug
Procedure;Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Drug
Other;Drug;Genetic
Drug
Other;Biological
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Biological;Drug
Drug
Biological
Biological;Drug
Drug
Procedure;Other;Radiation;Drug
Drug
Other;Biological;Drug
Biological;Radiation
Drug
Biological;Drug
Biological;Drug;Genetic
Biological;Drug
Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Drug
Drug
Other;Biological;Drug
Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Other;Biological;Genetic
Drug
Drug
Other;Biological
Biological
Procedure;Radiation;Drug
Drug
Biological;Drug
Drug
Other;Drug
Procedure;Drug
Procedure;Drug
Drug
Biological
Drug
Drug
Biological
Drug
Biological
Drug
Biological;Drug
Biological;Radiation;Drug
Procedure;Radiation;Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Procedure;Other;Biological;Drug
Procedure;Other;Biological
Procedure;Radiation;Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug;Genetic
Procedure;Other;Biological;Radiation
Drug
Other;Biological;Drug
Drug
Drug
Procedure;Drug
Procedure;Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Radiation;Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Biological;Drug
Biological;Drug
Drug
Other;Procedure;Drug
Other;Biological;Drug
Biological
Other;Biological;Drug
Drug
Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Other;Biological
Drug
Drug
Drug
Procedure;Drug
Procedure;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Procedure;Radiation;Biological;Drug
Drug
Biological
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Radiation;Drug
Drug
Drug
Biological
Biological;Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Procedure;Other;Radiation;Drug;Genetic
Drug
Biological
Drug
Drug
Procedure;Radiation;Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Radiation;Drug
Biological;Drug
Biological;Radiation
Drug
Drug
Drug
Drug
Drug
Biological;Radiation;Drug
Drug
Biological;Drug
Drug
Procedure;Drug
Procedure;Biological
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Genetic
Other
Drug
Drug
Procedure
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Drug
Other
Drug
Drug
Drug
Drug
Drug
Device
Drug
Other
Other
Drug
Other;Genetic
Drug
Drug
Drug
Drug
Biological
Other
Biological
Procedure;Drug
Drug
Drug
Device
Other;Biological;Genetic
Drug
Drug
Biological
Drug
Procedure
Drug
Drug
Drug
Other;Biological;Genetic
Drug
Drug
Drug
Other
Drug
Biological;Drug
Drug
Drug
Behavioral
Procedure;Other;Biological;Drug;Genetic
Other;Genetic
Drug
Drug
Drug
Other;Radiation
Other
Procedure;Biological;Radiation;Drug
Other
Drug
Drug
Other;Genetic
Drug
Drug
Drug
Procedure;Biological
Radiation;Drug
Drug
Drug;Behavioral
Drug
Drug
Drug
Procedure;Drug;Device
Other
Drug
Other
Other
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Other
Drug
Biological
Drug
Procedure;Radiation;Drug;Device
Drug
Drug
Other;Procedure
Biological;Drug
Drug
Drug
Drug
Other
Drug
Drug
Biological
Drug
Biological
Drug
Biological
Procedure;Radiation;Biological;Drug
Drug
Drug
Drug
Drug
Biological
Procedure;Drug
Biological;Radiation
Other
Drug
Drug
Drug
Drug
Procedure
Drug
Biological
Indications
Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma
Rheumatoid Arthritis; Insufficient Response to Methotrexate.
Rheumatoid Arthritis
Diabetes Mellitus, Type 1
Rheumatoid Arthritis
Renal Transplant
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Microscopic Polyangiitis; Wegener Granulomatosis
Hemophilia A With Inhibitor
Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma
Adult Acute Lymphocytic Leukemia
Nephrotic Syndrome
Rheumatoid Arthritis
Granulomatosis With Polyangiitis; Microscopic Polyangiitis
Chronic Lymphocytic Leukemia
Pompe Disease
Lymphocytic Leukemia, Chronic
Waldenström Macroglobulinemia
Non Hodgkin Lymphoma
Rheumatoid Arthritis
END STAGE RENAL DISEASE
Pompe Disease; Glycogen Storage Disease Type II
Lymphocytic Leukemia, Chronic
Adult Acute Lymphocytic Leukemia
Eosinophilic Granulomatosis With Polyangiitis
Autoimmune Adrenocortical Failure
Lymphocytic Leukemia, Chronic
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Renal Insufficiency
Purpura, Thrombocytopenic, Idiopathic; Immune Thrombocytopenia
HLA Sensitization
IgA Nephropathy
Post-transplant Lymphoproliferative Disease (PTLD); Non Burkitt
Rheumatoid Arthritis
Lymphoma, Non-Hodgkin;Hodgkin Disease
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Multiple Sclerosis
Rheumatoid Arthritis
Breast Cancer
Rheumatoid Arthritis
End Stage Renal Disease
Kidney Transplantation; Graft Rejection; Immunosuppression
Rheumatoid Arthritis
Recurrent IgA Nephropathy
Burkitt's Lymphoma; Burkitt's Leukemia; Mediastinal Neoplasms; Lymphoblastic Lymphoma; Large Cell Anaplastic Lymphoma
HIV Infections; Diffuse Large B Cell Lymphoma
Granulomatosis With Polyangiitis (Wegener's Granulomatosis)
Rheumatoid Arthritis
Ophthalmopathy, Thyroid-Associated
Refractory Epilepsy
Renal Transplant; Autoimmune Diseases
Waldenström Macroglobulinemia
Kidney Transplantation
Hepatitis B
Rheumatoid Arthritis
Multiple Sclerosis, Relapsing-Remitting
Rheumatoid Arthritis
Lymphoma, Non-Hodgkin; Lymphoma, Low-Grade
Wegener's Granulomatosis or Microscopic Polyangiitis
Pancytopenia Due to Chemotherapy
Neuromyelitis Optica Spectrum Disorder
Rheumatoid Arthritis
Function of Renal Transplant
Rheumatoid Arthritis
Rheumatoid Arthritis
DMARD Resistant Rheumatoid Arthritis
Mantle Cell Lymphoma
Indolent Non-Hodgkin's Lymphomas
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Lymphoma, Mantle-Cell
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Pemphigus
Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis; Primary Progressive Multiple Sclerosis
Chronic Lymphocytic Leukemia
Kidney Transplant Rejection; Antibody-mediated Rejection
Lymphoma, Non-Hodgkin's
Idiopathic Thrombocytopenic Purpura
Lymphoma, Follicular
Lymphoma, Mantle-Cell
Rheumatoid Arthritis
Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Renal Limited Forms
Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma; IPI≥2
Nephrotic Syndrome
Follicular Lymphoma
Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Breast Cancer
Follicular Lymphoma
Lupus Erythematosus, Systemic
Multiple Sclerosis, Relapsing-Remitting
Pemphigus Disease
Lymphoma, Non-Hodgkin
Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Small Lymphocytic Lymphoma; Marginal Zone Lymphoma
Diffuse Large B-cell Lymphoma; Follicular Lymphoma Grade 3B
Breast Cancer
B Cell Lymphoma
Rheumatoid Arthritis
Lymphoma,Non-Hodgkin
Diffuse Large B-Cell Lymphoma
Lymphoma, Large-Cell, Diffuse
Mantle Cell Lymphoma
Generalized Myasthenia Gravis
Diffuse Large B Cell Lymphoma
Autoimmune Diseases
Lymphoma
Immune Thrombocytopenia
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Microscopic Polyangiitis; Wegener Granulomatosis
Granulomatosis With Polyangiitis (Wegener's) (GPA); Microscopic Polyangiitis (MPA)
ANCA Associated Vasculitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Lymphoma, Non-Hodgkin
Lymphoma
Humoral Rejection in Kidney Transplantation
Non-Hodgkin's Lymphoma
Breast Cancer
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma
Lymphoma
Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma
Breast Cancer; Metastasis; Sur-expressing Her2-neu
Non-Hodgkin's Lymphoma
Idiopathic Nephrotic Syndrome
Lymphoma
Severe Forms of Mucous Membrane Pemphigoid
Lymphoma, Follicular
Lymphoma
Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Lymphoma
Lymphoma, Non-Hodgkin
Rheumatoid Arthritis
Rheumatoid Arthritis
CD20+ Aggressive B-Cell Lymphoma
Pemphigus Vulgaris
Wegener Granulomatosis; Microscopic Polyangiitis
Mature B-cell Non-Hodgkin Lymphoma
Glomerulonephritis, Membranous
Lymphoma, Follicular; Lymphoma, Low-Grade; Lymphoma, Intermediate-Grade
Neoplasms, Breast
Breast Cancer
Leukemia; Mucositis; Oral Complications
Indolent Non-Hodgkin's Lymphomas
MEMBRANOUS NEPHROPATHY
Non-Hodgkin's Lymphoma
Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia
Lupus Nephritis
Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
Immune Thrombocytopenia
Breast Cancer
Relapsing Remitting Multiple Sclerosis
Elderly Patients (>65 Years); Diffuse Large B Cell Lymphoma (DLBCL)
CD20-Positive Large B-Cell Lymphoma
Immune Thrombocytopenia
Lymphoma, Large B-Cell, Diffuse
Chronic Lymphocytic Leukemia
Graft Rejection
Diffuse Large B Cell Lymphoma
Rheumatoid Arthritis
Lymphoma
Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Acute Rejection
Chronic Lymphocytic Leukemia
Rheumatoid Arthritis; Interstitial Pneumonia
Lymphoma, Large-Cell, Diffuse
Rheumatoid Arthritis
HER2-negative Breast Cancer; HER2-positive Breast Cancer; Recurrent Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
Diffuse Large B-Cell Lymphoma
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Thalidomide
Follicular Lymphomas; Immunocytomas; Marginal Zone Lymphomas; Mantle-Cell Lymphomas; Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
Lymphoma
B-cell Lymphoma
Follicular Non-Hodgkin's Lymphoma; Nodal Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma
Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma
Immune Thrombocytopenia; Purpura, Thrombocytopenic, Idiopathic
Indolent Cutaneous B Cell Lymphomas
Purpura; Idiopathic Thrombocytopenic Purpura
CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma
Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Small Lymphocytic Lymphoma
Diffuse Large B-cell Lymphoma
Diffuse Large Cell Lymphoma
Mantle Cell Lymphoma
Breast Cancer
Lymphoma
ANCA-Associated Vasculitis
Purpura; Idiopathic Thrombocytopenic Purpura
Leukemia
DLBCL
Lymphoma
Follicular Lymphoma
Rheumatoid Arthritis
Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Breast Cancer
Rheumatoid Arthritis
Lymphoma, Non Hodgkin
Lymphoma, Mucosa-Associated Lymphoid Tissue
Acquired Haemophilia
Rheumatoid Arthritis
Lymphoma
Arthritis, Rheumatoid
Lymphoma
Leukemia
Nephrotic Syndrome
Breast Cancer
Rheumatoid Arthritis
Follicular Lymphoma; Lymphoma, Follicular
Burkitt Lymphoma
Rheumatoid Arthritis
Lymphoma
Diffuse Large B-Cell Lymphoma
Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Lymphoma
Chronic Lymphocytic Leukemia
Opsoclonus Myoclonus Syndrome; Neuroblastoma
Diffuse Large B-cell-lymphoma
DLBCL
Hodgkin Lymphoma
Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
Non-Hodgkin Lymphomas; Follicular Lymphomas; Immunocytomas; Lymphocytic Lymphomas; Marginal Zone Lymphomas
Diffuse Large B-cell Lymphoma
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Untreated Chronic Lymphocytic Leukemia
Idiopathic Membranous Nephropathy
Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Follicular Lymphoma; Marginal Zone Lymphoma
Lymphoma, High-grade
Multiple Sclerosis, Relapsing-Remitting
Anemia, Hemolytic, Autoimmune
Lymphoma
Rheumatoid Arthritis
Non Alcoholic Fatty Liver Disease
Thrombotic Thrombocytopenic Purpura
Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma
Lymphocytic Leukemia, Chronic
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
Lung Disease, Interstitial
Lymphoma
Breast Cancer
Lymphoma
Immune Thrombocytopenia (ITP)
FSGS; Proteinuria
Steroid-Dependent Nephrotic Syndrome
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Warm Autoimmune Hemolytic Anemia
Diffuse Large B-cell Lymphoma; Follicle Center Lymphoma
Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Bullous Pemphigoid
Follicular Lymphoma
Diffuse Large B-cell Lymphoma; de Novo DLBCL; DLBCL Transformed From Indolent Lymphoma; Follicular Grade 3 Lymphoma
Leukemia, Lymphocytic
Polyneuropathy
Rheumatoid Arthritis
Diffuse Large B-Cell Lymphoma
Waldenström's Macroglobulinemia
Lymphoma
Large B Cell Lymphoma
Pemphigus
Lymphoma
Non-Hodgkin's Lymphoma
Follicular Lymphoma
Rheumatoid Arthritis
ANCA-associated Vasculitides
Rheumatoid Arthritis
Rheumatoid Arthritis
Breast Cancer
Systemic Lupus Erythematosus
Lymphoma, Mantle Cell
Graft-versus-host Disease (GVHD)
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Purpura, Thrombocytopenic, Idiopathic
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Neoplasms, Breast
Purpura; Idiopathic Thrombocytopenic Purpura
Lymphoma, Non-Hodgkin
Lymphoma, Follicular
CD20 Positive; Mantle Cell Lymphoma
Idiopathic Thrombocytopenic Purpura
Diffuse Large-Cell Lymphoma
Metastatic or Locally Advanced Breast Cancer
Lupus Nephritis
Follicular Lymphoma
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Mantle Cell Lymphoma
Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin
Rheumatoid Arthritis
Lymphoma, Follicular; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Low-Grade
Frequent Relapsing Nephrotic Syndrome; Steroid Dependent Nephrotic Syndrome
Hodgkins Lymphoma
Idiopathic Nephrotic Syndrome; Minimal Change Disease; Focal Segmental Glomerulosclerosis
Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL
Lymphoma
Leukemia
Lymphoma
Follicular Lymphoma; Small Lymphocytic Lymphoma; Marginal Zone Lymphoma; Mucosal-Associated Lymphoid Tissue Lymphoma
Lupus Nephritis
Lymphoma, Large B-Cell, Diffuse
Acquired Hemophilia A
Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
Lymphoma, Non-Hodgkin
Rheumatoid Arthritis
Diffuse Large Cell Lymphoma
Follicular Lymphoma
Follicular Lymphoma
Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)
Lymphoma, Follicular
Lymphoma, Large B-Cell, Diffuse
Metastatic Breast Cancer
Neoplasms, Breast
Follicular Lymphoma
Lymphoma
Lymphocytic Leukemia
Hodgkin's Lymphoma
Systemic Lupus Erythematosus, Lupus Nephritis
Ann Arbor Stage I Grade 1 Follicular Lymphoma; Ann Arbor Stage I Grade 2 Follicular Lymphoma; Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma
Follicular Non-Hodgkin's Lymphoma
Leukemia
Nephrotic Syndrome
Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
Diffuse Large B-Cell Lymphoma (DLBCL); Follicular NHL Grade 3b
Lymphoma
Diffuse Large B-Cell Lymphoma
Frequently Relapsing Nephrotic Syndrome; Steroid-Dependent Nephrotic Syndrome
Rheumatoid Arthritis
Rheumatoid Arthritis
Membranoproliferative Glomerulonephritis
Lupus Nephritis
Chronic Lymphocytic Leukemia (CLL)
Leukemia; Lymphoma
Lymphoma, Non-Hodgkin's
Diffuse Large B-Cell Lymphoma; Elderly Patients
Lymphoma
B Acute Lymphoblastic Leukemia
Lymphoma
Diffuse Large B-cell Lymphoma
HER2-positive Carcinoma of Breast
Pemphigus
Neuromyelitis Optica; Devic's Disease; NMO Spectrum Disorder
Ankylosing Spondylitis
Kidney Transplantation
Immune Thrombocytopenic Purpura
Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma
Lung Diseases, Interstitial; Pneumonitis, Interstitial
Systemic Sclerosis
Ulcerative Colitis
Neuromyelitis Optica Spectrum Disorder
Thyroid-associated Ophthalmopathy
Systemic Sclerosis; Scleroderma
Chronic Fatigue Syndrome
Membranous Nephropathy
Childhood Idiopathic Nephrotic Syndrome
Lymphoma
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Follicular Lymphoma
Steroid Resistant Nephrotic Syndrome; Steroid Dependent Nephrotic Syndrome
Lymphoma, Non-Hodgkin
Interstitial Lung Disease; Scleroderma; Idiopathic Inflammatory Myositis; Mixed Connective Tissue Disease
Lupus Erythematosus, Systemic
Diffuse Large B-cell Lymphoma Refractory; Diffuse Large B-cell Lymphoma Recurrent
Sjogren's Disease
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune
Mature B-cell Non-Hodgkin Lymphoma
Mature B-Cell Lymphoma
Lymphoma, B-Cell
Diffuse Large B Cell Lymphoma
Multiple Sclerosis
Lymphoma, Non-Hodgkin
Idiopathic Membranous Nephropathy
Scleroderma, Systemic; Skin Sclerosis; Lung Fibrosis; Autoimmune Diseases; Collagen Diseases
Rheumatoid Arthritis
Hemophilia A
Kidney Transplantation
Diffuse, Large B-Cell, Lymphoma
Vasculitis; Wegener's Granulomatosis; Microscopic Polyangiitis
Systemic Lupus Erythematosus; ANCA Associated Vasculitis
Diffuse Large B Cell Lymphoma; CD79A Gene Mutation; CD79B Gene Mutation
HIV Infections; Giant Lymph Node Hyperplasia
Burkitt's Lymphoma; Burkitt'S-like Lymphoma
Diffuse Large B-Cell Lymphoma Unclassifiable
Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma
Marginal Zone B-cell Lymphoma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma; B-cell Lymphoma
Chemotherapy; Diffuse Large B-Cell Lymphoma (DLBCL), Nos; Elderly
Granulomatous and Lymphocytic Interstitial Lung Disease
Follicular Lymphoma
Leukemia; Lymphoma
Follicular Lymphoma
Non-Hodgkin Lymphoma; Hodgkin Disease
Sickle Cell Disease
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Small Lymphocytic Lymphoma
Lymphoma
Waldenstrom's Macroglobulinemia
Diffuse Large B-Cell Lymphoma.; Primary Mediastinal B-Cell Lymphoma; Follicular Lymphoma Grade III
Diffuse Large B Cell Lymphoma; DLBCL; Cancer
B-cell Lymphoma
Breast Neoplasms; Cancer of the Breast; Breast Cancer
Anti-NMDAR Encephalitis
Waldenstrom Macroglobulinemia
Leukemia; Lymphoma
Invasive Pneumococcal Infection
Rheumatoid Arthritis
Active Chronic Graft Versus Host Disease
Lymphoma
Lymphoma
Lymphoma
NHL With Hemophagocytic Lymphohistiocytosis
Leukemia
Chronic Lymphocytic Leukemia
CCND1 Positive; CD20-Positive Neoplastic Cells Present; Mantle Cell Lymphoma
Immune-related Adverse Events; Advanced Solid Tumor
Follicular Lymphoma
Follicular Lymphoma; Non-Hodgkin's Lymphoma; NHL
Diffuse Large B Cell Lymphoma
Leukemia
Large B Cell Diffuse Lymphoma
Hairy Cell Leukemia (HCL)
Breast Neoplasms; Malignant Tumor of the Breast
Diffuse Large B-Cell Lymphoma
Autoimmune Thrombocytopenic Purpura
Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Granulomatosis With Polyangiitis
Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma; T-Cell Large Granular Lymphocyte Leukemia
Marginal Zone Lymphoma
Breast Neoplasms
Steroid-Refractory Chronic GVHD
Non-Hodgkins Lymphoma
Liver Lymphoma; Mantle Cell Lymphoma
Acute Lymphoblastic Leukemia, in Relapse
Anaplastic Large Cell Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Mantle Cell Lymphoma
Leukemia
Mantle-Cell Lymphoma
Contiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Stage I Mantle Cell Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Mantle Cell Lymphoma
Lymphoma
Mantle Cell Lymphoma
Lymphoma
Lymphoma
Breast Neoplasms; Colonic Neoplasms; Lung Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
B-cell Lymphoma; Indolent B-cell Lymphoma
Lymphoma
Indolent or Intermediate Grade B-cell Malignancy
Non Hodgkin Lymphoma
PTLD; Lymphoid Tumor; Hematopoietic/Lymphoid Cancer; Plasmacytic Hyperplasia PTLD; Infectious Mononucleosis; Florid Follicular Hyperplasia PTLD; Polymorphic PTLD; Monomorphic PTLD; Classical Hodgkin Lymphoma Type PTLD
Diffuse Large B-Cell Lymphoma
Chronic Lymphocytic Leukemia
Lupus Erythematosus, Systemic
AIDS-related Lymphoma; Adult Non-Hodgkin's Lymphoma; Anaplastic Large Cell Lymphoma
Breast Neoplasms
Graft Versus Host Disease
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Leukemia
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma
Primary Central Nervous System Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Mantle-Cell
Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma; Cancer
Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Leukemia, Lymphocytic, Acute; Leukemia, Myelocytic, Acute; Leukemia, Myeloid, Chronic; Lymphoma, Non-Hodgkin
Leukemia
Leukemia
Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Myeloid Sarcoma; Chronic Myelogenous Leukemia (CML); Juvenile Myelomonocytic Leukemia (JMML); Myelodysplastic Syndrome (MDS); Non-Hodgkin Lymphoma (NHL)
Mantle Cell Lymphoma; Newly-diagnosed Mantle Cell Lymphoma
Lymphoma, Mantle Cell; Mantle Cell Lymphoma
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Lymphoma
Newly Diagnosed Diffuse Large B-Cell Lymphoma; Intermediate (Burkitt-Like) Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Small Lymphocytic Lymphoma
Mantle Cell Lymphoma
Lymphoma
Mantle-Cell Lymphoma
Lymphoma
Indolent Non-follicular; Non-Hodgkin's Lymphoma
Lymphoproliferative Disorder
Diffuse Large B Cell Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia; Marginal Zone Lymphoma
Leukemia
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood B-Lymphoblastic Lymphoma
Breast Cancer
Lymphoma; Leukemia; Myeloproliferative Disorders; Multiple Myleoma; Myelodysplastic Syndrome
Mantle Cell Lymphoma; Untreated
Waldenstrom Macroglobulinemia
Lymphoma
Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.
Diffuse Large B Cell Lymphoma
Lymphoma, Large Cell, Diffuse
Metastatic Breast Cancer
Lymphoma, High-Grade
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; CLL; Untreated; Front-line; First-Line; Initial Therapy
Polyneuropathies
Lymphoma, Follicular
B-Cell Lymphoma Originating in the CNS
Diffuse Large B-Cell Lymphoma
Mantle Cell Lymphoma
Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukaemia; Small Lymphocytic Lymphoma
Post-transplant Lymphoproliferative Disorder
Mantle Cell Lymphoma
Chronic Lymphocytic Leukaemia; Patients Resistant to a Purine Analogous; Patients Relapsed With Purines Therapy
Non-Hodgkin's Lymphoma
Adenocarcinoma of the Extrahepatic Bile Duct; Adenocarcinoma of the Gallbladder; Malignant Neoplasm; Recurrent Extrahepatic Bile Duct Cancer; Recurrent Gallbladder Cancer; Unresectable Extrahepatic Bile Duct Cancer; Unresectable Gallbladder Cancer
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma
Lymphoma, B-cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular, Grade 3b; Follicular Lymphoma, Grade 3b
Chronic Lymphocytic Leukemia
Idiopathic Pulmonary Fibrosis
Refractory Non Hodgkin Lymphoma; Relapsed Non Hodgkin Lymphoma
Hematologic Malignancies
Non Hodgkin's Lymphoma
Metastatic Breast Cancer
Leukemia; Lymphoma
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Immunocytoma/Morbus Waldenström; B-Cell Non-Hodgkin's Lymphoma; B-Cell Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma
Non Hodgkin's Follicular Lymphoma
Lymphoma
Malignant Melanoma of Skin Stage III; Metastatic Melanoma
Membranous Nephropathy; MN
Lymphoma, Follicular; Stem Cell Transplantation
Recurrent Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder
Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Chemotherapeutic Agent Toxicity; Cognitive/Functional Effects; Lymphoma; Neurotoxicity; Radiation Toxicity
Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Secondary AML; Myelodysplastic Syndrome (MDS); Secondary MDS; Chronic Myeloid Leukemia; Juvenile Myelomonocytic Leukemia (JMML); Paroxysmal Nocturnal Hemoglobinuria (PNH); Lymphoma, Non-Hodgkin; Hodgkin Disease
Hairy Cell Leukemia
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion
Leukemia; Lymphoma
Non-Hodgkin's Lymphoma; Burkitt Lymphoma; Primary Effusion Lymphomas
Psychosis; Autoimmune Encephalitis
Idiopathic Thrombocytopenic Purpura (ITP)
Gastric Cancer; Gastroesophageal Junction Cancer
Diffuse, Large B-Cell, Lymphoma; Follicular Lymphoma, Grade 3b; Transformed Lymphoma / DLBCL
Lymphoma
Gastroesophageal Junction Adenocarcinoma
Follicular Lymphoma; Follicular Non-Hodgkin´s Lymphoma; Autologous Effector Lymphocytes
Lymphoma, B-cell; Lymphoma, Large B-cell, Diffuse
Primary Non Hodgkin Lymphoma of the Central Nervous System
Rheumatoid Arthritis
Multiple Myeloma; Leukemia; Lymphoma
Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Lupus Nephritis
Follicular Lymphoma; B-cell Lymphoma; Non-Hodgkin's Lymphoma
Sjogren's Syndrome
Lymphoma
EBV-Related Post-Transplant Lymphoproliferative Disorder; Monomorphic Post-Transplant Lymphoproliferative Disorder; Polymorphic Post-Transplant Lymphoproliferative Disorder; Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder; Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder; Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder; Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
Mantle Cell Lymphoma
Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
KSHV Inflammatory Cytokine Syndrome (KICS); KSHV; HHV-8
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma; Hodgkin Lymphoma (Category); Nodular Lymphocyte Predominant Hodgkin Lymphoma
Lymphoma, Large Cell, Diffuse
Breast Neoplasms
Diffuse, Large B-Cell, Lymphoma
Lymphoma
Inflammatory Disease; Autoimmune Diseases
Hodgkin's Disease
Lupus Erythematosus, Systemic
Waldenstrom Macroglobulinemia
Diffuse Large B Cell Lymphoma
Waldenstrom Macroglobulinemia
Graft Rejection
Chronic Lymphocyte Leukemia; Adult Patients
Lymphoma
Lymphoma
Myositis; Dermatomyositis; Polymyositis; Juvenile Dermatomyositis
Follicular Lymphoma
Lymphoma, Follicular
Diffuse Large B-Cell Lymphoma
Lymphoma
Diffuse Large B-Cell Lymphoma; POOR PROGNOSIS
Richter Syndrome; Chronic Lymphocytic Leukemia
Untreated T-cell Angioimmunoblastic Lymphoma
Lymphoma
Lymphoma, Mantle-Cell
Diffuse Large B-cell Lymphoma
Lymphoma
Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma
Lymphoma, B-Cell
Lymphoma; Non-Hodgkin Lymphoma
Acquired Hemophilia A
Blastic Plasmacytoid Dendritic Cell Neoplasm
Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Untreated Childhood Acute Lymphoblastic Leukemia
Mantle Cell Lymphoma
Rheumatoid Arthritis
Lymphoma
Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia With BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia
Graft Versus Host Disease; Leukemia; Lymphoma
Lymphoma
Myasthenia Gravis
Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma
Pemphigus
Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
Diffuse Large B-cell Lymphoma
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Hairy Cell Leukemia
Lymphoma, AIDS Related; HIV Infections
Lymphocytic Leukemia, Chronic
Cancer
Lymphoma
Peripheral Neuropathy
Diffuse Large B-cell Lymphoma
Rheumatoid Arthritis
High-risk Diffuse Large B-Cell Lymphoma
Chronic Graft-versus-host Disease
Leukemia
Lymphoma
Lymphoma
Relapsed Follicular Lymphoma
Diffuse Large Cell Lymphoma; Burkitt's Lymphoma; High Grade B-cell Lymphoma
Leukemia
Chronic Lymphocytic Leukemia
Fatigue; Primary Biliary Cirrhosis
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
Non Hodgkin Lymphoma
Diffuse Large Cell Lymphoma
Lymphomas
Lymphoma
Hairy Cell Leukemia; Recurrent Hairy Cell Leukemia
Thrombotic Thrombocytopenic Purpura
Non-Hodgkin's Lymphoma
Leukemia, Lymphocytic, Chronic; Lymphoma, Small Lymphocytic
Waldenstrom's Macroglobulinemia
Lymphoma, Mantle-Cell
Marginal Zone Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory Marginal Zone Lymphoma; Refractory Waldenstrom Macroglobulinemia; Waldenstrom Macroglobulinemia
Posttransplant Lymphoproliferative Disorder
Non-Hodgkin Lymphoma
Mantle Cell Lymphoma
Lymphoma, Non-Hodgkin
Non-Hodgkin Lymphoma
Lymphoma
B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma
Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Aggressive Non-Hodgkin's Lymphoma in the Elderly.
Purpura, Thrombocytopenic, Idiopathic
Immune Thrombocytopenia
Chronic Lymphocytic Leukemia
Grafting; Renal Transplantation; Transplantation, Kidney; Chronic Allograft Nephropathy
B-cell Chronic Lymphocytic Leukemia; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
PCNSL
Lymphoma, B-Cell
Malignant Neoplasm of Stomach; Malignant Neoplasm of Cardio-esophageal Junction of Stomach; Epidermal Growth Factor Receptor (EGFR) Protein Overexpression
Lymphoma
Leukemia
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma
Breast Cancer
Lymphoma, Follicular
Non-Hodgkin's Lymphoma
Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia; Leukemia
Mantle Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Multiple Sclerosis
Fibrillary Glomerulonephritis
Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Transformed Lymphoma
Large B-cell Diffuse Lymphoma of Testis
Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia
Primary CNS Lymphoma
Indolent Non Hodgkin Lymphoma
Leukemia, Mast-Cell; Mantle-cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Lymphoma
Breast Neoplasms
Lymphoma
Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)
Diffuse Large B Cell Lymphoma; Lymphoma, Non-Hodgkin
Pemphigus
Follicular Lymphoma
Acute Bilineal Leukemia; Acute Biphenotypic Leukemia; Acute Leukemia of Ambiguous Lineage; Acute Undifferentiated Leukemia; Mixed Phenotype Acute Leukemia; Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified; Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified; Recurrent Mixed Phenotype Acute Leukemia
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma
Non-Hodgkins Lymphoma
MALT LYMPHOMA
Diffuse Large B-cell Lymphoma
Lymphoma
Lymphoma, Non-Hodgkin's
Follicular Lymphoma
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Nodal Marginal Zone Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Early and Severe Systemic Sclerosis
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Diffuse Large B-cell Lymphoma
Lymphoma
Diffuse Large B-Cell Lymphoma; Lymphoma, Diffuse Large-Cell; Diffuse Large-Cell Lymphoma; Lymphoma
Kidney Failure
Central Nervous System Lymphoma
Lymphoma, Non-Hodgkin's
Waldenstrom's Macroglobulinemia; Lymphoplasmacytic Lymphoma
Follicular Lymphoma
B-cell Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
Brain and Central Nervous System Tumors; Drug/Agent Toxicity by Tissue/Organ; Lymphoma; Thrombocytopenia
Diffuse Large B-cells Non-Hodgkin Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma, Non-Hodgkin; Lymphoma, B-Cell
Lymphoma
Lymphoma
Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Lymphoma
Diffuse Large B Cell Lymphoma
Lymphoma
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma
Mantle Cell Lymphoma
AIHA - Warm Autoimmune Hemolytic Anemia
Diffuse Large B-cell Lymphoma; Follicular Grade 3B Lymphoma
High Risk Non-Hodgkin's Lymphoma
Multicentric Castleman Disease
Lymphoma
Diffuse Large B-Cell Lymphoma
Breast Cancer
Breast Cancer; Brain Tumor - Metastatic
Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2 and BCL6 Rearrangements
Non-Hodgkin's Lymphoma
Waldenstrom's Macroglobulinemia
Follicular Lymphoma
Primary Central Nervous System Non-Hodgkin Lymphoma
Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia
Lymphoma
Non-Hodgkin's Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Cholangiocarcinoma of the Extrahepatic Bile Duct; Gallbladder Cancer
Hemophilia A
Diffuse Large B-cell Lymphoma; HIV
Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
Rheumatoid Arthritis
Lymphoid Leukemia; Small Lymphocytic Lymphoma; Lymphoma, Non-Hodgkin
Lymphoma
Breast Cancer
Chronic Lymphocytic Leukemia
Blastoid Variant Mantle Cell Lymphoma; CD20 Positive; Mantle Cell Lymphoma; Pleomorphic Variant Mantle Cell Lymphoma
Lymphoma
DLBCL; Lymphoma, B-Cell
Mantle Cell Lymphoma
HIV; Burkitt's Lymphoma
Hepatitis C; Vasculitis
Lung Transplant
Lymphoma, Small Lymphocytic; Lymphocytic Leukemia, Chronic
Leukemia; Lymphoma
Non-Hodgkin's Lymphoma
Follicular Lymphoma
Leukemia
HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
Precancerous Condition
AIDS-Related Burkitt Lymphoma; Atypical Burkitt/Burkitt-Like Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Recurrent Acute Lymphoblastic Leukemia; Recurrent Burkitt Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Burkitt Lymphoma
Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma; Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Marginal Zone B-cell Lymphoma
Non-Hodgkins Lymphoma
Rheumatoid Arthritis
Mantle-Cell Lymphoma
Non-Hodgkin's Lymphoma (CD20+)
Cold Agglutinin Disease
Acute Lymphocytic Leukemia; Adult Lymphoblastic Lymphoma
Gastric Cancer
Lymphoma
Renal Insufficiency, Chronic; Nephrotic Syndrome
B-Cell Lymphoma; Follicular Lymphoma; Marginal Lymphoma
Lymphoma
Blood Stem Cell Transplant Failure; Leukemia; Hematologic Malignancies
Chronic Lymphocytic Leukemia
Metastatic Breast Cancer
Hodgkin Lymphoma
Prostate Cancer
Lymphoma
Breast Cancer
Non Hodgkin's Lymphoma
Lymphoma; B-cell Non-Hodgkin's Lymphoma
Lymphoma
Sarcoidosis
Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma
Non-Hodgkin's Lymphoma; Diffuse Large Cell Lymphoma; Mantle Cell Lymphoma; Transformed Lymphoma; Other Subtypes of B-cell Lymphoma; Lymphoma
Waldenstrom's Macroglobulinaemia
Chronic Fatigue Syndrome; Myalgic Encephalomyelitis
AIDS Related Lymphoma
Lymphoma
Patients Receiving Mismatched Allogeneic HCT
Lymphoma
Lymphoma
Mantle Cell Lymphoma
Mantle Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Low-Grade
Chronic Lymphocytic Leukemia
Diffuse Large-Cell Lymphoma
Endometrial Adenocarcinoma; ERBB2 Gene Amplification; Recurrent Uterine Corpus Carcinoma; Stage III Uterine Corpus Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7
Diffuse Large B-Cell Lymphoma Unclassifiable; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed B-Cell Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma; B-cell Non-Hodgkin's Lymphoma
Non Hodgkin Lymphoma; Follicular Lymphoma
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Diffuse Large B Cell Lymphoma
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Leukemia; Multiple Myeloma and Plasma Cell Neoplasm
Lymphoproliferative Disorder; HHV-8; Malignancy; HIV
Leukemia
Leukemia; Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Relapsed or Refractory Marginal Zone B-cell Lymphoma
HER-2 Positive Metastatic Breast Cancer
Adult Diffuse Large B-Cell Lymphoma; B-Cell Non-Hodgkin Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Non-Hodgkin Lymphoma; T-Cell Non-Hodgkin Lymphoma
Minimal Change Nephrotic Syndrome (MCNS)
Follicular T-NHL Lymphoma; Rituximab Maintenance
Lymphocytic Leukemia, Chronic
MALT Lymphoma
Lymphocytic Leukemia, Chronic
Lymphoma
Breast Cancer
Non-Hodgkins Lymphoma
Lymphoma, Follicular
Rheumatoid Arthritis
PCNSL
Leukemia; Lymphoma
Diffuse Large B-cell Lymphoma
Graft Versus Host Disease
Multiple Myeloma
Philadelphia Chromosome Negative; Recurrent B Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia
Diffuse Large B Cell Lymphoma
Lymphoma; Follicular Lymphoma; Follicular Lymphoma, Grade 1; Follicular Lymphoma Grade 2; Follicular Lymphoma Grade IIIa; Marginal Zone Lymphoma; Marginal Zone B Cell Lymphoma
Breast Neoplasms; Breast Cancer
Breast Cancer
Follicular Lymphoma
Graft Versus Host Disease
Chronic Lymphocytic Leukemia
Pulmonary Alveolar Proteinosis; Primary Disease
Waldenstrom's Macroglobulinemia
Heart Transplantation
Breast Cancer
Lymphoma
Lymphoma; Mantle Cell Lymphoma; Indolent Lymphoma; SLL
Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma
Lymphoma, AIDS-related; Lymphoma, Large B-Cell, Diffuse
Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Myeloid Sarcoma; Chronic Myeloid Leukemia (CML); Juvenile Myelomonocytic Leukemia (JMML); Myelodysplastic Syndrome (MDS); Non-Hodgkin Lymphoma (NHL)
Neuroblastoma; Opsoclonus-Myoclonus
Lymphoma, Large B-Cell, Diffuse (DLBCL)
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Follicular Lymphoma
Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma
Mucopolysaccharidosis Disorders; Hurler Syndrome; Hunter Syndrome; Maroteaux Lamy Syndrome; Sly Syndrome; Alpha-Mannosidosis; Fucosidosis; Aspartylglucosaminuria; Glycoprotein Metabolic Disorders; Sphingolipidoses; Recessive Leukodystrophies; Globoid Cell Leukodystrophy; Metachromatic Leukodystrophy; Niemann-Pick B; Niemann-Pick C Subtype 2; Sphingomyelin Deficiency; Peroxisomal Disorders; Adrenoleukodystrophy With Cerebral Involvement; Zellweger Syndrome; Neonatal Adrenoleukodystrophy; Infantile Refsum Disease; Acyl-CoA Oxidase Deficiency; D-Bifunctional Enzyme Deficiency; Multifunctional Enzyme Deficiency; Alpha-methylacyl-CoA Racmase Deficiency; Mitochondrial Neurogastrointestingal Encephalopathy; Severe Osteopetrosis; Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation); Inherited Metabolic Disorders
Lymphoma
Graft Vs Host Disease
Lymphoma
Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Marginal Zone Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Marginal Zone Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; CD20 Positive; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Chronic Lymphocytic Leukemia
B-cell Adult Acute Lymphoblastic Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia; Untreated Adult Acute Lymphoblastic Leukemia
Lymphoma
Lymphoma
Lymphoma, Non-Hodgkin; Diffuse Large B-cell Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Primary Sjögren's Syndrome; Xerostomia; Hyposalivation; Keratoconjunctivitis Sicca; Fatigue
Indolent Non-Hodgkin's Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Waldenström Macroglobulinemia
Richter Syndrome
Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma
Leukemia; Lymphoma
Lupus Erythematosus, Systemic
Lymphoma
Type 1 Diabetes Mellitus
Leukemia; Chronic Lymphocytic Leukemia
Lymphocytic Leukemia, Chronic
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Breast Cancer
Lymphoma
Leukemia
Leukemia, Acute Lymphocytic (ALL); Leukemia, Myeloid, Acute(AML); Leukemia, Myeloid, Chronic(CML); Juvenile Myelomonocytic Leukemia (JMML); Hemoglobinuria, Paroxysmal Nocturnal (PNH); Hodgkin Lymphoma; Lymphoma, Non-Hodgkin (NHL); Myelodysplastic Syndrome (MDS)
Breast Cancer
Multiple Sclerosis
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Primary Central Nervous System Lymphoma
Immune Thrombocytopenia
Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Acute Lymphoblastic Leukemia in Remission; B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma
Refractory Aggressive Non-Hodgkin's Lymphoma; Relapsing Aggressive Non-Hodgkin's Lymphoma
Lymphoma
Lymphoma
Lymphoma
Lymphoma
Leukemia; Lymphoma
Progressive Multiple Sclerosis
Mantle Cell Lymphoma; Lymphoma
AIDS-Related-Primary Central Nervous System Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia; Lymphoma
Diffuse Large B-Cell Lymphoma
HER2-positive Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
Type 1 Diabetes Mellitus
Breast Cancer
Myeloma; Lymphoma
Kidney Transplantation
Lymphoma
Large-B-cell Diffuse Lymphoma; Chronic Lymphoid Leukemia
Immune Thrombocytopenia
Anemia, Aplastic; Red-Cell Aplasia, Pure; Anemia, Diamond-Blackfan
Follicular Lymphoma
Mantle Cell Lymphoma
Cardiac Allograft Vasculopathy; Heart Transplant Recipients
Primary Disease
Lymphoma; Neurotoxicity; Therapy-related Toxicity
Burkitt Lymphoma; Non-Hodgkins Lymphoma; Atypical Burkitt Lymphoma
Lymphoma
Lymphoma
Leukemia; Chronic Lymphocytic Leukemia; Lymphocytic Leukemia
Myositis; Myasthenia Gravis
Mantle Cell Lymphoma
Mantle Cell Lymphoma
Waldenstrom's Macroglobulinemia
Lymphoma, Large B-cell, Diffuse
Breast Neoplasms
Burkitt Lymphoma; Diffuse Large B-cell Lymphoma, c-MYC Positive; Plasmablastic Lymphoma
Marginal Zone Lymphoma; Nodal Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma
HER2-positive Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer
End Stage Renal Disease
Chronic Lymphocytic Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Diffuse Large B Cell Lymphoma
Mantle Cell Lymphoma; Lymphoma, Mantle Cell
Diffuse Large B-Cell Lymphoma
Mantle Cell Lymphoma
Low-grade B Cell Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated
CD20+, B-cell Lymphomas; Mantle Cell Lymphoma; Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL); Transformed Lymphoma/DLBCL/PMBCL; Hodgkin's Disease; Gray Zone Lymphoma
Classic Hodgkin Lymphoma; Lugano Classification Stage III Hodgkin Lymphoma AJCC v8; Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
Primary Focal Segmental Glomerulosclerosis
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive Non-Hodgkin Lymphoma
B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Leukemia; Lymphoma
B-Cell Non-Hodgkin Lymphoma
Refractory Large B-cell Lymphoma
Lymphoma
Immune Thrombocytopenic Purpura
Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkin Lymphoma
Diffuse Large B Cell Lymphoma; Primary Mediastinal (Thymic) Large B-cell Lymphoma; Transformed Indolent Lymphoma; Recurrent Disease; Refractory Cancer
Lymphoma
Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Burkitt Lymphoma; B-ALL
Relapsed/Refractory Mantle Cell Lymphoma
Thrombotic Thrombocytopenic Purpura; Hemolytic Uremic Syndrome
Follicular Lymphoma
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
Lymphoma
Multiple System Atrophy
Lymphoproliferative Disorder
Acute Lymphoblastic Leukemia; Burkitt's Lymphoma
Lymphoma
Chronic Lymphocytic Leukemia
Breast Cancer; Brain Metastases
Lymphoma
Acute Lymphoid Leukemia (ALL); Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML); Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia
Central Nervous System Lymphoma
Lymphoma, B-Cell
Chronic Lymphocytic Leukemia; Leukemia
Lymphoma, Non-Hodgkin
Lymphoma
CD20 Positive; Hematopoietic and Lymphoid Cell Neoplasm; Lymphocytic Neoplasm; Lymphoma
Lymphomatoid Granulomatosis; Granulomatosis, Lymphomatoid; Non-Hodgkins Lymphoma; Lymphoproliferative Disorder
Leukemia; Acute Lymphoblastic Leukemia
Graft Versus Host Disease; Systemic Scleroderma
Follicular Lymphoma; Non Hodgkin Lymphoma; Lymphoma
Waldenström's Macroglobulinemia
Systemic Sclerosis-Associated PAH
Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Untreated CD20-positive Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Lymphoma
Burkitt Leukemia; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Recurrent Acute Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Burkitt Leukemia; Recurrent Burkitt Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Acute Lymphoblastic Leukemia; Refractory Burkitt Leukemia; Refractory Burkitt Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Lymphoblastic Lymphoma
Primary Central Nervous System Lymphoma
Follicular Lymphoma
Lymphoma
Waldenstrom Macroglobulinemia
Non-Hodgkin Lymphoma
Breast Cancer
Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chemotherapy-Related Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Hodgkin Lymphoma; Langerhans Cell Histiocytosis; Minimal Residual Disease; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Non-Hodgkin Lymphoma; Recurrent Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Myelodysplastic Syndrome; Small Lymphocytic Lymphoma; Therapy-Related Myelodysplastic Syndrome
Diffuse Large B Cell Lymphoma; Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma
Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, Diffuse
Non-Hodgkin's Lymphoma
Leukemia; Lymphoma
Idiopathic Membranous Nephropathy
Nephrotic Syndrome; Proteinuria; Autoimmune Disease; Glomerular Disease; Membranous Glomerulonephritis
Diffuse Large B-cell Lymphoma (DLBCL)
B-cell Non Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Diffuse Large B-Cell Lymphoma
Hematologic Malignancies
Leukemia
Renal Transplantation
Lymphoma, Non-Hodgkin; MALT Lymphoma
B-cell Childhood Acute Lymphoblastic Leukemia; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; L3 Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma
Diffuse Large B-cell Lymphoma
Systemic Sclerosis
Lymphoma
Non-Hodgkin's Lymphoma
Graft vs Host Disease; Alogenic Hematopoietic Transplant
DLBCL
Rheumatoid Arthritis
Follicular Lymphoma; Small Lymphocytic Lymphoma
Non-Hodgkin's Lymphoma
Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Rheumatoid Arthritis
Advanced Refractory Chronic Lymphocytic Leukemia
Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Lymphoma
Non-Hodgkin's Lymphoma
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations
Lymphoma
Chronic Lymphocytic Leukemia; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
Lymphocytic Leukemia; Mantle Cell Lymphoma
Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma
Lymphoma of Mucosa-Associated Lymphoid Tissue
Diffuse Large Cell Lymphoma; Lymphoma
Kidney Failure, Chronic; Diabetic Nephropathies; Glomerulonephritis, IGA; Hypertension, Renal
Waldenstrom's Macroglobulinemia
Kidney Transplant; Kidney Transplant Recipient; Graft Function/Survival; de Novo HLA Antibodies Development
Leukemia, Lymphocytic, Acute
Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Lymphoma, Follicular
Breast Cancer
Mantle Cell Lymphoma
Behcet's Syndrome
Chronic Lymphocytic Leukemia
Multiple Myeloma
Breast Cancer
Kidney Transplantation; Kidney Failure, Chronic
Follicular Lymphoma
Metastatic Breast Cancer
Chronic B-Lymphocytic Leukemia
Systemic Sclerosis; Diffuse Sclerosis Systemic; Interstitial Lung Disease; Pulmonary Hypertension
Leukemia
No Hodgkin B Lymphoma
Large B Cell Lymphoma
B Cell Lymphoma
Ambulatory IPF
Focal Segmental Glomerulosclerosis (FSGS)
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell
Leukemia
Lymphoma
Stomach Neoplasms; Neoplasms Metastasis; ERBB2 Gene Amplification
B-cell Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Lymphoma
Chronic Lymphocytic Leukemia; CLL
Non-Hodgkin's Lymphoma
B-cell Chronic Lymphocytic Leukemia CLL
Non-Hodgkin's Lymphoma
Lymphoma
Lymphoma, Mantle-Cell
Rheumatoid Arthritis
Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
Leukemia
Leukemia; Lymphoma
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach
Thrombotic Thrombocytopenic Purpura (TTP)
Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
Waldenstrom Macroglobulinemia
Chidamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm by Histology; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Lymphoma, Non-Hodgkin; Cyclophosphamide; Rituximab; Gemcitabine; Cisplatin; Dexamethasone; HDAC Inhibitor
Idiopathic Pulmonary Fibrosis, Acute Fatal Form
Richter Syndrome
Follicular Lymphoma
Diffuse Large B Cell Lymphoma; Mediastinal Large B-cell Lymphoma; Grey Zone Lymphoma; High Grade B Cell Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Leukemia; Lymphoma
Untreated Mantle Cell Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Waldenstrom's Macroglobulinemia
Diffuse Large B-cell Lymphoma
Lymphoma
Lymphoma
Urinary Tract Cancer
Leukemia; Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma
Lymphoma
Leukemia
Diffuse Large B-cell Lymphoma
B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Recurrent T Lymphoblastic Leukemia/Lymphoma; Refractory B Lymphoblastic Lymphoma; Refractory T Lymphoblastic Lymphoma; T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma
Leukemia
Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
Heart Failure With Reduced Ejection Fraction
Diffuse Large B-cell Lymphoma Refractory; Follicular B-cell Non-Hodgkin's Lymphoma
Lymphoma, Non-Hodgkin; Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma
Churg-Strauss Syndrome
Recurrent B Acute Lymphoblastic Leukemia; Recurrent Ph-Like Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia; Refractory Ph-Like Acute Lymphoblastic Leukemia
Rheumatoid Arthritis
Chronic Lymphocytic Leukemia
Lymphoma; B-cell Lymphoma; Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia
Epstein Barr Virus Associated Non Hodgkin's Lymphoma; Epstein Barr Virus Associated Hodgkin's Lymphoma; Post-Transplant Lymphoproliferative Disease
Lymphoma
Leukemia; Lymphoma
Rheumatoid Arthritis
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Immune Thrombocytopenia; Thrombotic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura
B-Cell Lymphoma
Prolymphocytic Leukemia
Non-Hodgkin's Lymphoma
Diffuse Large B-cell Lymphoma
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Primary Intraocular Lymphoma
Non-Hodgkins Lymphoma
Contiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Stage I Mantle Cell Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Mantle Cell Lymphoma
PTLD; Posttransplant Lymphoproliferative Disorder
Diffuse Large B Cell Lymphoma; Age Over 80 Years
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Post-transplantation Lymphoproliferative Disorder
Lymphoma
Rheumatoid Arthritis
Primary Gastric Diffuse-Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma; Lymphoma, Large Cell; Diffuse, Mantle Cell Lymphoma, Lymphoma; Follicular Lymphoma; Large B-Cell, Diffuse
Diffuse Large B-Cell Lymphoma
Lymphoma
Diffuse Large B-cell Lymphoma
Stiff Person Syndrome
Purpura, Thrombocytopenic, Idiopathic
Recurrent Mantle Cell Lymphoma
Lymphoma
Primary Mediastinal Large B Cell Lymphoma
Sarcoma
Leukemia
Aggressive Lymphoma; Diffuse Large B-cell Lymphoma; Mantle Cell Lymphoma
Lymphoma, Small Lymphocytic; Leukemia, Lymphocytic, Chronic
Antiphospholipid Syndrome
Lymphoma; Relapse
Waldenstrom's Macroglobulinemia
Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor; Relapsed Pediatric AML; Refractory Pediatric AML
Lymphoma, B Cell
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Lymphocytic Leukemia, Chronic
Diffuse Large B Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
Relapsed or Refractory Diffuse Large B Cell Lymphoma
Waldenstrom; Prior Bortezomib Therapy Acceptable.
Lymphoma
Breast Cancer
Lymphoma
Diffuse Large Cell Lymphoma
Lymphoma; Leukemia
Aggressive Non-Hodgkin Lymphoma
Lymphoma
Diffuse Large B Cell Lymphoma
Chronic Fatigue Syndrome; Myalgic Encephalomyelitis
Diffuse Large B-Cell Lymphoma
Lymphocytic Leukemia, Chronic
Thrombotic Thrombocytopenic Purpura
B-Cell Lymphomas
Lymphoma
Lymphoma
Chronic Myeloid Leukemia
Lymphoma
Lymphoma
Lymphoma
Lymphoma
AIDS Related Lymphoma; AIDS-Associated Lymphoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma (DLBCL); Primary Mediastinal Large B-cell Lymphoma; Burkitt Lymphoma; Anaplastic Large-Cell Lymphoma; Gray Zone Lymphoma
Leukemia; Lymphoma
Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia; Leukemia
Lymphoma
Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
EBV-Positive DLBCL, Nos
Multiple Sclerosis, Chronic Progressive; Nervous System Diseases
Lymphoma, Large B-Cell, Diffuse
Lymphoma
Lymphoma
Post-transplant Lymphoproliferative Disease; Solid Organ Transplant; Stem Cell Transplant (Bone Marrow Transplant); Epstein Barr Virus Infections
Cold Agglutinin Disease; Autoimmune Hemolytic Anemia
Relapsed Non-Hodgkin-Lymphoma
Diffuse Large B-Cell Lymphoma
Primary Non Hodgkin Lymphoma of the Central Nervous System
Breast Cancer
Breast Cancer
Lymphoma
Lymphoma, Non-Hodgkin
Burkitt Lymphoma
AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma
Lymphoma
Systemic Lupus Erythematosus
Primary Central Nervous System Lymphoma
Mantle Cell Lymphoma
Aggressive Lymphoma
Lymphoma, Follicular
Lymphoma
Lymphoma
CCND1 Positive; CCND2 Positive; CCND3 Positive; CD20 Positive; Mantle Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Lymphoma
Leukemia; Lymphoma
Lymphoma
B-Chronic Lymphocytic Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma, Malignant
Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
Mantle-cell Lymphoma
CLL; Chronic Lymphocytic Leukemia
Lymphoma
Recurrent Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma; Mantle Cell Lymphoma; Burkitt's Lymphoma
Indolent Lymphoma
Devic's Disease
Lymphoma, B-Cell; Follicular Lymphoma
B-Cell Malignancies
Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma; Follicular Lymphoma
Mantle Cell Lymphoma
Breast Cancer; Neoplasm Metastasis
Brain Metastases; Lung Cancer; Breast Cancer; Melanoma; Malignant Glioma
Non-Hodgkin's Lymphoma
Focal Segmental Glomerulosclerosis
Lymphoma
Chronic Lymphocytic Leukemia
Lymphoma; Leukemia
Idiopathic Thrombocytopenic Purpura (ITP); Immune Thrombocytopenic Purpura (ITP)
Recurrent Breast Cancer
Lymphoma; Hodgkin's Lymphoma; Non-hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Epstein-Barr Virus Infections; Post-transplant Lymphoproliferative Disorder
Chronic Graft-versus-host-disease
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma
Chronic Lymphocytic Leukemia
Lymphoma
Diffuse Large B Cell Lymphoma Relapsed; Diffuse Large B Cell Lymphoma Refractory
Metastatic Breast Cancer
Chronic Lymphocytic Leukemia
Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Thrombotic Thrombocytopenic Purpura
Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Acute Leukemia; Myelodysplastic Syndrome; Solid Tumors
Follicular Lymphoma; Lymphoma, Large B-Cell, Diffuse
CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell Lymphoma
Idiopathic Pulmonary Fibrosis; Emphysema or COPD
Adult Burkitt Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Diffuse Large B-Cell Lymphoma; MYC Gene Mutation; Plasmablastic Lymphoma
Blood And Marrow Transplantation; Leukemia; Lymphoma; Transplantation Infection; Myelodysplastic Syndrome (MDS); Non-Hodgkin's Lymphoma (NHL); Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma, Lymphoma Follicular
Ocular Cicatricial Pemphigoid
Waldenstrom's Macroglobulinemia
Non-Hodgkin's Lymphoma (NHL)
Non-Hodgkin's Lymphoma
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; t(9;22)
Lymphoma, Diffuse Large-Cell B-cell; Diffuse, Large B-cell Lymphoma; Lymphoma, Diffuse Large-Cell; Large-Cell Lymphoma, Diffuse
Mantle Cell Lymphoma Refractory
Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
B-cell Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Non Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Myelodysplastic Syndrome; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Acute Leukemia; Multiple Myeloma
Lymphoma
Leukemia; Lymphoma
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Untreated Adult Acute Lymphoblastic Leukemia
Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma
DLBCL
Malignant Lymphoma
Treatment
Chronic Rejection; Kidney Insufficiency
Richter's Transformation; Leukemia
Lymphoma
Advanced Cancers; Lymphoma
Non Hodgkin Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Lymphoma
End Stage Renal Disease
Graves' Dysthyroid Ophthalmopathy; Thyroid Related Orbitopathy
Primary Central Nervous System Lymphoma; Recurrent Cancer
Scleritis; Orbital Disease
Lymphoma
B-Cell Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma
Crohn's Disease
Lymphoma; Non Hodgkin's Lymphoma
Non Hodgkin Lymphoma
High Grade Lymphomas CD20 Positive
Breast Cancer
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Bullous Pemphigoid
Lupus Erythematosus, Systemic
B-cell Non-Hodgkin Lymphoma
Follicular Lymphoma; Mantle Cell Lymphoma
Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Lymphoma
Lymphoma
Hematopoietic and Lymphoid Cell Neoplasm
Lymphoma
Breast Cancer
Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Progressive Hairy Cell Leukemia, Initial Treatment; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
Breast Cancer
Non-Hodgkin's Lymphoma; Diffuse Large B-cell Lymphoma; Mantle Cell Lymphoma
Metastatic Breast Cancer; Breast Carcinoma; HER-2 Positive Breast Cancer
Recurrent B Acute Lymphoblastic Leukemia; Recurrent T Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia; Refractory T Acute Lymphoblastic Leukemia
Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma
Leukemia; Lymphoid Malignancies; Metastatic Malignant Neoplasm to the Leptomeninges
Ischemic Heart Disease; Myocardial Infarction; Inflammation
Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma
Hodgkin's Disease; Lymphoma
Lymphoma
Leukemia; Lymphoma
Rheumatoid Arthritis
Indolent B-Cell Non-Hodgkin Lymphoma
Diffuse Large B Cell Lymphoma
Myelodysplastic Syndrome; Hodgkin's Lymphoma; Non-Hodgkin's Disease; Acute Leukemia; Multiple Myeloma
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease; Primary Effusion Lymphoma
Lymphoma; DLBCL; Follicular Lymphoma
Leukemia; Lymphoma
Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Waldenström Macroglobulinemia
Lymphoma
Ann Arbor Stage I Grade 1 Follicular Lymphoma; Ann Arbor Stage I Grade 2 Follicular Lymphoma; Ann Arbor Stage II Grade 1 Follicular Lymphoma; Ann Arbor Stage II Grade 2 Follicular Lymphoma
Sickle Cell Anemia; Beta-thalassemia Major; Diamond-blackfan Anemia
Diffuse Large B Cell Lymphoma
Diffuse Large B-cell-lymphoma
Primary Biliary Cirrhosis
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
CD30 Positive Primary Mediastinal Large B-cell Lymphoma; CD30-Positive Diffuse Large B-Cell Lymphoma; CD30-Positive Gray Zone Lymphoma
Non-Hodgkin's Lymphoma
End Stage Renal Disease
B Cell Lymphoma
Mantle Cell Lymphoma
Breast Cancer
Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia
Non-hodgkin's Lymphoma
Non-Hodgkins Lymphoma
CD20 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Stage I Diffuse Large B-Cell Lymphoma; Stage II Diffuse Large B-Cell Lymphoma; Stage III Diffuse Large B-Cell Lymphoma; Stage IV Diffuse Large B-Cell Lymphoma
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
CD20+ Follicular Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma
Lymphoma
Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma
Mantle Cell Lymphoma
Refractory Myasthenia Gravis
Diffuse Large B-cell Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma
B-Cell Lymphoma
Primary Effusion Lymphoma; B-Cell Neoplasm
HER2/Neu Positive; Recurrent Breast Carcinoma; Stage IV Breast Cancer
Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative; Recurrent Anaplastic Large Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Central Nervous System Lymphoma
Graves´ Disease; Thyroid Associated Ophthalmopathy
Kidney Transplant
B-cell Malignancies; Cancer
Chronic Lymphocytic Leukemia
Lymphoma
Opsoclonus-myoclonus Syndrome; Opsoclonus; Myoclonus; Ataxia
Diffuse Large B-Cell Lymphoma
Breast Cancer
Retroperitoneal Fibrosis; Autoimmune Pancreatitis; Sialadenitis; Pseudotumor
Diffuse Large B Cell Non-Hodgkin Lymphoma
IPF
Rheumatoid Arthritis
Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkin Lymphoma (NHL); Multiple Myeloma (MM); Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL); Acute Myeloid Leukemia (AML)
B-cell Lymphoma Recurrent
Leukemia; Solid Tumors
Non Hodgkin Lymphoma
B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Waldenström Macroglobulinemia
Diffuse Large B-cell Lymphoma (DLBCL)
B Cell Lymphoma; Lymphoma
Sjogren's Syndrome
Metastatic Breast Cancer; HER2 Positive Breast Carcinoma
Non-Hodgkin's Lymphoma
Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Epstein-Barr Virus Infection; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Progressive Hairy Cell Leukemia, Initial Treatment; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
Leukemia, Lymphocytic, Chronic, B-Cell
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
Lymphoma
HER-2 Positive Breast Cancer
Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma
Lymphoma, Non Hodgkin
Non-Hodgkin's Lymphoma
AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma
Urticaria
Lymphoma
Leukemia
Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma; B-cell Chronic Lymphocytic Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Stage II Marginal Zone Lymphoma; Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Waldenström Macroglobulinemia
Brain and Central Nervous System Tumors; Lymphoma
Chronic Lymphocytic Leukemia
Breast Cancer
Adult B Acute Lymphoblastic Leukemia; Adult Nasal Type Extranodal NK/T-Cell Lymphoma; Adult Solid Neoplasm; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma; Chronic Lymphocytic Leukemia; Cutaneous B-Cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Hepatosplenic T-Cell Lymphoma; Intraocular Lymphoma; Lymphomatous Involvement of Non-Cutaneous Extranodal Site; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Nodal Marginal Zone Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Plasma Cell Myeloma; Small Intestinal Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Diffuse Large B-cell Lymphoma.
B-cell Lymphoma
Follicular Lymphoma (FL/Indolent NHL); Aggressive NHL (a NHL); Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL); T-cell Lymphoma (PTCL and CTCL); B-cell Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma; Diffuse Large B-Cell Lymphoma
B-cell Lymphoma; Chronic Lymphocytic Leukaemia; Waldenström Macroglobulinaemia
Renal Transplant Rejection
Stiff-Person Syndrome
Adult Non-Hodgkin Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Nodal Marginal Zone Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Lymphoma
Multiple Sclerosis
Diffuse Large B-cell Lymphoma (DLBCL); Follicular Lymphoma Grade III (FL III°); Mantle Cell Lymphoma (MCL), Blastoid Variant; Burkitt Lymphoma (BL); Aggressive Marginal Zone Lymphoma (MZL)
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma
Non Hodgkin Lymphoma
Graft vs Host Disease
Hematopoietic Cell Transplantation Recipient; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory T-Cell Non-Hodgkin Lymphoma
Hematological Malignancies
Lymphoma, B-cell, Diffuse
DLBCL
Lymphoma, Non-Hodgkin; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Small-Cell; Waldenstrom Macroglobulinemia; Lymphoma, B-Cell, Marginal Zone
Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma (MCL)
B-cell Chronic Lymphocytic Leukemia; Leukemia; Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Waldenstrom's Macroglobulinemia
Pompe Disease
Chronic Lymphocytic Leukemia
CD20 Positive; Recurrent B-Cell Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma
Lymphoma
Lymphoma; Relapsed Lymphoma; Refractory Lymphoma; Relapsed and/or Refractory Lymphoma; Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL); Refractory Diffuse Large B-Cell Lymphoma (DLBCL); Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL); Double-hit Lymphoma (DHL); Triple-hit Lymphoma (THL); Double-expressor Lymphoma (DEL); High-grade B-cell Lymphoma (HGBL)
Diffuse B-Cell Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL); Follicular Lymphoma (FL); Marginal Zone B Cell Lymphoma; Diffuse Large B-cell Lymphoma (DLBCL); High Grade Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma (MCL)
Lymphoma
Aggressive Non-Hodgkin Lymphoma; ALK-Positive Large B-Cell Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Glomerulonephritis, Membranoproliferative
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma
Rheumatoid Arthritis
Metastatic Cancer; Solid Tumor; Advanced Cancer; NonHodgkin Lymphoma
Myelodysplastic Syndrome; Leukemia
Non-Hodgkin Lymphoma
B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Lymphoma
Lymphoma, Low-Grade; Lymphoma, Small Lymphocytic; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular
Lymphoma; Leukemia; Transplantation, Stem Cell; Lymphoid Malignancies; Disorder Related to Transplantation
Lymphoma
Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Composite Lymphoma; Grade 3b Follicular Lymphoma; Stage I Diffuse Large B-Cell Lymphoma; Stage I Follicular Lymphoma; Stage II Diffuse Large B-Cell Lymphoma; Stage II Follicular Lymphoma; Stage III Diffuse Large B-Cell Lymphoma; Stage III Follicular Lymphoma; Stage IV Diffuse Large B-Cell Lymphoma; Stage IV Follicular Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hematopoietic/Lymphoid Cancer; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
Contiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia
AIDS-Related Burkitt Lymphoma; AIDS-Related Diffuse Large B-cell Lymphoma; AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; HIV Infection; AIDS Related Non-Hodgkin Lymphoma
CD20-positive B-cell Non-Hodgkin Lymphoma
Refractory Chronic Lymphocytic Leukemia
Primary Central Nervous System Lymphoma (PCNSL)
Lymphoma
Lymphoma
Follicular Lymphoma
Lymphoma
Non-Hodgkin's Lymphoma; Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma; Follicular Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Hodgkin Lymphoma; Refractory T-Cell Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Primary Central Nervous System Lymphoma (PCNSL); Secondary Central Nervous System Lymphoma (SCNSL)
Leukemia, Lymphocytic, Chronic, B-Cell; Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Acute Myelogenous Leukemia; B-cell Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Acute Myeloid Leukemia
T-Cell Peripheral Lymphoma; Gamma Delta Hepatosplenic T-Cell Lymphoma; Subcutaneous Panniculitis-Like T-Cell Lymphoma; NK T-Cell Lymphoma
End-stage Renal Disease; Renal Transplantation; Kidney Transplantation
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
Indolent Non-Hodgkin Lymphoma; Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia
B-cell Chronic Lymphocytic Leukemia; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Progressive Hairy Cell Leukemia, Initial Treatment; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Splenic Marginal Zone Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
CD20-Positive Lymphoid Malignancies; Chronic Lymphoid Leukemia; Hematological Malignancies; Non-Hodgkin's Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Non-Hodgkin's Lymphoma; B-cell Lymphoma
Breast Cancer
Macular Degeneration
Lymphoma, B-Cell
Mantle Cell Lymphoma
Non Hodgkins Lymphoma; Diffuse Large B-cell Lymphoma
Brain and Central Nervous System Tumors; Lymphoma
Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma
Anaplastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Diffuse Large B-cell Lymphoma; Follicular Lymphoma; Burkitt Lymphoma
Rheumatoid Arthritis
B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia; Lymphoma
Recurrent/Refractory CNS; Intraocular Lymphoma
Hairy Cell Leukemia
Psoriatic Arthritis
Leukemia; Lymphoma; Myeloma
Lymphoma
Leukemia
Autoimmune Disease
B-Cell Malignancies
Lymphoma
Lymphoma, B-Cell; Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphoid Malignancies
Lymphoma
Lymphoma, Non-Hodgkin
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Leukemia; Lymphoma; Myeloma
Mantle Cell Lymphoma
Mantle Cell Lymphoma
Lymphoma
Malignancies; Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Non-Hodgkin's Lymphoma; Neuroblastoma
Multiple Myeloma; CLL; Chronic Lymphocytic Leukemia; Lymphoma; Hodgkin Lymphoma
Primary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis
Kidney Insufficiency
Lymphoma
Lymphoma, B-Cell
Sjogren's Syndrome
Lymphoma; Chronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma; T-cell Lymphoma
Immune Thrombocytopenic Purpura
Recurrent Central Nervous System Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Central Nervous System Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Lymphoma
Neuromyelitis Optica
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
Follicular Lymphoma
Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma
Breast Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Nodal Marginal Zone Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Breast Cancer AJCC v6 and v7
Adult Grade III Lymphomatoid Granulomatosis; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Myeloid Diseases
Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia
Breast Cancer
B-cell Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Central Nervous System Lymphoma; Diffuse Large B-Cell Lymphoma
Adult Non-Hodgkin Lymphoma; Adult Grade III Lymphomatoid Granulomatosis; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell of Head and Neck; Malignant Melanoma
Irradiated Bone Marrow; Transplant-Related Hematologic Malignancy; Leukemia, Acute; Multiple Myeloma; Graft Vs Host Disease
Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma; Richter Syndrome; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Lymphoma, Non-Hodgkin
Primary Central Nervous System Lymphoma
Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia
Advanced or Metastatic Solid Tumors; Cancer; Solid Cancers
MYOPATHY
Diffuse Large B-cell Lymphoma; High-Grade B-cell Lymphoma
Diffuse Large B-Cell Lymphoma; Mediastinal B-cell Lymphoma
Diffuse Large B-Cell Lymphoma
Stem Cell Transplantation; Leukemia; Lymphoma; Pediatric Disorders
B-cell Lymphoma
Lymphoma, B Cell
Lymphoma; Hodgkin Disease; Lymphoma, Non-Hodgkin
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Mantle Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Lymphoma
Grade 3b Follicular Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Non-Hodgkin's Lymphoma
B-cell Lymphoma
Hematologic Malignancies
AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Rheumatoid Arthritis
CD20 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Acute Lymphoblastic Leukemia; ALL, Childhood; ALL
Chronic Lymphocytic Leukemia
Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Ulcerative Colitis; Inflammatory Bowel Disease
B-cell Lymphoma
HER2 Positive Untreated Metastatic Breast Cancer; Asymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer
Hematologic Malignancies; Solid Tumor
Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
Breast Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Prolymphocytic Leukemia
Wegener's Granulomatosis
Mantle Cell Lymphoma
Follicular Lymphoma
Solid Tumor; Lymphoma
Chronic Lymphocytic Leukemia; CLL; Relapsed CLL; Refractory Chronic Lymphocytic Leukemia; Relapsed Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; SLL; Relapsed Small Lymphocytic Lymphoma; Refractory Small Lymphocytic Lymphoma
Non-Hodgkin's Lymphomas
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Immunoglobulin G Subclass 4 Related Disease; IgG4-related Disease; Autoimmune Pancreatitis; IgG4-related Sclerosing Cholangitis; Retroperitoneal Fibrosis
Diffuse Large B-cell Lymphoma Recurrent; Diffuse Large B Cell Lymphoma Refractory
Lymphoma
Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Aplastic Anemia; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Lymphoblastic Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Therapy-Related Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; Peripheral T-cell Lymphoma
Lymphocytic Leukemia, Chronic
Lymphoma; Myeloma
Leukemia
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Leukemia
Transplants and Implants
Lymphoma
Lymphoma, Large B-Cell, Diffuse
Relapsed/Refractory Mantle Cell Lymphoma
Multiple Myeloma; Non-Hodgkin Lymphoma; B-Cell Lymphoma
Renal Transplantation
Non-hodgkin Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
Lymphoma
Inflammatory Breast Cancer
Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
Unspecified Adult Solid Tumor, Protocol Specific
Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Focal Encephalitis; Rasmussen's Encephalitis
Leukemia Lymphocytic Chronic B-Cell
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
Metastatic Melanoma
Leukemia; Lymphoma; Lymphoproliferative Disorder
NHL; Non Hodgkin Lymphoma; Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma
Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
Blood And Marrow Transplantation; Leukemia; Lymphoma; Transplantation Infection; Transplantation, Bone Marrow
Renal Failure
Lymphoma, Non-Hodgkin; Lymphoma
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Pulmonary Alveolar Proteinosis (PAP); Severe Mucocutaneous Candidoasis
Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Head and Neck Squamous Carcinoma
Lymphoma, Follicular
B-cell Small Lymphocytic Lymphoma Recurrent
Hematologic Neoplasms
Central Nervous System Lymphoma; Intraocular Lymphoma
B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
HER2-Positive Metastatic Breast Cancer; HER2-Negative Metastatic Breast Cancer; Locally Advanced or Early Breast Cancer
Lymphoma
Lymphoma
Lymphoma
Lymphoma
Prostate Cancer
Breast Neoplasms
Diffuse Large B Cell Lymphoma; Post Transplant Lymphoproliferative Disorder; Primary Mediastinal (Thymic) Large B-cell Lymphoma
Membranous Nephropathy
Brain and Central Nervous System Tumors; Lymphoma; Neurotoxicity
Central Nervous System Lymphoma
Nonneoplastic Condition
Renal Transplant Recipients
Neuroblastoma
Post-transplant Lymphoproliferative Disease; Transplant-Related Hematologic Malignancy
Mantle Cell Lymphoma; Lymphoma
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Waldenström Macroglobulinemia
Hematologic Disorders; Oncologic Disorders; Rheumatologic Disorders
Lymphoma, B-Cell
Liver Dysfunction; Immune Suppression; Hepatitis B
Non Hodgkin Lymphoma
Rheumatoid Arthritis
Lymphocytic Leukemia, Chronic
Intestinal Transplant; Cellular Rejection
Rheumatoid Arthritis
Immune Thrombocytopenia
Rheumatoid Arthritis
Lymphoma
Lymphoma, B-Cell, Marginal Zone
Breast Cancer
Non-Hodgkin Lymphoma
Rheumatology; Cardiovascular Diseases; Arthritis, Rheumatoid; Spondyloarthritis
Rheumatoid Arthritis; Inflammatory Bowel Disease; Psoriasis; Psoriatic Arthritis; Ankylosing Spondylitis
Lymphoma, Non-Hodgkin
Lymphoma
Lymphoma
Non-Hodgkin's Lymphoma; Lymphoma
Lymphoma, Mantle-Cell
Rheumatoid Arthritis; Inflammation
Rheumatoid Arthritis
Diffuse Large B Cell Lymphoma
Breast Cancer
Chronic Lymphocytic Leukaemia
Chronic Lymphocytic Leukemia
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Atopic Dermatitis
Autoimmune Hemolytic Anemia
Rheumatoid Arthritis
Diffuse Large B-cell Lymphoma
Aplastic Anemia
Transplant; Complication, Rejection
Lymphoma; Leukemia
Granulomatosis, Wegener's; Microscopic Polyangiitis
Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma
Non-Hodgkins Lymphoma
Rheumatoid Arthritis
Purpura, Thrombocytopenic, Idiopathic
Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Acute; Lymphoma, Low-Grade; Lymphoma, T-Cell; Lymphoma, B-Cell
Dermatitis, Atopic
Lymphoma
Rheumatoid Arthritis
Wegener's Granulomatosis; Churg-Strauss Syndrome; Microscopic Polyangiitis
Thyroid Eye Disease
Hematological Malignancies B
Chronic Lymphocytic Leukemia
Renal Transplant Rejection
Diffuse Large B-Cell Lymphoma
Lymphoma
Leukemia; Acute Lymphoblastic Leukemia; ALL
Interstitial Lymphocytic Lung Disease
Gastric Cancer
Lymphoma, B-Cell, Lymphoma, Follicular
Lymphoma; Leukemia
Lymphoma
Rheumatoid Arthritis
Lymphoma, Follicular
Rheumatoid Arthritis
Lymphoma
Relapsing-remitting Multiple Sclerosis
Acute Rejection; Renal Transplantation
Anemia, Aplastic; Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Kostmann Syndrome
Lymphoma
Diffuse Large B-Cell Lymphoma
Graft vs Host Disease
Rheumatoid Arthritis
Idiopathic Thrombocytopenia Purpura
Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Rheumatoid Arthritis
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
End Stage Renal Disease
Non-Hodgkins Lymphoma
Lupus Nephritis
Lymphocytic Leukemia, Chronic
Lymphoma
Breast Cancer
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Lymphoma; Non-Hodgkin's Lymphoma
Rheumatoid Arthritis
Burkitt's Lymphoma; High-grade B-cell Lymphoma
Exposure to Hepatitis B Virus
Waldenstrom's Macroglobulinemia
Lymphoma
Cognitive Impairment; Autoimmune Encephalitis
Lymphoma
Patient's Satisfaction
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma
Lymphoma
B-cell Lymphoma
Lymphoma
Lymphoma, Follicular
Non-Hodgkin's Lymphoma
Primary Mediastinal B-cell Lymphoma
Hairy-cell Leukemia
Lymphoma
Granulomatosis With Polyangiitis; Microscopic Polyangiitis
Rheumatoid Arthritis
Multiple Sclerosis
Chronic Lymphocytic Leukemia (CLL)
CLL; B-cell; Small Lymphocytic Lymphoma; Untreated B-CLL; Elderly Patients
Lymphoma
Endothelial Function; Rheumatoid Arthritis; Inflammation
Lupus Nephritis; Children; Steroid; Immunosuppressive Treatment
Follicular Lymphoma
Rheumatoid Arthritis
Lymphocytic Leukemia, Chronic
Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma; Patients Treated With Rituximab-CHOP or Rituximab-CVP
Immune Thrombocytopenia
Follicular Lymphoma
Lymphoma, Large-Cell, Diffuse
Non Hodgkin Lymphoma (NHL); Diffuse Large B-cell Lymphoma (DLBCL)
Rheumatoid Arthritis
Grade 3b Follicular Lymphoma
Breast Cancer; Pregnancy
Psoriasis
Gastroesophageal Reflux Disease (GERD); Community-acquired Pneumonia
Osteopetrosis
Lymphoma
Rheumatoid Arthritis
Lymphoma, Non-Hodgkin
Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenia
Skin Cancer
Lymphocytic Leukemia, Chronic, Chronic Lymphocytic Leukemia, Cancer
End Stage Renal Disease
Lymphoma, Follicular
Diffuse Large B Cell Lymphoma; Neutropenia, Febrile
Uveitis; Scleritis
Rheumatoid Arthritis
Relapsed or Refractory Chronic Lymphoproliferative Disorders
Rheumatoid Arthritis
Lymphocytic Leukemia, Chronic
Lymphoma
Pemphigus
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Off-Label Use
Rheumatoid Arthritis
Sickle Cell Anemia; Sickle Cell-hemoglobin C Disease; Sickle Cell-β0-thalassemia
Pemphigus; Auto-immune Thrombocytopenic Purpura; Hemolytic Auto-immune Anaemia; Cold Agglutinin Disease; Cryoglobulinemia
Immune Thrombocytopenia
Long-term Effects Secondary to Cancer Therapy in Adults; Lymphoma
Primary Immune Thrombocytopenia
Brain and Central Nervous System Tumors; Lymphoma
Rheumatoid Arthritis
Rheumatoid Arthritis
Lymphoma, Non-Hodgkin; Lymphomas: Non-Hodgkin; Lymphomas: Non-Hodgkin Cutaneous Lymphoma; Lymphomas: Non-Hodgkin Diffuse Large B-Cell; Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell; Lymphomas: Non-Hodgkin Mantle Cell; Lymphomas: Non-Hodgkin Marginal Zone; Lymphomas: Non-Hodgkin Peripheral T-Cell; Lymphomas: Non-Hodgkin Waldenstr Macroglobulinemia
To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
Rheumatoid Arthritis
Lymphoma, Large B-cell, Diffuse
Lymphoma, Large B-cell, Diffuse
Lymphoma
Hodgkin's Disease; Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma
Rheumatoid Arthritis
Breast Cancer; Lung Cancer; Ovarian Cancer; Prostate Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
Chronic Lymphocytic Leukemia
Epstein-Barr Viraemia; Hematologic Diseases; Allogeneic Disease
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
LYMPHOMA
Lymphoma
Chronic Lymphocytic Leukaemia
Immune Thrombocytopenic Purpura
Diffuse Large B-Cell Lymphoma of the Breast
Rheumatoid Arthritis
Lymphocytic Leukemia, Chronic
Follicular Lymphoma
Rheumatoid Arthritis
Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Graft vs Host Disease
Lymphoma
Immune Thrombocytopenia
Pompe Disease
Granulomatosis With Polyangiitis; Microscopic Polyangiitis
Acquired Haemophilia
Lymphoma; Hodgkin's Disease
Lymphoma; Diffuse Large Cell
Graft vs Host Disease
HBV
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Unknown status
Completed
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Unknown status
Completed
Recruiting
Completed
Completed
Unknown status
Unknown status
Terminated
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Terminated
Recruiting
Terminated
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Unknown status
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Unknown status
Completed
Completed
Terminated
Completed
Unknown status
Not yet recruiting
Completed
Unknown status
Completed
Unknown status
Completed
Recruiting
Terminated
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Unknown status
Completed
Completed
Completed
Terminated
Active, not recruiting
Unknown status
Terminated
Completed
Completed
Not yet recruiting
Active, not recruiting
Recruiting
Terminated
Completed
Recruiting
Unknown status
Completed
Completed
Active, not recruiting
Completed
Unknown status
Completed
Active, not recruiting
Unknown status
Recruiting
Completed
Active, not recruiting
Terminated
Active, not recruiting
Completed
Active, not recruiting
Withdrawn
Unknown status
Terminated
Terminated
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Unknown status
Active, not recruiting
Unknown status
Not yet recruiting
Completed
Withdrawn
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Completed
Terminated
Completed
Terminated
Terminated
Completed
Completed
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Recruiting
Terminated
Completed
Withdrawn
Active, not recruiting
Terminated
Withdrawn
Completed
Withdrawn
Completed
Recruiting
Completed
Terminated
Unknown status
Recruiting
Completed
Unknown status
Recruiting
Completed
Suspended
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Recruiting
Recruiting
Unknown status
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Not yet recruiting
Unknown status
Completed
Unknown status
Completed
Recruiting
Completed
Active, not recruiting
Unknown status
Completed
Completed
Withdrawn
Completed
Completed
Completed
Unknown status
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Unknown status
Not yet recruiting
Completed
Completed
Terminated
Completed
Recruiting
Active, not recruiting
Completed
Terminated
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Unknown status
Not yet recruiting
Terminated
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Unknown status
Unknown status
Completed
Completed
Not yet recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Completed
Terminated
Withdrawn
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Active, not recruiting
Unknown status
Completed
Completed
Terminated
Completed
Unknown status
Completed
Completed
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Recruiting
Completed
Completed
Unknown status
Terminated
Unknown status
Completed
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Terminated
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Completed
Terminated
Active, not recruiting
Recruiting
Unknown status
Terminated
Active, not recruiting
Terminated
Terminated
Unknown status
Completed
Withdrawn
Unknown status
Terminated
Suspended
Active, not recruiting
Terminated
Completed
Completed
Unknown status
Completed
Completed
Completed
Withdrawn
Completed
Completed
Unknown status
Unknown status
Recruiting
Withdrawn
Terminated
Not yet recruiting
Completed
Recruiting
Completed
Unknown status
Completed
Completed
Withdrawn
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Terminated
Unknown status
Completed
Active, not recruiting
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Recruiting
Completed
Unknown status
Completed
Recruiting
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Completed
Recruiting
Terminated
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Unknown status
Unknown status
Terminated
Not yet recruiting
Withdrawn
Unknown status
Completed
Completed
Completed
Terminated
Terminated
Completed
Active, not recruiting
Completed
Not yet recruiting
Terminated
Completed
Not yet recruiting
Recruiting
Withdrawn
Recruiting
Terminated
Withdrawn
Unknown status
Completed
Completed
Active, not recruiting
Withdrawn
Completed
Withdrawn
Not yet recruiting
Completed
Recruiting
Unknown status
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Unknown status
Completed
Recruiting
Recruiting
Completed
Completed
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Completed
Unknown status
Completed
Completed
Terminated
Completed
Recruiting
Withdrawn
Completed
Completed
Completed
Withdrawn
Unknown status
Unknown status
Completed
Active, not recruiting
Terminated
Completed
Terminated
Active, not recruiting
Completed
Completed
Terminated
Terminated
Completed
Completed
Completed
Terminated
Completed
Terminated
Not yet recruiting
Active, not recruiting
Recruiting
Completed
Withdrawn
Not yet recruiting
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Terminated
Recruiting
Completed
Active, not recruiting
Completed
Terminated
Active, not recruiting
Recruiting
Completed
Unknown status
Recruiting
Completed
Completed
Unknown status
Completed
Unknown status
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Terminated
Recruiting
Completed
Withdrawn
Completed
Terminated
Recruiting
Completed
Terminated
Completed
Withdrawn
Recruiting
Completed
Completed
Unknown status
Completed
Unknown status
Completed
Unknown status
Active, not recruiting
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Terminated
Terminated
Completed
Terminated
Recruiting
Withdrawn
Completed
Terminated
Completed
Active, not recruiting
Unknown status
Terminated
Unknown status
Completed
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Unknown status
Active, not recruiting
Completed
Completed
Active, not recruiting
Recruiting
Terminated
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Unknown status
Completed
Terminated
Active, not recruiting
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Unknown status
Completed
Terminated
Recruiting
Terminated
Completed
Recruiting
Recruiting
Completed
Completed
Terminated
Completed
Terminated
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Completed
Completed
Enrolling by invitation
Completed
Withdrawn
Recruiting
Completed
Completed
Terminated
Withdrawn
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Unknown status
Completed
Recruiting
Completed
Completed
Terminated
Completed
Completed
Terminated
Active, not recruiting
Unknown status
Completed
Completed
Completed
Withdrawn
Recruiting
Completed
Unknown status
Completed
Unknown status
Terminated
Terminated
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Terminated
Not yet recruiting
Unknown status
Completed
Completed
Recruiting
Active, not recruiting
Completed
Recruiting
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Unknown status
Active, not recruiting
Terminated
Completed
Completed
Unknown status
Terminated
Completed
Completed
Completed
Unknown status
Terminated
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Withdrawn
Terminated
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Completed
Withdrawn
Recruiting
Active, not recruiting
Completed
Completed
Not yet recruiting
Completed
Unknown status
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Terminated
Completed
Terminated
Terminated
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Unknown status
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Unknown status
Not yet recruiting
Active, not recruiting
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Terminated
Recruiting
Terminated
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Terminated
Terminated
Unknown status
Terminated
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Recruiting
Completed
Active, not recruiting
Unknown status
Completed
Unknown status
Active, not recruiting
Withdrawn
Recruiting
Completed
Completed
Recruiting
Unknown status
Terminated
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Terminated
Completed
Unknown status
Completed
Unknown status
Completed
Completed
Recruiting
Not yet recruiting
Recruiting
Completed
Completed
Completed
Terminated
Withdrawn
Unknown status
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Unknown status
Unknown status
Not yet recruiting
Active, not recruiting
Recruiting
Recruiting
Completed
Recruiting
Completed
Completed
Active, not recruiting
Completed
Withdrawn
Active, not recruiting
Completed
Completed
Recruiting
Completed
Terminated
Terminated
Not yet recruiting
Unknown status
Completed
Withdrawn
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Terminated
Terminated
Completed
Completed
Unknown status
Withdrawn
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Unknown status
Terminated
Recruiting
Recruiting
Completed
Completed
Recruiting
Terminated
Completed
Active, not recruiting
Terminated
Completed
Completed
Completed
Completed
Not yet recruiting
Active, not recruiting
Terminated
Unknown status
Completed
Active, not recruiting
Recruiting
Completed
Unknown status
Completed
Completed
Unknown status
Active, not recruiting
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Withdrawn
Completed
Completed
Terminated
Completed
Recruiting
Active, not recruiting
Completed
Recruiting
Completed
Completed
Unknown status
Completed
Active, not recruiting
Terminated
Recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Recruiting
Completed
Completed
Not yet recruiting
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Recruiting
Recruiting
Recruiting
Terminated
Active, not recruiting
Terminated
Completed
Unknown status
Recruiting
Not yet recruiting
Terminated
Terminated
Completed
Recruiting
Recruiting
Completed
Unknown status
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Terminated
Terminated
Recruiting
Unknown status
Terminated
Withdrawn
Recruiting
Recruiting
Terminated
Terminated
Completed
Completed
Terminated
Completed
Unknown status
Completed
Unknown status
Completed
Terminated
Completed
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Terminated
Active, not recruiting
Completed
Completed
Recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Recruiting
Completed
Unknown status
Unknown status
Completed
Active, not recruiting
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Unknown status
Terminated
Active, not recruiting
Withdrawn
Active, not recruiting
Terminated
Completed
Unknown status
Completed
Not yet recruiting
Recruiting
Recruiting
Recruiting
Completed
Withdrawn
Active, not recruiting
Completed
Completed
Recruiting
Completed
Unknown status
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Withdrawn
Terminated
Terminated
Not yet recruiting
Terminated
Active, not recruiting
Completed
Terminated
Active, not recruiting
Completed
Completed
Terminated
Terminated
Completed
Completed
Completed
Withdrawn
Recruiting
Completed
Completed
Terminated
Completed
Withdrawn
Active, not recruiting
Terminated
Recruiting
Completed
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Withdrawn
Active, not recruiting
Completed
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Terminated
Completed
Unknown status
Unknown status
Unknown status
Recruiting
Completed
Completed
Completed
Active, not recruiting
Withdrawn
Terminated
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Terminated
Active, not recruiting
Completed
Terminated
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Active, not recruiting
Terminated
Terminated
Completed
Terminated
Completed
Terminated
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Terminated
Completed
Completed
Completed
Withdrawn
Completed
Recruiting
Recruiting
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Withdrawn
Recruiting
Unknown status
Terminated
Withdrawn
Withdrawn
Recruiting
Active, not recruiting
Unknown status
Completed
Completed
Active, not recruiting
Terminated
Terminated
Recruiting
Withdrawn
Completed
Completed
Completed
Withdrawn
Completed
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Unknown status
Completed
Completed
Terminated
Completed
Recruiting
Recruiting
Terminated
Completed
Completed
Recruiting
Completed
Withdrawn
Unknown status
Recruiting
Completed
Recruiting
Completed
Withdrawn
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Completed
Completed
Active, not recruiting
Recruiting
Recruiting
Terminated
Active, not recruiting
Active, not recruiting
Completed
Terminated
Completed
Terminated
Recruiting
Completed
Completed
Withdrawn
Recruiting
Terminated
Completed
Completed
Recruiting
Recruiting
Completed
Suspended
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Recruiting
Completed
Withdrawn
Completed
Unknown status
Unknown status
Recruiting
Recruiting
Terminated
Withdrawn
Unknown status
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Recruiting
Unknown status
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Terminated
Active, not recruiting
Withdrawn
Completed
Recruiting
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Completed
Terminated
Completed
Terminated
Active, not recruiting
Active, not recruiting
Completed
Terminated
Active, not recruiting
Terminated
Withdrawn
Completed
Terminated
Completed
Completed
Terminated
Completed
Unknown status
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Terminated
Terminated
Recruiting
Completed
Not yet recruiting
Completed
Recruiting
Completed
Recruiting
Terminated
Active, not recruiting
Completed
Completed
Recruiting
Terminated
Terminated
Recruiting
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Terminated
Recruiting
Withdrawn
Recruiting
Completed
Active, not recruiting
Completed
Terminated
Terminated
Recruiting
Completed
Withdrawn
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Not yet recruiting
Completed
Terminated
Not yet recruiting
Active, not recruiting
Completed
Recruiting
Completed
Completed
Recruiting
Terminated
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Completed
Active, not recruiting
Not yet recruiting
Completed
Completed
Completed
Terminated
Terminated
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Terminated
Unknown status
Recruiting
Completed
Recruiting
Recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Not yet recruiting
Terminated
Active, not recruiting
Terminated
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Suspended
Active, not recruiting
Recruiting
Completed
Unknown status
Completed
Not yet recruiting
Terminated
Terminated
Recruiting
Terminated
Completed
Completed
Terminated
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Completed
Terminated
Completed
Withdrawn
Completed
Withdrawn
Active, not recruiting
Withdrawn
Completed
Recruiting
Completed
Recruiting
Terminated
Completed
Not yet recruiting
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Terminated
Recruiting
Terminated
Recruiting
Terminated
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Completed
Active, not recruiting
Completed
Recruiting
Withdrawn
Completed
Completed
Completed
Recruiting
Unknown status
Active, not recruiting
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Unknown status
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Completed
Not yet recruiting
Active, not recruiting
Withdrawn
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
Unknown status
Completed
Completed
Completed
Withdrawn
Recruiting
Completed
Terminated
Active, not recruiting
Recruiting
Recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Recruiting
Completed
Unknown status
Recruiting
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Unknown status
Completed
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Unknown status
Withdrawn
Not yet recruiting
Completed
Terminated
Terminated
Completed
Terminated
Withdrawn
Terminated
Completed
Completed
Unknown status
Completed
Terminated
Unknown status
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
Unknown status
Terminated
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Completed
Unknown status
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Terminated
Completed
Recruiting
Completed
Completed
Unknown status
Active, not recruiting
Completed
Withdrawn
Terminated
Enrolling by invitation
Recruiting
Approved for marketing
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Active, not recruiting
Completed
Unknown status
Completed
Recruiting
Completed
Terminated
Completed
Completed
Completed
Unknown status
Active, not recruiting
Completed
Withdrawn
Terminated
Recruiting
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Withdrawn
Completed
Completed
Completed
Terminated
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Not yet recruiting
Rituximab biosimilar (Sandoz)
GP-2013
Approved
Sandoz
Granulomatosis with Polyangiitis, Lymphoma, B-Cell, Microscopic Polyangiitis, Arthritis, Rheumatoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Pemphigus
NCT Number
NCT01419665
NCT02514772
NCT03474744
NCT01274182
NCT01933516
Intervention Type
Biological
Biological
Drug
Biological
Drug
Indications
Follicular Lymphoma
Rheumatoid Arthritis
Marginal Zone Lymphoma
Rheumatoid Arthritis
Indolent B-cell Non-Hodgkin's Lymphoma
Study Phase
Phase 3
Phase 3
Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Completed
Completed
Recruiting
Completed
Completed
Iodine 131 tositumomab
TST/I131-TST
Approved
Glaxosmithkline Plc
Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT00268983
NCT00004874
NCT00006721
NCT00078598
NCT00319332
NCT00135200
NCT00022932
NCT00073931
NCT00992992
NCT00475332
NCT00938041
NCT00022945
NCT00996593
NCT00479167
NCT01224821
NCT01573000
NCT00268203
NCT01663714
NCT01389076
NCT01868035
NCT00003784
NCT00577629
NCT00989664
NCT00490490
NCT00770224
NCT00490009
NCT00950755
NCT00933335
NCT00996996
NCT00476047
NCT00240565
NCT00484874
NCT00062894
NCT00434629
NCT00110071
NCT00022906
NCT00022880
NCT01536561
NCT00574509
NCT00777114
NCT00992758
NCT00315731
NCT00416312
NCT00022893
NCT00022958
NCT00023530
NCT00240591
NCT00240578
NCT01988272
NCT00098566
Intervention Type
Biological
Radiation
Biological;Radiation;Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Radiation
Biological
Procedure;Drug
Biological
Drug
Biological
Drug
Biological
Biological
Biological
Biological
Drug
Drug
Radiation;Drug
Drug
Biological
Procedure;Drug
Biological;Radiation;Drug
Drug
Biological
Biological
Biological
Combination Product
Drug
Drug
Drug
Drug
Procedure;Other;Radiation;Drug;Genetic
Drug
Drug
Biological
Radiation
Drug
Biological
Biological
Device
Drug
Drug
Procedure;Drug
Device
Indications
Lymphoma, Non-Hodgkin
Lymphoma
Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Large-Cell, Follicular; Lymphoma, Follicular; Lymphoma, Non-Hodgkin
Multiple Myeloma
Non-Hodgkin's Lymphoma
Lymphoma
Lymphoma, Mantle-Cell
Non-Hodgkin's Lymphoma; Follicular Lymphoma
Lymphoma, Non-Hodgkin
Mantle Cell Lymphoma
Lymphoma, Non-Hodgkin
Follicular Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Follicular Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Lymphoma
Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Lymphoid Leukemia in Remission; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Lymphoma, Non-Hodgkin
Hodgkin's Disease
Non-Hodgkin's Lymphoma
B-cell Lymphoma; Non-Hodgkin's Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Lymphoma, Non-Hodgkin
Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, Follicular
Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Graft vs Host Disease
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
Lymphoma; Quality of Life
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Terminated
Active, not recruiting
Unknown status
Withdrawn
Active, not recruiting
Unknown status
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
LY007
LY007
IND
Shanghai Longyao Biotechnology
Lymphoma, Non-Hodgkin
Rituximab biosimilar (Dr Reddy's Laboratories)
Approved
Dr. Reddy'S Laboratories
Arthritis, Rheumatoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT03976102
NCT03315923
NCT02660710
NCT02296775
Intervention Type
Other;Biological
Drug
Drug
Biological
Indications
Follicular Lymphoma
Secondary Progressive Multiple Sclerosis
Diffuse Large B-cell Lymphoma; HIV
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 2/Phase 3
Phase 2
Phase 1/Phase 2
Recruitment Status
Recruiting
Completed
Active, not recruiting
Completed
Ibritumomab tiuxetan
IDEC-Y2B8, IDEC-129, IDEC-2B8-MX-DTPA, SHL-749, IDEC-In2B8, BAY86-5128
Approved
Biogen Inc
Lymphoma, B-Cell, Lymphoma, Mantle-Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT00168727
NCT00057343
NCT00463463
NCT00319332
NCT00491491
NCT01827605
NCT01510184
NCT01662102
NCT00722930
NCT00493454
NCT00859001
NCT00414089
NCT00038623
NCT00644371
NCT00088881
NCT00193505
NCT00607854
NCT00850512
NCT00336843
NCT00493467
NCT00220285
NCT00354822
NCT00521560
NCT01157988
NCT00119730
NCT00689169
NCT00591630
NCT00453102
NCT00505232
NCT01434472
NCT00577278
NCT00005592
NCT00193440
NCT00662948
NCT01811368
NCT00438581
NCT00514475
NCT01207765
NCT00646750
NCT00290511
NCT01686165
NCT00064246
NCT00372905
NCT01538472
NCT00012298
NCT00477815
NCT00392691
NCT00036855
NCT00387023
NCT01479387
Intervention Type
Drug
Drug
Drug
Drug
Procedure;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Procedure;Drug
Drug
Drug
Procedure;Other;Radiation;Biological;Drug
Procedure;Other;Biological;Radiation;Drug
Radiation;Biological
Drug
Drug
Procedure;Biological;Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Radiation;Drug
Biological;Radiation
Drug
Procedure;Drug
Biological
Biological;Radiation;Drug
Procedure;Drug
Procedure;Other;Biological;Radiation
Drug
Drug
Indications
Lymphoma, Non-Hodgkin; Lymphoma, Low-Grade
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Large-Cell, Follicular; Lymphoma, Follicular; Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
Relapsed Follicular Lymphoma
Diffuse Large B-cell Lymphoma; Follicle Center Lymphoma
Follicular Lymphoma
Follicular Lymphoma
Lymphoma
Follicular Lymphoma
Lymphoma
Lymphoma, Mantle-Cell
Non-Hodgkin Lymphoma
Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Non-Hodgkins Lymphoma
Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Non-Hodgkin's Lymphoma; Lymphoma, B-Cell; Lymphoma, Low-Grade
Lymphoma, Non-Hodgkin
Primary Non-Hodgkin-Lymphoma; Refractory Non-Hodgkin-Lymphoma; CD20+ Aggressive Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
Mantle Cell Lymphoma
Lymphoma, Large Cell, Diffuse
Diffuse Large Cell Lymphoma; Lymphoma
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Graft Versus Host Disease; Leukemia; Lymphoma
Lymphoma
Non-Hodgkins Lymphoma
Lymphoma
Refractory Non Hodgkin Lymphoma; Relapsed Non Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin's Lymphoma
Lymphoma
Anaplastic Large Cell Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Mantle Cell Lymphoma
Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Waldenström Macroglobulinemia
Lymphoma
Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma
AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma
Non-Hodgkin's Lymphoma; Lymphoma
Non-Hodgkin's Lymphoma (NHL)
Study Phase
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
N/A
N/A
Recruitment Status
Completed
Terminated
Unknown status
Withdrawn
Completed
Active, not recruiting
Terminated
Terminated
Unknown status
Terminated
Completed
Withdrawn
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Recruiting
Unknown status
Completed
Terminated
Completed
Active, not recruiting
Completed
Completed
Terminated
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Rituximab biosimilar (Innovent Biologics)
IBI-301
Approved
Innovent Biologics (Suzhou) Co Ltd
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT02003222
NCT02048813
NCT02867566
NCT01886872
NCT03984448
NCT01424982
NCT04216524
NCT04220008
NCT00602459
NCT02727803
NCT01145495
NCT04285268
NCT04022239
NCT04323956
NCT00880815
NCT02945215
Intervention Type
Procedure;Other;Biological;Drug
Other;Biological;Drug
Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Other;Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Biological;Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Procedure;Biological;Drug
Drug
Indications
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Diffuse, Large B-Cell, Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Blastic Plasmacytoid Dendritic Cell Neoplasm
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
B-Cell Lymphoma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Withdrawn
Recruiting
Recruiting
Completed
Completed
Rituximab biosimilar (Genor Biopharma)
GB-241
Phase 3 Clinical
Genor Biopharma Co Ltd, Nanjing Yoko Biomedical Co Ltd
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
NCT Number
NCT03650933
NCT03984448
NCT02727803
NCT04216524
NCT04404088
NCT04155840
NCT04285268
NCT04220008
NCT04047797
NCT01145495
NCT01424982
NCT04022239
NCT03991884
NCT00880815
NCT03003039
NCT04323956
Intervention Type
Biological
Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Procedure;Biological;Drug
Biological
Biological;Drug
Indications
Diffuse Large B-Cell Lymphoma, Unspecified Site
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Blastic Plasmacytoid Dendritic Cell Neoplasm
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
B-Cell Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Study Phase
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Withdrawn
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Unknown status
Recruiting
Rituximab biosimilar (CTTQ Pharma)
TQB-2303
Phase 3 Clinical
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
NCT Number
NCT03777085
NCT04285268
NCT04220008
NCT04047797
NCT04404088
NCT04216524
NCT03456466
NCT04022239
NCT04323956
Intervention Type
Drug
Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Indications
Diffuse Large B-cell Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Blastic Plasmacytoid Dendritic Cell Neoplasm
Non-hodgkin's Lymphoma
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Study Phase
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Recruiting
Withdrawn
Not yet recruiting
Recruiting
Recruiting
Recruiting
Unknown status
Recruiting
Recruiting
Rituximab biosimilar (Samsung)
SAIT-101
Phase 3 Clinical
Samsung Biologics
Arthritis, Rheumatoid, Lymphoma, Follicular
NCT Number
NCT02003222
NCT02809053
NCT01886872
NCT02048813
NCT03984448
NCT01434472
NCT04047797
NCT04220008
NCT01424982
NCT04155840
NCT00602459
NCT01145495
NCT04216524
NCT04285268
NCT04404088
NCT02727803
NCT04022239
NCT03991884
NCT02819726
NCT00880815
NCT04323956
Intervention Type
Procedure;Other;Biological;Drug
Biological
Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Procedure;Other;Radiation;Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Other;Biological;Drug
Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Biological
Procedure;Biological;Drug
Biological;Drug
Indications
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Lymphoma, Follicular
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Blastic Plasmacytoid Dendritic Cell Neoplasm
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
Rheumatoid Arthritis
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Recruiting
Recruiting
Completed
Completed
Recruiting
Ublituximab
R-603, EMAB-6, TG-1101, TG-1303, LFB-R603, TGTX-1101
Phase 3 Clinical
Tg Therapeutics
Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Multiple Sclerosis, Relapsing-Remitting, Lymphoma, Large B-Cell, Diffuse, Multiple Sclerosis, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Neuromyelitis Optica, Lymphoma, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT02612311
NCT02301156
NCT04130997
NCT03277248
NCT03277261
NCT02793583
NCT04508647
NCT04624633
NCT03828448
NCT04016805
NCT02656303
NCT02738775
NCT04149821
NCT03801525
NCT03381170
NCT03207256
NCT02013128
NCT02535286
NCT01647971
NCT03379051
NCT04692155
NCT01744912
NCT03671590
NCT02276963
NCT04635683
NCT02006485
NCT01098188
Intervention Type
Biological;Drug
Drug
Biological
Biological;Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Indications
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis (RMS)
Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma
Marginal Zone Lymphoma; Follicular Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
Follicular Lymphoma; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Multiple Sclerosis
Chronic Lymphocytic Leukemia; CLL Progression; CLL/SLL
Chronic Lymphocytic Leukemia
Relapsing Remitting Multiple Sclerosis
Chronic Lymphocytic Leukemia; Non Hodgkin Lymphoma
Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia; Richter Syndrome
Non-Hodgkins Lymphoma; B-cell Lymphoma; Waldenstrom's Macroglobulinemia; Marginal Zone Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Primary Central Nervous System Lymphoma
Chronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma
Mantle Cell Lymphoma
Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B-cell Lymphomas; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Waldenstrom's Macroglobulinemia
Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia
Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorder
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Splenic Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Nodal Marginal Zone Lymphoma; Refractory Splenic Marginal Zone Lymphoma; Refractory Waldenstrom Macroglobulinemia
Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Enrolling by invitation
Completed
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Completed
Recruiting
Completed
Recruiting
Not yet recruiting
Completed
Recruiting
Completed
Not yet recruiting
Completed
Completed
Rituximab biosimilar (Hualan Biological Engineering)
WBP-263
Phase 3 Clinical
Hualan Genetic Engineering Co Ltd
Lymphoma, B-Cell, Arthritis, Rheumatoid, Lymphoma, Lymphoma, Non-Hodgkin
NCT Number
NCT02787239
NCT03355872
Intervention Type
Drug
Drug
Indications
B-cell Non Hodgkin's Lymphoma
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 1/Phase 2
Recruitment Status
Completed
Completed
Rituximab biosimilar (Boehringer Ingelheim)
BI-695500
Phase 3 Clinical
C.H. Boehringer Sohn Ag & Co. Kg
Arthritis, Rheumatoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT01886872
NCT02003222
NCT02048813
NCT02417129
NCT01955733
NCT01682512
NCT03984448
NCT02727803
NCT03749018
NCT04285268
NCT04216524
NCT03505762
NCT04220008
NCT03418038
NCT04404088
NCT04155840
NCT04047797
NCT01434472
NCT04115631
NCT00602459
NCT01145495
NCT01424982
NCT03579927
NCT04022239
NCT03704714
NCT00880815
NCT04231877
NCT04323956
NCT01950273
NCT03991884
NCT03742258
NCT04447716
Intervention Type
Other;Biological;Drug
Procedure;Other;Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Drug
Other;Procedure;Biological;Radiation;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Other;Biological;Drug;Dietary Supplement
Biological;Drug
Biological;Drug
Biological;Drug
Procedure;Other;Radiation;Biological;Drug
Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Procedure;Biological;Radiation;Drug
Other;Biological;Drug
Procedure;Biological;Drug
Biological;Drug
Biological;Drug
Drug
Biological;Drug
Biological;Drug
Biological;Drug
Indications
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Lymphoma, Non-Hodgkin
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Blastic Plasmacytoid Dendritic Cell Neoplasm
B-Cell Non-Hodgkin Lymphoma
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma
Post-Transplant Lymphoproliferative Disorder; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Liver Lymphoma; Mantle Cell Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia
CD19 Positive; Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma
Allogeneic Hematopoietic Stem Cell Transplant Recipient; Donor; Hematopoietic and Lymphoid Cell Neoplasm
Aggressive Non-Hodgkin Lymphoma; B-Cell Non-Hodgkin Lymphoma; CD20 Positive; Diffuse Large B-Cell Lymphoma Unclassifiable; Intravascular Large B-Cell Lymphoma; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
CD20 Positive; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; T-Cell Non-Hodgkin Lymphoma
Aggressive Non-Hodgkin Lymphoma; ALK-Positive Large B-Cell Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
Lymphoma, Follicular
Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Terminated
Terminated
Recruiting
Recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Withdrawn
Recruiting
Recruiting
Completed
Recruiting
Recruiting
Completed
Recruiting
Recruiting
Recruiting
Recombinant chimeric anti-CD20 antibody (Shanghai Institute of Biological Products)
Phase 3 Clinical
Shanghai Institute Of Biological Products Co Ltd
Lymphoma, Large B-Cell, Diffuse
Glofitamab
RG-6026, RO-7082859
Phase 3 Clinical
F. Hoffmann-La Roche Ltd
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma
NCT Number
NCT04408638
NCT04703686
NCT04657302
NCT04246086
NCT03533283
NCT03075696
NCT04313608
NCT04077723
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma Refractory; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Transformed B-cell Non-Hodgkin Lymphoma; Refractory Primary Mediastinal Large B-Cell Cell Lymphoma; Refractory Mantle Cell Lymphoma
Lymphoma
Follicular Lymphoma
Non-Hodgkins Lymphoma
Non-Hodgkin's Lymphoma
B-cell Lymphoma
Lymphoma, Non-Hodgkin
Study Phase
Phase 3
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
H02
H-02
Phase 3 Clinical
Shandong New Time Pharmaceutical Co Ltd
Lymphoma, Large B-Cell, Diffuse
Rituximab biosimilar (Hisun Pharma/Beijing Mabworks Biotech)
Phase 3 Clinical
Zhejiang Hisun Pharmaceutical Co Ltd, Beijing Mabworks Biotech Co Ltd
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
Ocrelizumab biosimilar (CinnaGen)
Phase 3 Clinical
Cinnagen
Multiple Sclerosis
Dual specificity CD19 and CD20 or CD22 CAR-T cell (Chinese PLA General Hospital)
Phase 2 Clinical
Pla General Hospital
Leukemia, Lymphoma, B-Cell
NCT Number
NCT03398967
Intervention Type
Biological
Indications
B Cell Leukemia; B Cell Lymphoma
Study Phase
Phase 1/Phase 2
Recruitment Status
Recruiting
Veltuzumab
hA20, IMMU-106
Phase 2 Clinical
Immunomedics Inc
Lymphoma, B-Cell, Purpura, Thrombocytopenic, Idiopathic, Leukemia, Lymphoid, Arthritis, Rheumatoid, Lymphoma, Large B-Cell, Diffuse, Pain, Postoperative, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Anaplastic, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic
NCT Number
NCT01390545
NCT00547066
NCT00285428
NCT01279707
NCT01147393
NCT00989586
NCT01101581
NCT00596804
NCT00546793
Intervention Type
Drug
Biological
Drug
Biological
Biological;Drug
Procedure;Biological
Drug
Drug
Biological
Indications
Rheumatoid Arthritis
Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune
Non-Hodgkin's Lymphoma
Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia
Follicular Lymphoma
Lymphoma
Non Hodgkin's Lymphoma; NHL; Aggressive NHL; Diffuse Large B-cell Lymphoma
Non-Hodgkin's Lymphoma; Lymphoma, Diffuse; Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
NHL; Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Intermediate-Grade; Lymphoma, Large-Cell; Lymphoma, Low-Grade; Lymphoma, Mixed-Cell; Lymphoma, Small-Cell; Leukemia, Lymphocytic, Chronic; Leukemia, B-Cell, Chronic; Leukemia, Prolymphocytic; Leukemia, Small Lymphocytic; Lymphoma, Small Lymphocytic; Lymphoma, Lymphoplasmacytoid, CLL; Lymphoplasmacytoid Lymphoma, CLL; CLL; SLL
Study Phase
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Terminated
Terminated
Completed
Unknown status
Terminated
Completed
Withdrawn
Completed
Completed
Anti-CD3 anti-CD20 bispecific antibody (Genmab)
GEN-3013
Phase 2 Clinical
Genmab
Hematologic Neoplasms
4SCAR-T cell therapy (Shenzhen Geno-Immune Medical Institute)
4SCAR-T
Phase 2 Clinical
Shenzhen Geno-Immune Medical Institute
Neoplasms
NCT Number
NCT04637503
NCT04430530
Intervention Type
Biological
Biological
Indications
Neuroblastoma
CD19 Negative B-cell Malignancies
Study Phase
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Recruiting
Recruiting
MRG001
MRG-001
Phase 2 Clinical
Shanghai Miracogen Inc
Coronavirus Disease 2019 (COVID-19), Lymphoma, Non-Hodgkin
NCT Number
NCT04646603
Intervention Type
Drug
Indications
COVID-19
Study Phase
Phase 1/Phase 2
Recruitment Status
Not yet recruiting
Anti-CLEVER-1 antibodies (Faron Pharmaceuticals)
FP-1115, FP-1302, FP-1304, FP-1305
Phase 2 Clinical
Faron
Neoplasms
NCT Number
NCT03733990
Intervention Type
Biological
Indications
Cancer
Study Phase
Phase 1/Phase 2
Recruitment Status
Recruiting
Chimeric antigen receptor T-cell therapy (Fred Hutchinson Cancer Research Center)
Phase 2 Clinical
Fred Hutchinson Cancer Research Center
Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT03277729
Intervention Type
Other;Procedure;Biological;Drug
Indications
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma; Recurrent Transformed Chronic Lymphocytic Leukemia; Refractory Marginal Zone Lymphoma; Refractory Transformed B-Cell Non-Hodgkin Lymphoma; Refractory Transformed Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Study Phase
Phase 1/Phase 2
Recruitment Status
Recruiting
Recombinant humanized monoclonal antibody MIL62
Phase 2 Clinical
Innocare Pharma, Beijing Mabworks Biotech Co Ltd
Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT04304040
NCT04103905
Intervention Type
Drug
Drug
Indications
B-cell Lymphoma Recurrent; B-cell Lymphoma Refractory
CD20-positive B Cell Non-Hodgkin Lymphoma
Study Phase
Phase 1/Phase 2
Phase 1
Recruitment Status
Not yet recruiting
Active, not recruiting
BCD-132
BCD-132
Phase 2 Clinical
Biocad
Multiple Sclerosis
NCT Number
NCT04056897
NCT03551275
Intervention Type
Biological;Drug
Biological
Indications
Multiple Sclerosis
Multiple Sclerosis
Study Phase
Phase 2
Phase 1
Recruitment Status
Recruiting
Unknown status
MT-3724
MT-3724
Phase 2 Clinical
Molecular Partners Ag
Hematologic Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT03488251
NCT03645395
NCT02361346
NCT02556346
NCT02715843
Intervention Type
Drug
Drug
Drug
Drug
Drug
Indications
Non-hodgkin Lymphoma,B Cell; Refractory Diffuse Large B-Cell Lymphoma; Relapsed Diffuse Large B-Cell Lymphoma
Non-hodgkin Lymphoma
Non-Hodgkin's B-cell Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Small Lymphocytic Leukemia; Diffuse Large B Cell Lymphoma; Blood Cancer; Hematological Malignancy
Chronic B-cell Lymphocytic Leukemia; Small Lymphocytic Leukemia
Non-Hodgkin's B-cell Lymphoma
Study Phase
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
N/A
Recruitment Status
Active, not recruiting
Active, not recruiting
Active, not recruiting
Withdrawn
No longer available
Anti-CD19 and anti-CD20 CAR-T cell therapy (Medical College of Wisconsin)
Phase 2 Clinical
The Medical College Of Wisconsin Nonprofit
Neoplasms
NCT Number
NCT04186520
NCT04049383
Intervention Type
Biological
Biological
Indications
Non Hodgkin Lymphoma (NHL); Mantle Cell Lymphoma (MCL)
Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia With Failed Remission; Acute Lymphoblastic Leukemia Recurrent; Acute Lymphoblastic Leukemia Not Having Achieved Remission; Acute Lymphoblastic Leukemia, Pediatric; Acute Lymphoblastic Leukemia
Study Phase
Phase 1/Phase 2
Phase 1
Recruitment Status
Recruiting
Recruiting
MB-CART2019.1
MB-CART2019.1
Phase 2 Clinical
Miltenyi Biotec
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT03870945
Intervention Type
Biological
Indications
B-cell Non Hodgkin Lymphoma
Study Phase
Phase 1/Phase 2
Recruitment Status
Active, not recruiting
Anti-CD20 CAR T-cell therapy (Southwest Hospital Chongqing)
Phase 2 Clinical
Southwest Hospital Chongqing
Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT02737085
NCT02710149
Intervention Type
Biological
Biological
Indications
Lymphoma, Large B-Cell, Diffuse
Leukemia; Lymphoma
Study Phase
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Unknown status
Recruiting
Allogeneic anti-CD20 CAR-T cell therapy (Precision BioSciences)
PBCAR-20A
Phase 2 Clinical
Precision Biosciences
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT04030195
Intervention Type
Drug;Genetic
Indications
Non-Hodgkin's Lymphoma, Relapsed; Chronic Lymphoid Leukemia in Relapse; Non-Hodgkin's Lymphoma Refractory; Chronic Lymphocytic Leukemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic; B-cell Chronic Lymphocytic Leukemia; B-cell Non Hodgkin Lymphoma; Small Lymphocytic Lymphoma
Study Phase
Phase 1/Phase 2
Recruitment Status
Recruiting
MB-106
MB-106
Phase 2 Clinical
Fred Hutchinson Cancer Research Center
Lymphoma, Non-Hodgkin
BVX20-CD20 antibody (Biocon/Vaccinex)
BVX-20, BVX20-MAb
Phase 2 Clinical
Biocon, Vaccinex
Lymphoma, Non-Hodgkin
Mosunetuzumab
RG-7828, BTCT-4465A, RO-7030816
Phase 2 Clinical
Genentech Inc
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT03677154
NCT03671018
NCT04246086
NCT04313608
Intervention Type
Drug
Drug
Drug
Drug
Indications
Diffuse Large B-cell Lymphoma
B-cell Non-Hodgkin Lymphoma
Follicular Lymphoma
B-cell Lymphoma
Study Phase
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Recruitment Status
Recruiting
Recruiting
Recruiting
Recruiting
MB-CART20.1 (Miltenyi Biotec)
Phase 2 Clinical
Miltenyi Biotec
Lymphoma, Non-Hodgkin, Melanoma
NCT Number
NCT03893019
Intervention Type
Biological
Indications
Melanoma (Skin)
Study Phase
Early Phase 1
Recruitment Status
Recruiting
Anti-CD20 CART-transduced T cells (Cellular Biomedicine Group)
CART-20, CBM-C20.1, CBM-CD20 1
Phase 2 Clinical
Pla General Hospital
Leukemia, Lymphoma, B-Cell
NCT Number
NCT01735604
Intervention Type
Other;Biological
Indications
Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission; B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma
Study Phase
Phase 1/Phase 2
Recruitment Status
Unknown status
Odronextamab
REGN-1979
Phase 2 Clinical
Regeneron Pharmaceuticals Inc
Lymphoma, B-Cell, Leukemia, Lymphoid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT03888105
NCT02651662
NCT02290951
Intervention Type
Drug
Drug
Drug
Indications
B-cell Non-Hodgkin Lymphoma (NHL)
Lymphoma
Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia
Study Phase
Phase 2
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Active, not recruiting
Active, not recruiting
Anti-CD20 CAR T-cell therapy (Shanghai Longyao Biotechnology)
Phase 2 Clinical
Shanghai Longyao Biotechnology
Lymphoma, Large B-Cell, Diffuse
DI-Leu16-IL2
DI-Leu16-IL2
Phase 2 Clinical
Merck Serono
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin
NCT Number
NCT01874288
NCT02151903
NCT00720135
Intervention Type
Drug
Drug
Other;Biological;Genetic
Indications
B-cell Non-Hodgkin Lymphoma
B-cell Non-Hodgkin Lymphoma
Anaplastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Study Phase
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Terminated
Terminated
Completed
Recombinant anti-CD20 chimeric monoclonal antibody (Livzon Group)
LZM-002
Phase 1 Clinical
Livzon Pharmaceutical Group Inc
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
BAT-4406F
BAT-4406, BAT-4406F
Phase 1 Clinical
Bio-Thera Solutions Ltd
Neuromyelitis Optica
NCT Number
NCT04146285
Intervention Type
Drug
Indications
Neuromyelitis Optica Spectrum Disorders
Study Phase
Phase 1
Recruitment Status
Not yet recruiting
Rituximab biosimilar (Zhejiang Teruisi Pharmaceutical)
TRS001
Phase 1 Clinical
Zhejiang Teruisi Pharmaceutical Inc
Lymphoma
Rituximab conjugate (BioIntegrator)
CON-4619
Phase 1 Clinical
Biointegrator
Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT03057418
Intervention Type
Drug
Indications
Lymphoma, Non-Hodgkin; Lymphoma, Follicular
Study Phase
Phase 1
Recruitment Status
Completed
Recombinant anti-CD20 humanized monoclonal antibody (Shanghai Pharma)
Phase 1 Clinical
Shanghai Pharmaceuticals Holding Co Ltd
Lymphoma
CD19/CD20 bispecific chimeric antigen receptor (CAR)-T cell therapy (Jonsson Comprehensive Cancer Center)
Phase 1 Clinical
Uclas Jonsson Comprehensive Cancer Center
Lymphoma, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT04007029
Intervention Type
Biological;Drug
Indications
CD19 Positive; CD20 Positive; Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Small Lymphocytic Lymphoma
Study Phase
Phase 1
Recruitment Status
Recruiting
IMM-0306
IMM-0306
Phase 1 Clinical
Yiming Angke Biomedical Technology (Shanghai) Co Ltd
Lymphoma, B-Cell
CD19/CD20 bispecific CAR-T cells (Henan Cancer Hospital)
Phase 1 Clinical
Henan Provincial Cancer Hospital
Lymphoma, B-Cell
NCT Number
NCT03881761
Intervention Type
Biological
Indications
B-Cell Lymphoma Stage I; Refractory; Relapsed
Study Phase
Phase 1
Recruitment Status
Recruiting
CD20/CD22 dual Targeted CAR T-cell therapy (Zhejiang University)
Phase 1 Clinical
Zhejiang University
Hematologic Neoplasms
NCT Number
NCT04283006
Intervention Type
Drug
Indications
Relapsed and Refractory; Lymphoid Hematological Malignancies
Study Phase
Early Phase 1
Recruitment Status
Recruiting
ACTR-707
Phase 1 Clinical
Unum Therapeutics
Lymphoma, Lymphoma, Non-Hodgkin
NCT Number
NCT03189836
NCT03680560
Intervention Type
Biological
Biological;Drug
Indications
Lymphoma
Solid Tumor; HER-2 Protein Overexpression
Study Phase
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Terminated
CD20 x CD3 bispecific antibody (IGM Biosciences)
IGM-2323
Phase 1 Clinical
Igm Biosciences
Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin
NCT Number
NCT04082936
Intervention Type
Drug
Indications
Non-Hodgkin Lymphoma; Follicular Lymphoma; DLBCL; Mantle Cell Lymphoma; Marginal Zone Lymphoma
Study Phase
Phase 1
Recruitment Status
Recruiting
Rituximab/Paclitaxel
AR-160
Phase 1 Clinical
Mayo Clinic
Lymphoma, Non-Hodgkin
NCT Number
NCT03003546
Intervention Type
Other;Drug
Indications
Aggressive Non-Hodgkin Lymphoma; CD20 Positive; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma
Study Phase
Phase 1
Recruitment Status
Recruiting
Anti-CD20 allogeneic CAR-T cell therapy (Nanjing Medical University)
LUCAR-20S
Phase 1 Clinical
Nanjing Medical University
Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT04176913
Intervention Type
Drug
Indications
Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma
Study Phase
Phase 1
Recruitment Status
Recruiting
CD19/CD20 Dual-CAR-T cell therapy (HeBei Yanda hospital)
Phase 1 Clinical
Hebei Yanda Hospital
Lymphoma, B-Cell
NCT Number
NCT04260945
NCT04260932
Intervention Type
Biological
Biological
Indications
B-cell Leukemia
B-cell Lymphoma
Study Phase
Phase 1
Phase 1
Recruitment Status
Recruiting
Recruiting
CD20 CAR-T cell therapy (Shanghai Longyao Biotechnology)
Phase 1 Clinical
Shanghai Longyao Biotechnology
Lymphoma, Non-Hodgkin
NCT Number
NCT04169932
Intervention Type
Biological
Indications
Relapsed and Refractory B Cell Lymphoma; Non-Hodgkin Lymphoma
Study Phase
Early Phase 1
Recruitment Status
Recruiting
Bendamustine Hydrochloride/Rituximab
Phase 1 Clinical
1globe Biomedical Co Ltd
Lymphoma, B-Cell
Plamotamab
XmAb-13676
Phase 1 Clinical
Xencor
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT02924402
Intervention Type
Biological
Indications
B-cell Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia
Study Phase
Phase 1
Recruitment Status
Recruiting
Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein (Fred Hutchinson Cancer Research Center)
Phase 1 Clinical
Fred Hutchinson Cancer Research Center, National Cancer Institute
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Burkitt Lymphoma, Lymphoma, Non-Hodgkin
NCT Number
NCT02483000
Intervention Type
Procedure;Other;Biological;Radiation;Drug
Indications
Burkitt Lymphoma; CD20-Positive Neoplastic Cells Present; Diffuse Large B-Cell Lymphoma; Indolent Non-Hodgkin Lymphoma; Mantle Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Refractory Mature B-Cell Non-Hodgkin Lymphoma
Study Phase
Phase 1
Recruitment Status
Terminated
Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T cell therapy (First Affiliated Hospital of Zhejiang University)
Phase 1 Clinical
First Affiliated Hospital Of Zhejiang University
Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT04486872
Intervention Type
Biological
Indications
Diffuse Large B Cell Lymphoma
Study Phase
Phase 1
Recruitment Status
Recruiting
Rituximab biosimilar (Fred Hutchinson Cancer Research Center)
Phase 1 Clinical
Fred Hutchinson Cancer Research Center
Multicentric Castleman's Disease (MCD), Sarcoma, Kaposi
NCT Number
NCT03864419
Intervention Type
Biological;Drug
Indications
Burkitt Lymphoma; KSHV-associated Multicentric Castleman Disease; Diffuse Large B-Cell Lymphoma
Study Phase
Phase 1
Recruitment Status
Recruiting
Rituximab biosimilar (International Biotech Center Generium)
GNR-006
Phase 1 Clinical
International Biotech Center Generium
Lymphoma, B-Cell
Rituximab biosimilar (Gedeon Richter)
RGB-03
Phase 1 Clinical
Gedeon Richter
Arthritis, Rheumatoid
TRS-005
TRS-005
Phase 1 Clinical
Zhejiang Teruisi Pharmaceutical Inc
Lymphoma, Non-Hodgkin
Recombinant Fc-glycosylated anti-CD20 monoclonal antibody (Bio-Thera Solutions)
BAT-4306F
Phase 1 Clinical
Bio-Thera Solutions Ltd
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin
NCT Number
NCT04152148
Intervention Type
Biological
Indications
Non-Hodgkin's Lymphoma
Study Phase
Phase 1
Recruitment Status
Enrolling by invitation
IGN-002
IGN-002
Phase 1 Clinical
Immunogen
Lymphoma, Non-Hodgkin
NCT Number
NCT02519270
NCT02847949
Intervention Type
Biological
Biological
Indications
Non-Hodgkin Lymphoma
NHL
Study Phase
Phase 1
Phase 1
Recruitment Status
Suspended
Not yet recruiting
Humanized anti-CD19 and anti-CD20 dual specific CAR-T cell therapy (Fujian Medical University)
Phase 1 Clinical
Fujian Medical University
Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT04215016
Intervention Type
Biological
Indications
Relapsed or Refractory DLBCL Patients With Either CD19 or CD20 Positive
Study Phase
Phase 1
Recruitment Status
Recruiting
Humanized monoclonal antibody targeting CD20 (Shanghai Pharma)
B-001
Phase 1 Clinical
Shanghai Pharmaceuticals Holding Co Ltd
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
CD20-CD19 cCAR T cell therapy (iCell Gene Therapeutics)
Phase 1 Clinical
Icell Gene Therapeutics
Lymphoma, B-Cell, Leukemia, Leukemia, B-Cell
NCT Number
NCT04156178
Intervention Type
Biological
Indications
B Cell Lymphoma; B Cell Leukemia
Study Phase
Early Phase 1
Recruitment Status
Recruiting
Rituximab biosimilar (Shenzhen Main Luck Pharmaceuticals)
Phase 1 Clinical
Shenzhen Main Luck Pharmaceuticals Inc
Arthritis, Rheumatoid, Lymphoma
Anti-CD20 CAR-T cell therapy (Wuhan Bio-Raid)
Clinical
Wuhan Bio-Raid Biotechnology
Neoplasms
Ocaratuzumab
AME-133, AME-133v, LY-2469298
Pending
Applied Molecular Evolution
Lymphoma, Follicular, Lymphoma, Non-Hodgkin
NCT Number
NCT00354926
NCT01858181
Intervention Type
Biological
Biological
Indications
Non-Hodgkin's Lymphoma
Previously Treated CD20+ B-cell Malignancies
Study Phase
Phase 1
Phase 1
Recruitment Status
Completed
Unknown status
Rituximab biosimilar (Bionovis/The Instituto)
Pending
Bionovis, The Instituto Vital Brazil
Granulomatosis with Polyangiitis, Arthritis, Rheumatoid, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
GB-4542 (Gliknik)
GB-4542
Pending
Gliknik
Autoimmune Diseases
177-Lu-DOTA-rituximab (University of Basel)
Pending
University Hospital Basel
Neoplasms
Rituximab biosimilar (AXXO)
Pending
Axxo
Leukemia, Arthritis, Rheumatoid
Anti-CD20 monoclonal antibodies (Verenium)
Pending
Basf Corp
Lymphoma, Non-Hodgkin
Rituximab biosimilar (Lupin)
Pending
Lupin
Arthritis, Rheumatoid
64Cu-DOTA-rituximab (Stanford University)
Cu-64 Rituximab, 64Cu-DOTA-Rituximab, Cu64-DOTA-rituximab, [64Cu]DOTA-rituximab
Pending
Stanford University
Lymphoma, Non-Hodgkin
NCT Number
NCT01598558
Intervention Type
Drug
Indications
Non-Hodgkin's Lymphoma
Study Phase
N/A
Recruitment Status
Withdrawn
Rituximab biosimilar (Zhejiang hisun pharmaceutical)
HS-006
Pending
Zhejiang Hisun Pharmaceutical Co Ltd
Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT03485118
Intervention Type
Drug
Indications
Diffuse Large B-cell Lymphoma
Study Phase
Phase 2
Recruitment Status
Completed
Radiolabeled anti-CD20 antibody (NeoRx)
Pending
Poniard Pharmaceuticals
Lymphoma, B-Cell
Anti-CD20 monoclonal antibody (BioMedics)
BM-ca
Pending
Biomedics
Lymphoma, Non-Hodgkin
Rituximab biosimilar (Lonza/Teva Pharmaceutical Industries)
TL-011
Discontinued
Teva Pharmaceutical Industries, Lonza
Arthritis, Rheumatoid, Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT01123070
NCT01205737
Intervention Type
Biological
Biological
Indications
Rheumatoid Arthritis
DLBCL
Study Phase
Phase 1/Phase 2
Phase 1
Recruitment Status
Completed
Completed
Anti-CD3/anti-CD20 bispecific antibody-armed activated T-cells (Barbara Ann Karmanos Cancer Institute)
Discontinued
National Cancer Institute, Barbara Ann Karmanos Cancer Institute
Lymphoma
NCT Number
NCT00521261
Intervention Type
Biological
Indications
Lymphoma
Study Phase
Phase 1
Recruitment Status
Withdrawn
Recombinant human anti-CD20 monoclonal antibody (Sailemin Biotech)
Discontinued
Sinomab Bioscience (Shenzhen) Ltd
FBTA-05
Bi-20, FBTA-05
Discontinued
Trion Research
Lymphoma, B-Cell, Leukemia, Lymphoid
NCT Number
NCT01138579
Intervention Type
Drug
Indications
Leukemia; Stem Cell Transplantation
Study Phase
Phase 1/Phase 2
Recruitment Status
Terminated
CD20-specific-T-cells
Discontinued
Fred Hutchinson Cancer Research Center, National Cancer Institute
Leukemia, Lymphoma, Waldenstrom Macroglobulinemia
NCT Number
NCT04160195
Intervention Type
Biological;Drug
Indications
Lymphoma, B-Cell; Lymphoma, Non-hodgkins; Chronic Lymphocytic Leukemia; B-Cell Chronic Lymphocytic Leukemia
Study Phase
Phase 1
Recruitment Status
Suspended
B-cell lymphoma gene therapy (City of Hope)
Discontinued
City Of Hope National Medical Center
Lymphoma, B-Cell
Pretarget lymphoma therapy (Poniard)
Discontinued
Poniard Pharmaceuticals
Lymphoma, Non-Hodgkin
Rituximab biosimilar (JHL Biotech)
JHL-1101
Discontinued
Jhl Biotech
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Arthritis, Rheumatoid
NCT Number
NCT03670901
NCT04404088
NCT04216524
NCT04155840
NCT04285268
NCT04220008
NCT03161457
NCT04323956
NCT03670888
Intervention Type
Biological
Biological;Drug
Biological;Drug
Biological;Drug
Biological;Drug
Procedure;Biological;Drug
Biological
Biological;Drug
Biological
Indications
Diffuse Large B-Cell Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Blastic Plasmacytoid Dendritic Cell Neoplasm
Lymphoid Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Rheumatoid Arthritis; Arthritis, Rheumatoid
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
B Cell Lymphoma
Study Phase
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Recruitment Status
Terminated
Recruiting
Recruiting
Recruiting
Withdrawn
Not yet recruiting
Terminated
Recruiting
Terminated
PF-5212374
TRU-015, PF-5212374
Discontinued
Emergent
Lymphoma, B-Cell, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Lymphoma, Non-Hodgkin
NCT Number
NCT00634933
NCT00521638
NCT00479622
Intervention Type
Drug
Biological
Drug
Indications
Arthritis, Rheumatoid
Lymphoma, B-Cell
Systemic Lupus Erythematosus
Study Phase
Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Terminated
Terminated
Terminated
IDM-4
IDM-4
Discontinued
Takeda Pharmaceutical Co Ltd
Leukemia, Lymphocytic, Chronic, B-Cell
Rituximab biosimilar (Shanghai CP Guojian Pharmaceutical)
CMAB-304
Discontinued
Shanghai Cp Guojian Pharmaceutical Co Ltd
Lymphoma, Large B-Cell, Diffuse
NCT Number
NCT01459887
Intervention Type
Drug
Indications
Diffuse Large B Cell Lymphoma
Study Phase
Phase 3
Recruitment Status
Completed
PRO-131921
PRO-131921
Discontinued
Genentech Inc
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT00452127
NCT00496132
Intervention Type
Drug
Drug
Indications
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Study Phase
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Terminated
Terminated
SBI-087
SBI-087, PF-5230895, PF-05230895
Discontinued
Emergent
Arthritis, Rheumatoid, Lupus Erythematosus, Systemic
NCT Number
NCT01008852
NCT00815906
NCT00714116
NCT00641225
Intervention Type
Drug
Drug
Drug
Drug
Indications
Active Rheumatoid Arthritis
Arthritis, Rheumatoid
Lupus Erythematosus, Systemic
Rheumatoid Arthritis
Study Phase
Phase 2
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Rituximab biosimilar (BioIntegrator)
Discontinued
Biointegrator
Arthritis, Rheumatoid
NCT Number
NCT03061838
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 1
Recruitment Status
Terminated
MK-8808
MK-8808
Discontinued
Merck & Co Inc
Arthritis, Rheumatoid, Lymphoma, Follicular
NCT Number
NCT01370694
NCT01390441
Intervention Type
Drug
Biological;Drug
Indications
Follicular Lymphoma
Rheumatoid Arthritis
Study Phase
Phase 1
Phase 1
Recruitment Status
Terminated
Terminated